The minor capsid proteins of the filamentous bacteriophage M13: characterization and regulation of synthesis by Simons, A.F.M.
il о 7-
THE MINOR CAPSID PROTEINS OF THE FILAMENTOUS 
BACTERIOPHAGE M13 
Characterization and Regulation of Synthesis 
A. F.M.SIMONS 

THE MINOR CAPSID PROTEINS OF THE FILAMENTOUS 
BACTERIOPHAGE M13 
Characterization and Regulation of Synthesis 
PROMOTOR : PROF DR. J G. G. SCHOENMAKERS 
CO-REFERENT· DR R.N.H KONINGS 
THE MINOR CAPSID PROTEINS OF THE FILAMENTOUS 
BACTERIOPHAGE M13 
Characterization and Regulation of Synthesis 
PROEFSCHRIFT 
TER VERKRIJGING VAN DE GRAAD VAN DOCTOR IN DE 
WISKUNDE EN NATUURWETENSCHAPPEN 
AAN DE KATHOLIEKE UNIVERSITEIT TE NIJMEGEN, 
OP GEZAG VAN DE RECTOR MAGNIFICUS, 
PROF DR Ρ G А В WIJDEVELD 
VOLGENS BESLUIT VAN HET COLLEGE VAN DEKANEN 
IN HET OPENBAAR TE VERDEDIGEN 
OP DONDERDAG 22 APRIL 1982 
DES NAMIDDAGS TE 2 UUR PRECIES 
door 
AUGUSTINUS FRANCISCUS MARIA SIMONS 
geboren te Tilburg 
И 
krips repro meppel 

aan mijn ouders 
voor Jeannette, 
Ward en Flip 
Part of the experimental work described m this thesis has 
already been published. 
CHAPTER II - Simons, G.F.M., Konings, R.N.H. and 
Schoenmakers, J.G.G. (1979). Identification 
of two new capsid proteins m bacteriophage 
M13. 
FEBS Lett. 106, 8-12. 
CHAPTER III - Simons, G.F.M., Konings, R.N.H. and 
Schoenmakers, J.G.G. (1981). Genes VI, VII and 
IX of phage M13 code for minor capsid 
proteins of the virion. 
Proc. Natl. Acad. Sci. USA /8, 4194-4198. 
- Simons, G.F.M., Beintema, J., Duisterwinkel, 
F.J., Konings, R.N.H. and Schoenmakers, 
J.G.G. (1981). Genes VI, VII and IX of 
bacteriophage M13: Identification of their 
products as minor capsid proteins. 
In: Bacteriophage Assembly (Dubow, M.S., ed.) 
pp. 401-411. Alan R. Liss, Inc., New York. 
CHAPTER IV - Simons, G.F.M., Veeneman, G.H., Konings, 
R.N.H., Van Boom, J.H. and Schoenmakers, 
J.G.G. (1982). Oligonucleotide-directed 
mutagenesis of gene IX of bacteriophage M13. 
Nucleic Acids Res. 11, in press. 
CONTENTS 
CHAPTER I Introduction 
CHAPTER II Identification of two new capsid 
proteins in bacteriophage M13 
31 
CHAPTER III Genes VI, VII and IX of phage M13 
code for minor capsid proteins of 
the virion 
47 
CHAPTER IV Oligonucleotide-directed mutagenesis 
of gene IX of bacteriophage M13 
67 
CHAPTER V Synthesis of the minor capsid 
proteins of phage M13 in Escherichia 
coli minicells 
85 
CHAPTER VI Expression of in vitro constructed 
recombinant plasmids carrying various 
parts of the gene V-VII-IX operon 
101 
CHAPTER VII Translational reinitiation events 
underlying the synthesis of the minor 
capsid proteins encoded by genes VI, 
VII and IX 
121 
SUMMARY 149 
SAMENVATTING 152 
DANKWOORD 156 
CURRICULUM VITAE 157 

CHAPTER I 
INTRODUCTION 
The single-stranded DNA phages fall into two general 
classes which are denoted 'filamentous' and 'icosahedral' 
on the basis of the shape of their représentants. In con-
trast to the icosahedral phages which follow the convent-
ional infection cycle of adsorption, reproduction and re-
lease of progeny particles accomplished by lysis of their 
host, the filamentous phages do not lyse nor kill their 
host cell. The infected cell continues to grow and to 
divide though at a slightly reduced rate while progeny 
virions are extruded through the host cell membrane in a 
continuous fashion. 
The filamentous phages which only can infect hschenclna 
аоіг cells carrying the F transmissable sex factor, in­
clude M13, fd, fl, ZJ/2, EC9, AE2 and 6A. Of these, the 
phages M13 fd and fl have been most intensively studied 
during the last decade in terms of DNA replication, tran­
scription and translation and recombination mechanisms as 
well. 
In this Introduction, only a brief review of the biol­
ogy and properties of the F-specific filamentous (Ff) 
phages will be presented. For a more extensive coverage, in 
particular with respect to the replication of these phages, 
the reader is referred to the Cold Spring Harbor monograph: 
'The Single-Stranded DNA Phages' (1). 
Infection cycle 
The Ff phages infect male E.coli cells by adsorption 
to the tip of the F-pilus (2). Subsequently, the viral DNA 
is transferred into the cell and rapidly replicated. In 
this replication process three major stages can be distin­
guished. In the first stage, the circular single-stranded 
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(ss) DNA is converted into a covalently closed, circular 
double-stranded replicative form DNA (RF) molecule. For 
this conversion only host functions are required (3-6). In 
the second stage, starting about one minute after infection, 
the RF molecule is replicated yielding up to 100 RF mole­
cules per cell (7). This replication occurs presumably by 
a rolling circle mechanism (8) and is, in addition to a 
number of host-encoded proteins, dependent on the phage 
specific polypeptide encoded by gene II (9,10). In the 
third stage, the RF replication process is switched over to 
the synthesis of new viral strands (RF ->• ss) . The trans­
ition from the second to the third stage is regulated by 
the amount (about 10 5 molecules/cell) of the DNA helix-
destabilizmg protein, encoded by gene V (11-13). 
Progeny single-stranded DNA molecules are released 
from the cell as filamentous particles by a still unknown 
morphogenetic process occurring within or at the host-cell 
membrane (14-16) . During this assembly process the capsid 
proteins become associated with the viral DNA as it is ex­
truded through the cell surface without killing the host-
cell. Up to 500 phage particles may be released per cell 
per generation. 
Structure of the virion 
The Ff virion has a long flexible rod-like structure 
with a length of 895 nm and a diameter of 6 nm (17,18). It 
consists of a single-stranded circular DNA molecule of 6407 
nucleotides for M13 (19) and fl (20) and 6408 nucleotides 
for fd (21) and encodes ten proteins (cf. Fig. 1). 
The viral DNA is encapsulated in a narrow cylindrical 
sheath, composed of 2700 copies of the major coat protein 
(B protein) encoded by gene VIII (22-25). These major cap­
sid protein molecules account for virtually all the protein 
mass of the virion. At the tips of the filament several 
minor capsid proteins designated А, С and D protein, are 
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situated. One tip contains five molecules of the A protein 
(product of gene III) (26-29) and five molecules of D pro­
tein (product of gene VI)(30-34, this thesis). At the op­
posite tip approximately 8-10 molecules of the С protein 
are situated (32,33, this thesis). С protein actually is 
a mixture of equimolar amounts of the products encoded by 
genes VII and IX (30,31,33,34,this thesis). 
Electron microscopy studies on the structure of Ff 
phages have revealed that the ends of the virion are dif­
ferent (35). Only at one end at least three 3 or 4 globular 
units (knobs) with a diameter of 6 nm are arranged. They 
are connected to the filament by a very thin stem of about 
7 nm in length. Each knob most probably consists of an A 
protein monomer (35). The stem is presumed to be a connect­
ing protein bridge, the composition of which has not yet 
been established. It is assumed that this cluster of pro-
teinaceous knob-on-a-stem units forms the adsorption com­
plex of the virion. At the other end of the virion, at 
which the С protein molecules are arranged, electron micros­
copy did not reveal any typical morphological structure. 
Analyses of the orientation of the single-stranded 
circular DNA molecule within the tubular coat have demonstr­
ated that the viral DNA region which codes for gene III-
protein is located at the end which contains the A and D 
proteins (36). The DNA region which is physically orient­
ated opposite gene III (of. Fig. 1) termed the intergenic 
region, is located at the other end of the virion contain­
ing the С protein molecules. Recent studies on chimeric 
phages of variable length have shown that the latter region 
and more precisely the DNA sequence which is located at the 
junction of gene IV, is always found at the С protein end 
(36). These data strongly suggest that this sequence near 
the junction of gene IV and the intergenic region and which 
has the capability of forming a stable stem-loop structure, 
plays an important role in the initiation of phage assembly. 
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A very interesting characteristic of the Ff virion is 
its great flexibility in size. Particles of variable 
lengths have been observed to be present in isolates of 
wild-type phages (37-39). These isolates contain on the 
average 2-3% dimer phages, 1% miniphages (0.2-0.6 χ normal 
length) and 0.1% midiphages (1.2-1.8 χ normal length)(40-
43). Generally, the length of the viral DNA in these ab­
normal phages corresponds to the size of the phage particle 
(44) . 
Due to the fact that there is little constraint on the 
size of the phage particle, the Ff phages have proven to 
be suitable cloning vehicles in recombinant DNA studies 
(45-55). Pieces of foreign DNA of up to two times the 
length of wild-type viral DNA have successfully been in­
serted in the intergenic region (cf. Fig. 1) of the Ff 
genome without destroying its viability. As a result, large 
amounts of foreign DNA can be isolated in the single-stranded 
form which can be used as a template for DNA sequencing 
using the dideoxy chain termination method (56). 
Genes and gene-produats 
A detailed analysis on the genetic content of the Ff 
genome was started by Pratt and co-workers (57,58). They 
isolated a large number of conditionally lethal mutants. On 
the basis of their complementation behaviour, these mutants 
were classified into eight complementation groups, being 
indicative for the number of biological functions directed 
by the viral genome. Recombination experiments with various 
amber mutants enabled Lyons and Zmder to determine the 
relative positions of a number of these complementation 
groups on the genetic map (59). They are indicated with 
Roman numerals I through VIII (of. Fig. 1). 
The accuracy of the genetic map increased considerably 
when defined DNA fragments could be isolated with the aid 
of restriction endonucleases. By application of marcer 
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rescue experiments between these DNA fragments and amber 
mutant viral DNA (60-63) and by гп vitro protein synthesis 
studies under direction of various DNA fragments (64), a 
precise alligment of the individual genes became possible. 
These studies revealed that between genes II and IV 
a large non-coding region of considerable length (ca. 500 
nucleotides) is located (63). Furthermore, a phage specific 
polypeptide could be detected called X-protein, which could 
not be assigned to any of the known genes (64). 
An exact localization of the individual genes became 
possible after the elucidation of the complete nucleotide 
sequence of the genome (19-21). Moreover, from the DNA 
nucleotide sequence data the existence of a new gene, de­
signated gene IX, could be postulated (21,65). Detailed 
studies on the protein composition of the Ff virion (30,31, 
33,34, this thesis) and the analysis of conditionally 
lethal mutants constructed by site-directed mutagenesis (66, 
this thesis), definitely have proven that gene IX forms an 
essential gene of the Ff phage. The position of the M13 
genes on the genetic map is shown in Fig. 1. 
With respect to the function of the different gene 
products, the genome can be divided into three gene clus­
ters. The first cluster encompasses genes II, X and V. The 
encoded polypeptides of genes II and V are involved in the 
replication of the Ff genome. Recently, a dense complex 
has been isolated from Ff infected bacteria under conditions 
where gene V-protem is inactive (67). The fact that this 
complex contains large amounts of gene II- and X-protein 
may be evidence that the X-protein is involved in DNA 
replication. The X-protem is contained entirely m , and 
translated in phase with gene II. The second cluster con­
sists of genes I and IV. The polypeptides encoded by these 
genes are required for virus assembly but their specific 
role has yet to be ascertained. These two gene clusters are 
separated by a third cluster consisting of the contiguous 
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Figure 1 : Circu lar genet ic map of bacteriophage M13. The 
Roman numerals represent the M13 genes. The d i r e c t i o n of 
t r a n s c r i p t i o n i s counterclockwise around the genet ic map. 
The p o s i t i o n s of the in vitro G-promoters, the A-promoters 
and the promoter in front of gene I I I (Xo.25' a r e indicated 
with black bars. The position of the central rho-independent 
terminator is as indicated. IG refers to the intergenic 
region in which the replication origins for both the viral 
and complementary strand are located. The single site at 
which M13 RF is cleaved with restriction enzyme ЯгпаІІ is 
indicated. 
genes VII, IX, VIII, I I I and VI. The products of a l l these 
genes are present in the mature virion. A salient feature 
of the capsid proteins encoded by genes VIII and III is 
that these polypeptides are synthesized in a precursor form 
(68,69). Prior to packaging 23 and 18 amino acids are 
cleaved off at the amino terminal end of gene VIII- and 
gene I l l-protein, respectively. The capsid proteins en­
coded by genes VI, VII and IX, however, are not subject 
to proteolytic processing but are assembled into mature 
virions as their primary translational products. 
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The s i z e s and t h e m o l e c u l a r weights of t h e M13 gene 
p r o d u c t s , as deduced from t h e n u c l e o t i d e sequence, and 
t h e i r p h y s i o l o g i c a l r o l e a r e summarized in Table I . 
Table I : Genes and gene p r o d u c t s of b a c t e r i o p h a g e M13. 
Ammo M o l e c u l a r 
Gene a c i d s w e i g h t P h y s i o l o g i c a l r o l e 
I 
II 
III 
IV 
V 
VI 
VII 
VIII 
IX 
X 
348 
410 
406 
(424) 
426 
87 
112 
33 
50 
(73) 
32 
111 
39,500 
46,117 
42,675 
(44,748)" 
45,791 
9666 
12,264 
3587 
5234 
(7622)" 
3654 
12,670 
morphogenesis 
DNA replication 
endonuclease/topoisomerase 
minor coat protein/ 
adsorption complex 
morphogenesis 
DNA replication 
helix-destabilizing protein 
minor coat protein 
minor coat protein 
ma]or coat protein 
minor coat protein 
DNA replication? 
χ These values r e p r e s e n t the molecular weights of the precursor 
polypept ides . 
GENE EXPRESSION 
Regulated synthesis of gene products 
During i n f e c t i o n of male E.coli c e l l s wi th Ff phages 
no s h u t - o f f of t h e s y n t h e s i s of h o s t - s p e c i f i c RNA and p r o ­
t e i n o c c u r s . T h e r e f o r e i d e n t i f i c a t i o n of phage s p e c i f i c 
p r o d u c t s i s l i m i t e d t o t h e p r o t e i n s which a r e s y n t h e s i z e d 
d u r i n g t h e i n f e c t i o n c y c l e in very l a r g e amounts i.e. t h e 
p r o t e i n s encoded by genes V and VIII ( 1 4 , 7 0 ) . Gene V-
p r o t e i n has been e s t i m a t e d t o be p r e s e n t in a t l e a s t 10 5 
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copies per cell (71) while per cell generation about 106 
copies of the protein encoded by gene VIII are made. The 
other phage-specific products are synthesized in relatively 
small amounts and can only be detected by applying tech-
niques which suppress the synthesis of host-encoded pro-
teins . 
The enormous divergency m the synthesis of the dif-
ferent gene products already is reflected in part in the 
transcription and translation process of the circular Ff 
genome. 
Trans cripti on 
In vitro transcription studies have learned us that all 
Ff genes are preceded by a promoter with the exception of 
gene VIII, the promoter of which is located in front of its 
proximal gene IX and gene VII which is not equipped with a 
promoter at all (62,72-75). The in vitro transcripts formed 
which have been initiated at these promoter sites all ter-
minate at the central rho independent termination signal, 
which is located immediately after gene VIII (76-79). As a 
result of such a cascade transcription process the region 
preceding the central terminator which comprises genes V 
and VIII, is transcribed most frequently. 
Furthermore, it has been noted that most of the so-
called 'G-start' promoters have a higher affinity for RNA 
polymerase holoenzyme than the 'A-start' promoters (73,80) 
and that they cluster m the vicinity of the genes the 
products of which are required in largest amounts (cf. Fig. 
1). The in vitro 'A-start' promoters are located m front 
of the genes VI, I and IV all of which are expressed at a 
low level in vivo. 
The overall picture obtained from these in vitro tran-
scription studies suggests that the divergency in expres-
sion of the individual Ff genes is largely determined by 
the location and strengths of the promoters and by the 
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location of the single vhoindependent terminator. 
During the last few years, however, several studies 
have demonstrated that the in υίυο situation is different 
and more complex than one would expect on the basis of this 
multi-promoter single-terminator transcription model. 
Studies on the occurrence of phage specific mRNAs in 
the infected cell (81) as well as molecular cloning of the 
in vitro promoters into a promoter probe plasmid and sub­
sequent studies on their function (82) have shown that only 
six of the nine RNA initiation sites detected in vitro are 
also functional in the infected cell. In addition, the 
occurrence of two other termination signals has been 
demonstrated (81). One of these signals is located within 
gene I and the other in the DNA region which is located 
immediately after gene IV. These findings indicate that the 
region encompassing the genes III to IV does not follow the 
in vitro cascade mechanism of transcription. 
In the infected cell several other mRNA species have 
been identified which are not primary transcripts but arise 
as a result of RNA processing events (81,83,84). The vast 
majority of these secondary transcripts are formed from 
RNA products transcribed from the DNA region encompassing 
genes II through VIII. 
From these data it is evident that the transcription 
process m the infected cell is only partly covered by the 
cascade mechanism of transcription and that additional 
regulatory signals such as rho dependent (?) termination 
sites and RNA processing sites undoubtedly contribute to 
the final diversity of gene expression in vivo. 
Translation 
Most of our knowledge concerning the synthesis of the 
phage-specific proteins is derived from in vitro translation 
studies using replicative form DNA (RF) from wild-type and 
amber mutant phages or its RNA transcripts as a template. 
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In an in vitro coupled transcription-translation system Ff 
RF directs the synthesis of substantial amounts of the pro­
teins encoded by genes IV, V, VIII and X (68,85). Further­
more, low but detectable amounts of the polypeptides en­
coded by genes I, II and III can be observed whereas recent­
ly also the in vitro synthesis of gene IX-protein has been 
demonstrated (66, this thesis). Despite many efforts the 
products of genes VI and VII have not yet been detected 
in vitro . 
The divergency in gene expression, as observed in such 
in vitro studies, is also apparent in the infected E. coli 
cell. Generally, among the total population of Έ. coli and 
phage proteins, the proteins of genes V and VIII are easily 
recognized whereas the polypeptides encoded by genes II, 
III and IV have only been traced after infection of UV-
irradiated £. coli cells. 
Albeit it is assumed that the observed differences in 
the frequency of transcription of the various M13 genes 
and the differences in the biological half-life time of the 
primary and secondary transcripts are largely determining 
the overall pattern of phage-specific proteins m the in­
fected cell, additional observations suggest that several, 
more subtile regulations are operating during the trans­
lation of the phage-specific mRNAs: 
1. Binding studies between in vitro synthesized RNA and 
purified E.coli have shown that only the ribosome binding 
sites of genes IV, V and VIII are capable of forming 
nuclease resistant ribosome-protected regions (86,87). 
2. If RNA transcribed in vitro from Ff RF is translated in 
an uncoupled cell-free system, the synthesis of gene II-
protem and gene X-protein is, with respect to the syn­
thesis of gene V- or gene VHI-protein, less pronounced 
(88). Most probably, the ribosome binding sites of the 
mRNA species which code for gene II- or gene X-protem 
are less accessible to nbosomes than the growing RNA 
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chains synthesized in a coupled transcription-translation 
system. 
3. Though recent studies by Smits et al.(89) have shown that 
m the infected cell both gene III as well as its con-
tiguous gene VI are transcribed via a mRNA species 
which is initiated at the Xn -c- promoter, synthesis of 
gene Ill-protem can easily be detected in vitro and in 
vivo while gene VI-protein cannot be visualized. 
4. A single RNA transcript carrying the information of 
genes V, VII, IX and VIII, when translated m a RNA-
dependent cell-free system gives rise to high levels of 
gene V- and gene Vlll-protein whereas the products of 
gene VII and gene IX can hardly be detected (81). 
In this thesis special attention has been paid to the 
mechanism(s) underlying the regulation of synthesis of the 
minor capsid proteins encoded by genes VI, VII and IX. Al-
though the observations cited above argue for a regulating 
principle at the level of translation for these genes, it 
is by no means clear which mechanism is involved and how 
this regulation is accomplished at the molecular level. 
Detailed studies on other translational systems have 
evidenced that the efficiency of translation of various 
messenger RNAs is determined at various levels of which 
recognition, secondary structures and RNA-protein inter-
actions are the most predominant. The following examples 
are only indicative and by no means complete. 
Strength (rate of use) of a vibosome binding site 
A basic step in the process of translational initi-
ation is the selection of initiation regions. With the aid 
of in vitro translation studies with E.ooli nbosomes and RNA 
obtained from the RNA coliphages (MS2, R17, Qß), it has 
been demonstrated that cistron selection is an intrinsic 
property of the 30S nbosomal particle (90-92). 30S part-
icles bind to the initiation region via base pairing 
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between the 3'-end of 16S rRNA and a region on the mRNA at 
the 5'-end of the initiation codon which is generally known 
as the 'Shine and Dalgarno domain' (93). Although the data 
are still ambiguous, it furthermore has been shown that a 30S 
mRNA·binary complex can enter the ribosome cycle even in 
the presence of several inhibitors of translational initi-
ation and that an oligonucleotide complementary to the 3'-
end of 16S rRNA cannot displace mRNA in a binary complex 
that was preformed (94-96). Formation of complexes was in-
hibited, however, if the oligonucleotide was added before 
or simultaneously with the mRNA. 
Due to the rapid accumulation of RNA and DNA sequencing 
data, the nucleotide sequences of over one hundred trans-
lational initiation regions are known (97). They all share 
an initiation codon (AUG or GUG), a Shine and Dalgarno 
sequence and an appropriate spacing between these two. The 
complementarity with the 3'-end of 16S rRNA can be as short 
as 3 or as long as 9 residues,- the average is 4.8. The 
average spacing is 7 nucleotides; spacings less than 5 or 
longer than 9 nucleotides are rare. 
Mutations in either the initiation codon (98,99) or 
the Shine and Dalgarno domain (98,100) or variations in 
spacing (101) can reduce or even abolish translation of the 
affected cistron, suggesting that these three elements 
determine the efficiency by which a mRNA species is trans-
lated. 
There are, however, several observations which argue 
against these criteria. For instance, the 5'-end of the Xcl 
mRNA starts with an AUG codon (102). It has been demonstr-
ated that this AUG functions as the translational initi-
ation codon, suggesting that ribosome recognition and bin-
ding is also influenced by other elements of the mRNA. 
Generally, it is assumed that the strength (rate of 
use) of a ribosome binding site is not determined solely 
by a Shine and Dalgarno sequence which preceeds 
-20-
the initiation codon by a proper spacing. The latter se­
quence undoubtedly will contribute to nbosome recognition 
but other yet unknown elements are also involved. 
Seoondary structures 
The importance of mRNA secondary structures in trans-
lational initiation was first evidenced by the clover leaf 
model for bacteriophage MS2 RNA (103). Only the coat pro­
tein initiator region can bind nbosomes. The initiator 
regions of the A protein gene and replicase gene are nor­
mally masked in the intact viral RNA molecule. They become 
accessible only after partial unfolding of base paired 
regions. 
Another example is provided by the expression of the 
λ aro gene protein (104). Roberts et al. have constructed 
a set of recombinant plasmids which contain the complete 
aro gene sequence at various distances downstream from the 
laa promoter. The transcripts formed all share the same 5'-
end but have different leader sequences preceding the ini­
tiator region of the ero gene. Even though the differences 
in leader sequence occur more than 15 nucleotides 5' to 
the Shine and Dalgarno region, a 20 fold difference in the 
amount of aro protein expression was observed. Substantial­
ly different RNA secondary structures in which the initi­
ator region is involved can explain nearly all the observed 
differences in aro gene expression (105). 
Translational repression 
Elements which determine the translational yield from 
specific transcripts are regulatory molecules which can 
repress (or activate) translation. An example of trans­
lational repression is provided by the bacteriophage T4 
gene 32 protein. This protein binds to single-stranded DNA 
(106). It has been demonstrated that T4 gene 32 protein 
represses its own translation in vivo and in vitro (107,108) . 
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Recent DNA sequence analysis of the gene 32 initiation 
region has revealed that the mRNA contains a rather stun-
ning unstructured sequence of A and U residues. Most prob-
ably this sequence is bound by gene 32 protein during 
autogenous, translational repression. 
Translational repression is also apparent during the 
expression of the replicase gene of bacteriophage MS2 and 
R17 (109). Once the infection cycle is well under way and 
no more replicase enzyme is needed, its further synthesis 
is shut-off by the phage coat protein. This repression is 
abolished when cells are infected with a non-polar amber 
mutant in the coat protein gene. In vitro binding studies 
have demonstrated that the coat protein interacts with a 
hairpin structure, which contains the initiation AUG codon 
and the Shine and Dalgarno domain of the replicase gene 
(110,111). As a result, unfolding of the hairpin is greatly 
decreased and expression of the replicase cistron is pre-
vented . 
Another example of translational control by specific 
repressors is given by the T4 reg A protein gene (112). 
Mutations in this gene lead to an overproduction of a small 
number of polypeptides which normally are synthesized only 
during the early stages of phage development. The mechanism 
by which phage T4 reg h protein represses translation of 
several early mRNAs is not completely understood. It is 
proposed that this protein initiates mRNA breakdown and 
that it acts as a message-specific nbonuclease. However, 
the possibility that the regA protein is a regulatory pro-
tein which recognizes and binds to a specific sequence of 
several early T4 mRNAs cannot be excluded. 
Translational reinitiation 
A mechanism which underscores the importance of RNA· 
RNA interactions in the initiation process is translational 
reinitiation. Evidence for the existence of such a regula-
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tory mechanism was first provided by studies on the expres-
sion of the trp operon (113). The first two genes (trpE and 
trpD) of this operon are expressed via a polycistronic mRNA 
and their gene products are synthesized in equimolar 
amounts. Although the initiation domains of genes E and D 
show about equal complementarity to the Shine and Dalgarno 
sequence, ribosomes are not able to bind and to start 
initiation of translation at the beginning of the trpO 
message. Instead, translation of the trpD cistron is achiev-
ed by a translational reinitiation event at the end of the 
trpE message. Ribosomes remain, after termination, trans-
iently attached to the polycistronic mRNA and are capable 
of shifting their reading frame and to start translation 
of the next cistron. 
During the course of our study the mechansim of trans-
lational reinitiation also has been found to be operative 
during the expression of the bacteriophage T4 rllB cistron 
(114) and the lysis gene of bacteriophage MS2 (115).Several 
restarts have been analysed at the nucleotide level but the 
features which transform a sequence into a potential re-
initiation site are not yet fully understood. 
In the following chapters, first the results will be 
given or our studies on the genetic origin of the minor 
capsid proteins of the filamentous bacteriophage M13 and 
their location and possible function in the phage architect-
ure and second, the results will be given of our efforts 
to gain a better understanding of the regulatory principle 
underlying the synthesis of these minor capsid proteins. 
Evidence will be presented that regulation of synthesis of 
the minor capsid proteins is mainly accomplished at the 
level of translational reinitiation. 
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CHAPTER I I 
IDENTIFICATION OF TWO NEW CAPSID PROTEINS IN BACTERIOPHAGE MIZ 
ABSTRACT 
The protein components of mature M13 phage particles 
have been studied by differential ammo acid labeling and 
electrophoretic analyses. Our data demonstrate that besides 
the major capsid protein В (encoded by gene VIII) and the 
minor capsid protein A (encoded by gene III) two other 
structural protein components are present within the M13 
virion. These polypeptides, designated С and D protein, 
have molecular weights of about 3500 and 11,500. Radio­
active amino acid analyses of these structural components 
suggest that the smallest capsid protein is not a single 
component but most probably is composed of two proteins of 
which one is specified by gene VII and the other by a newly 
discovered gene (gene IX) which is located between genes 
VII and VIII. At least part of the larger component is en­
coded by gene VI. 
INTRODUCTION 
M13 is a male-specific filamentous coliphage, closely 
related to phage fd and fl (for a review, see ref. 1,2). 
The virion is composed of a circular single-stranded DNA 
(M 2xl06) encapsulated in a tubular protein coat of about 
895 nm long and 6 nm wide. Up to now it generally has been 
assumed that the virion coat is composed of a major and 
minor coat protein. The major coat protein (B protein, M 
5200), encoded by gene VIII, is present in about 2700 
copies and accounts for virtually all the protein mass of 
the virion coat. The minor coat protein (A protein, M 
42,600), which is encoded by gene III, is only present in 
4-5 copies and is located at one end of the filament (3,4). 
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The DNA of bacteriophage M13 contains at least eight 
genes which have been ordered into a genetic map (5,6). By 
using a DNA dependent in vitro protein synthesizing system 
six of the eight gene products have been identified (7,8). 
The products of gene VI and gene VII, however, have not yet 
been identified either in vivo or in vitro. Elucidation of 
the M13 DNA sequence (9,10) has made clear that the trans­
lation products of these genes are 112 and 33 amino acids 
long. The DNA sequence further demonstrated that the region 
between genes VII and VII could theoretically comprise 
another gene (gene IX) with a coding function of 32 amino 
acids. Up to now there is no direct evidence that this 
gene IX really exists. 
In the last ten years several reports have been pu­
blished (3,4,11) which suggest that the filamentous phages 
still contain an additional protein component. To find out 
whether this protein indeed is a structural component of 
the virion, we have examined the protein composition of M13 
phage particles in more detail. 
In this paper we demonstrate that the M13 virion con­
tains besides the gene III-and gene VHI-encoded products 
not one but at least two additional structural components. 
These components, designated С and D protein, have apparent 
molecular weights of 3500 and 11,500. Furthermore, data 
will be presented which suggest that D protein is composed 
of the polypeptide encoded by gene VI whereas С protein 
actually is a mixture of two small polypeptides of which 
one is specified by gene VII and the other by the above 
mentioned gene IX. 
MATERIALS AND METHODS 
Materials 
All materials were of reagent grade and were purchased 
from sources given previously (12). The 3H-labeled amino 
acids arginine and histidine were from New England Nuclear . 
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All other radioactive amino acids were from Radiochemical 
Center, Amersham. In all cases the radioactive compounds 
with the highest available specific activity were used. 
Growth and purification of radioactive phages 
To prepare 3H-labeled phages, E.coli K38 was grown in 
M9 minimal medium (13) supplemented with glucose (20 mM) 
and the common 20 amino acids (1 mM) minus the amino acid 
used for labeling. At a density of IxlO8 cells/ml the 
culture was infected with M13 phages (multiplicity of in­
fection of 20) and at 15, 30, 45 and 60 m m after infection 
2.5 pCi/ml of 3H-amino acid was added as described by 
Makino et al. (14). After 90 min of infection the cells were 
spun down and the virus was precipitated from the superna­
tant as described by Yamamoto et al. (15). The recovered 
phages were resuspended in 15 ml of 0.01 M Tns-HCl (pH 
7.6), 1 mM EDTA, 0.1% Sarkosyl and kept at room temperature 
for 30 min. After reprecipitation of the phages with 5% 
polyethylene glycol 6000 and 0.5 M NaCl for 2 h at 40C, 
they were resuspended in 9 ml of STE-buffer (0.1 M NaCl, 
0.01 M Tns-HCl (pH 7.6), 1 mM EDTA). The phages were 
further purified by CsCl-density gradient centrifugation 
for 20 h at 150C at 42,000 rpm in an IEC-B60 rotor. The 
fractions of the gradient containing the radioactive phages 
were collected, dialysed against STE-buffer and the phages 
were pelleted for 4 h at 58,000 rpm in an IEC-SB60 rotor 
and finally resuspended in a small volume of STE-buffer. 
Labeling with a ^C-amino acid mixture was carried 
out in 25 ml cultures of E.coli K38 grown in M9 minimal 
medium supplemented with 20 mM glucose but no amino acids 
added. At a density of 1x10й cells/ml, M13 phages were 
added (2xl09/ml) followed at 30,60,90 and 120 m m after 
infection by the addition of one-fourth part of 150 yCi of 
i'+C-algal hydrolysate supplemented with 10 yCi each offici 
methionine, histidine, asparagine and glutamine (16). After 
5 h of infection the cells were spun down and further used 
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for the isolation of ^C-labeled gene V protein. The phages 
were recovered from the supernatant and further purified as 
described. 
Polyaarylamide gel eleotrophoreais and recovery of phage proteins 
Fractionation of M13 capsid proteins was performed on 
Polyacrylamide slab gels (14 cm χ 12 cm χ 0.12 cm) contain­
ing 15% acrylamide, 0.4% bisacrylamide, 8 M urea and 0.1% 
NaDodSÛ!, in 0.5 M Tris-HCl (pH 8.9). The running buffer was 
6 M urea, 77 mM glycine, 10 mM Tris-HCl (pH 8.9) and 0.1% 
NaDodSOi,. Prior to electrophoresis, samples of M13 phages 
were diluted with cracking buffer (8 M urea, 0.0625 M Tris-
HCl (pH 6.8), 2% NaDodSO^, 5% 2-mercaptoethanol, 10% gly-
cerol and 0.001% bromphenol blue) and heated for 5 min at 
100 C. After electrophoresis for 5 h at 200 volt, the gels 
containing ^H-labeled samples were fixed in 15% trichloro-
acetic acid and the radioactive bands were visualized by 
means of fluorography (17). Gels containing ^C-labeled 
material were fixed and stained with Coomassie brilliant 
blue R (0.1%), destained, dried and autoradiographed (12). 
Electrophoretic elution of radioactive proteins from 
gelsegments was performed in 2 ml of 25 mM Tris, 192 mM 
glycine, 0.1% NaDodSOi, and 0.5% 2-mercaptoethanol in the 
presence of 200 ug of bovine serum albumin using an ISCO-
Sample concentrator. After dialysis of the eluate, the 
proteins were precipitated, washed and lyophilized according 
to Shaw et al. (16). 
Isolation of 1цС-1аЬе1еа gene V protein was performed 
essentially as described by Garssen et al. (18). The radio­
active protein was further purified by electrophoresis on 
Polyacrylamide gels as described. 
Radioactive amino acid analysis 
Radioactive protein samples were hydrolysed with 6 N 
HCl in sealed evacuated tubes for 22 h at 110 С and analysed 
on a Rank-Hilger Chromaspek amino acid analyser. Fractions 
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were collected every 30 sec and their radioactivity was 
determined in 3 ml of Rialuma (Baker) using a Packard 
scintillation spectrometer. Throughout the pH gradient, the 
counting efficiences of the eluted fractions remained 
essentially the same. 
RESULTS 
Electrophoretic analysis of M13 aapsid proteins on Polyacrylamide gels 
E l e c t r o p h o r e t i c f r a c t i o n a t i o n of t h e p r o t e i n s p r e s e n t 
in p u r i f i e d M13 phages , fol lowed by s t a i n i n g t h e P o l y ­
acry lamide g e l wi th Coomassie b r i l l i a n t b lue R, r e v e a l e d as 
expected, t h e p r e s e n c e of t h e major (B) and minor (A) 
c a p s i d p r o t e i n s ( F i g . l a ) . The s t a i n i n g i n t e n s i t i e s r e f l e c t 
t h e i r r e l a t i v e amounts in t h e M13 v i r i o n . In c a s e , t h e 
e l e c t r o p h o r e t i c a n a l y s i s was performed wi th ' ' ' C - l a b e l e d M13 
phages and t h e e l e c t r o p h e r o g r a m was exposed t o X-ray f i lm, 
t h e p r e s e n c e w i t h i n t h e v i r i o n of two a d d i t i o n a l p o l y p e p ­
t i d e s became a p p a r e n t ( F i g . l b ) . These p o l y p e p t i d e s d e s i g ­
nated С and D p r o t e i n , have m o l e c u l a r w e i g h t s of about 3500 
and 11,500. Repeated CsCl d e n s i t y g r a d i e n t and/or s u c r o s e 
g r a d i e n t c e n t r i f u g a t i o n of 1 L t C - l a b e l e d M13 phages d i d not 
change t h e e l e c t r o p h o r e t i c p a t t e r n of t h e s e p r o t e i n s . On 
t h e b a s i s of t h e s e d a t a , we conclude t h a t t h e s e p o l y p e p ­
t i d e s a r e not i m p u r i t i e s c o n t r i b u t e d by t h e h o s t c e l l b u t 
r e p r e s e n t s t r u c t u r a l components of t h e v i r i o n . 
To c h a r a c t e r i z e t h e s e p o l y p e p t i d e s and t o d e t e r m i n e 
t h e i r g e n e t i c o r i g i n we have a t t e m p t e d t o i s o l a t e t h e s e 
p r o t e i n s on a p r e p a r a t i v e s c a l e by c o n v e n t i o n a l i o n - e x ­
change and e x c l u s i o n c h r o m a t o g r a p h i c p r o c e d u r e s . Mainly 
because of t h e g r e a t abundancy of gene VIII p r o t e i n as 
x In a later stage of our investigations we observed that С and D 
protein also can be visualized on the electropherogram by the 
highly sensitive silver staining technique developed by Switzer 
et al. (19,20). This silver stain i s about 100 times more sensitive 
than the conventional Coomassie blue staining procedure and i t s 
sensit ivity i s comparable to radioautography of radioactively 
labeled proteins. 
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Figure 1 : E l e c t r o p h o r e t i c ana lys i s of the p r o t e i n s present 
in M13 v i r i o n s . 
Conditions for e l e c t r o p h o r e s i s and autoradiography are des­
cribed in Mater ia l s and Methods. 
( a ) . M13 capsid p r o t e i n s s t a i n e d with Coomassie b r i l l i a n t b l u e . 
(b) . Autoradiograph of ^ C - l a b e l e d M13 capsid p r o t e i n s . 
( c ) . [ З н ] h i s t i d i n e labeled capsid p r o t e i n s . 
(d) . [^н] a rg in ine labeled capsid p r o t e i n s . 
(e) . Pur i f i ed [-^ н] leucine labeled gene VIII p r o t e i n . 
A and В denote the mature p r o t e i n s encoded by gene I I I and 
gene V I I I . 
c o m p a r e d t o С and D p r o t e i n , t h e i r s m a l l d i f f e r e n c e s i n 
m o l e c u l a r w e i g h t s and t h e t e n d e n c y of t h e p h a g e s t r u c t u r a l 
p r o t e i n s t o a g g r e g a t e e v e n u n d e r s t r o n g d e n a t u r i n g c o n d i ­
t i o n s , t h e s e a t t e m p t s , h o w e v e r , h a v e b e e n u n s u c c e s s f u l . F o r 
t h i s r e a s o n a p r e l i m i n a r y c h a r a c t e r i z a t i o n of t h e s e p r o ­
t e i n s was made on t h e b a s i s o f t h e i r c a p a b i l i t y t o i n c o r ­
p o r a t e [ 3 H ] h i s t i d i n e and [ 3 H] a r g i n i n e ( F i g . l e and l d ) . 
To p r o v e t h a t t h e r a d i o a c t i v e l a b e l i n g of t h e p r o ­
t e i n s was s o l e l y d u e t o i n c o r p o r a t i o n o f t h e 3 H - a m i n o a c i d 
o r i g i n a l l y a d d e d t o t h e g r o w i n g c u l t u r e a n d n o t by a m e t a ­
b o l i s e d p r o d u c t , t h e r a d i o a c t i v e p r o t e i n h y d r o l y s a t e s w e r e 
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analysed by thin-layer chromatography (21). In each case a 
single spot was observed on the autoradiogram which could 
not be discriminated from the radioactive precursor used to 
label the virion proteins (data not shown). 
Based on the incorporation data, several possibilities 
for the genetic origin of these proteins can already be ex­
cluded. It is well known that the gene III- and gene VIII-
encoded capsid proteins are synthesized m the infected 
cell in a precursor form (7,22). Prior to packaging of 
these proteins into mature virions, 18 amino terminal amino 
acid residues of the gene Ill-encoded precursor are cleaved 
off at the host cell membrane, whereas the gene VIII-pro­
tein precursor is deprived from its leader peptide consti­
tuting 23 amino acid residues. From the nucleotide sequence 
of M13 DNA we know that both precursor parts lack arginine, 
while histidine is only present in the precursor part of 
gene Ill-protein (9,10). These data, therefore, rule out 
the possibility that С protein is one of these amino 
terminal cleavage products and that D protein m some way 
is derived from the ammo terminal end of the gene III-pro-
t e m precursor. Gene VHI-protem lacks histidine but also 
arginine (see Fig. 1c and Id)(23). Since С and D protein 
can be labeled with[3Hlarginine (Fig. Id), it also can be 
excluded that С protein is a degradation product of gene 
VHI-protein and that D protein, for instance, represents a 
dimer of this major capsid protein. 
To establish a gene-product relationship for these two 
newly discovered capsid proteins, we inspected the entire 
nucleotide sequence of the M13 genome for possible coding 
regions which irrespective of the reading frame chosen, 
could agree with our amino acid incorporation data and 
apparent molecular weights of these proteins. As far as С 
protein is concerned two regions were found which approx­
imated the above requirements, namely gene VII (its encoded 
product is 33 amino acids long and lacks histidine) and the 
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DNA region of 94 nucleotides between genes VII and VIII, 
the coding function of which never has been established so 
far by genetic or biochemical data and which therefore is 
designated the hypothetical gene IX (10,24). Both the pro­
ducts of gene VII and gene IX lack histidine but contain 
arginine. With respect to D protein a good candidate would 
be the product of gene VI. This product does not contain 
histidine and has, as deduced from the M13 DNA nucleotide 
sequence (10,25), a molecular weight of 12,260. 
Radioactive amino aoid analysis 
To find out whether the newly discovered minor capsid 
proteins С and D indeed originate from gene VII or IX and 
VI, as suggested from our amino acid labeling experiments, 
we have carried out radioactive amino analysis of uniformly 
^C-labeled С and D protein and of uniformly ^'C-labeled 
gene ν-,νΐΙΙ-and Ill-protein. 
Radioactive С and D protein as well as the mature gene 
III-and gene VHI-protein were isolated from uniformly R e ­
labeled phages by preparative electrophoresis on Polyacryl­
amide slab gels containing 8 M urea and 0.1% NaDodSO^. 
Uniformly 1 ''C-labeled gene V-protein was isolated from the 
corresponding M13 phage-mfected cells by the procedure 
described by Garssen et al. (18). Each protein was subjected 
to amino acid analysis. As the ammo acid sequences of the 
latter three proteins are known (23,25,26), the exact 
number of each 1¿HC-amino acid residue in С and D protein 
can be calculated using these proteins as external 
standards. 
Our analysis data of С protein, presented in Table I, 
show that its three independently determined amino acid 
compositions are in very good agreement with each other. 
It is also evident that the number of amino acid residues 
estimated for С protein did not correspond with the numbers 
calculated for either one of the proteins encoded by gene 
VII or gene IX. For several amino acids intermediate 
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Table I• Amino Acid Composition of С protein 
Amino Acid Number of Residues 
a b c IX-p d V I I - p d 
Aspartic acid 
Threonine 
Serine 
Glutamic acid 
Proline 
Glycine 
Alanine 
Cysteine 
Valine 
Methionine 
Isoleucme 
Leucine 
Tyrosine 
Phenylalanine 
Histidine 
Tryptophan 
Lysine 
Arginine 
0.4 
2.3 
3.0 
1.6 
0.1 
2.1 
3.0 
_f 
4.6 
1.7 
2.3 
3.8 
1.8 
2.6 
0.1 
_g 
0.3 
1.3 
0.5 
2.2 
3.3 
1.9 
0.1 
2.4 
2.6 
_f 
4. 1 
1.6 
2.5 
2.9 
1.9 
2.3 
e 
_g 
0.3 
_e 
0.5 
2.4 
3.1 
2.1 
0.1 
2.5 
2.2 
_f 
3.2 
1.9 
2.1 
3.0 
2.0 
3.3 
0.1 
_g 
0.2 
1.7 
0 
3 
6 
1 
0 
2 
1 
1 
3 
2 
1 
4 
2 
3 
0 
1 
0 
2 
2 
1 
1 
5 
0 
3 
4 
1 
3 
2 
5 
2 
1 
2 
0 
0 
0 
1 
a,b,c. These columns represent the independently determined 
amino acid compositions of С protein with uniformly 
l^C-labeled gene V-, VIII-and Ill-protein, respectively, 
as external standards. 
d. This number of residues is deduced from the 
nucleotide sequence of the M13 genes IX and VII. 
e. Residues are absent in gene VHI-protein. 
f. Not determined. 
g. Not determined because of destruction after acid 
hydrolysis. 
-39-
Table II : Amino Acid Composition of D protein 
Amino Acid Number of Residues 
a b c VI-p' 
Aspartic acid 
Threonine 
Serine 
Glutamic acid 
Proline 
Glycine 
Alanine 
Cysteine 
Valine 
Methi опте 
Isoleucine 
Leucine 
Tyrosine 
Phenylalanine 
Histidine 
Tryptophan 
Lysine 
Arginine 
4.9 
4.4 
6.7 
4.7 
3.Θ 
8.1 
15.2 
e 
12.2 
1.7 
9.7 
16.2 
4.5 
9.4 
0.1 
_g 
7.9 
0.5 
5.9 
4.3 
7.5 
5.4 
3.6 
9.0 
14.6 
e 
11.0 
1.6 
10.9 
12.6 
5.0 
θ.5 
_f 
_g 
9.1 
_f 
6.5 
4.6 
7.1 
5.9 
4.5 
9.3 
11.3 
e 
8.4 
1.8 
8.6 
12.8 
5.2 
12.0 
0.1 
_g 
10.1 
0.6 
7 
2 
8 
4 
5 
8 
7 
1 
9 
1 
13 
24 
4 
10 
0 
1 
7 
1 
a,b,c. These columns represent the independently determined 
amino acid compositions of D protein with uniformly 
l^c-labeled gene V-, VIII-and Ill-protein, respectively, 
as external standards. 
d. This number of residues is deduced from the nucleotide 
sequence of the M13 gene VI. 
e. Not determined. 
f. Residues are absent in gene VHI-protein. 
g. Not determined because of destruction after acid 
hydrolysis. 
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figures were found e.g. threonine, serine, alanine, iso-
leucme and leucine. On the other hand, it is also clear 
that С protein not only lacks histidme but also proline 
and lysine. As these amino acids are also absent in both 
gene VII and IX protein, we favour the hypothesis that С 
protein is a mixture of both the polypeptides encoded by 
gene VII and gene IX. 
Similar to the a m m o acid analysis of С protein, the 
analysis data of D protein, presented in Table II, did not 
allow us to establish unambiguously a gene-product relation­
ship for this polypeptide. Nevertheless, it is remarkable 
that the amino acid composition estimated has several 
characteristics in common with the deduced ammo acid 
composition of gene VI protein e.g. the absence of histi-
dine, a low percentage of methionine and arginine residues 
and a relatively high amount of leucine, phenylalanine and 
isoleucine residues. 
DISCUSSION 
On the basis of labeling with histidme and arginine 
and subsequent electrophoretic analysis we have demonstra­
ted in this report that besides the products encoded by 
genes III and VIII, two additional protein components, 
named С and D protein, are present in M13 phage particles. 
Our ammo acid analysis data further suggest but do not 
proof that С protein is composed of the products encoded by 
genes VII and IX and that gene VI protein is a good 
candidate for D protein. 
A serious obstacle in our efforts to determine un­
ambiguously the genetic origin of these minor capsid pro­
teins has been the tendency of the structural phage com­
ponents, particularly the major capsid protein, to aggre­
gate even under strong denaturing conditions. This and the 
very low amounts of С and D protein in M13 virions, has 
made various standard isolation and characterization 
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procedures unsuccessful. Quantitative separation of the 
phage components could only be achieved by Polyacrylamide 
gel electrophoretic methods in the presence of 8 M urea and 
NaDodSO4 provided the load of protein was kept low. As a 
consequence of this limitation we have chosen for the 
method of radioactive amino acid analysis to characterize 
С and D protein. Gene products, similarly isolated,and 
whose amino acid sequence are known were used as calib­
ration references to correct for intrinsic differences m 
radioactive ammo acid incorporation. The validity of the 
method applied was confirmed by determining the amino acid 
composition of one of the known gene products (г.е. gene VIII-
protein) using another known product (gene V-protein) as 
external reference. The estimated ammo acid composition 
was found in close agreement to the theoretical value. The 
reliability of the method was further substantiated by our 
findings that the amino acid compositions of С protein were 
identical irrespective of the protein used for external 
calibration, (cf. Table I). Based on these results we infer 
that С protein does not consist of either pure gene IX- or 
gene Vll-protein. Taken into account that the amino acid 
residues histidine, but also lysine and proline are absent 
in С protein (cf. Table I), a condition which is only full-
filled by both gene VII-and IX-protein, we assume that С 
protein is most probably a mixture of both gene products. 
The amino acid composition of D protein deviates from 
that of gene VI-protein albeit the overall distribution of 
amino acid residues found strongly suggests that this pro­
tein component contains a substantial amount of the gene 
VI-encoded product. Most probably D protein isolated from 
Polyacrylamide gels is still contaminated with the gene 
VHI-encoded major capsid protein. This contamination could 
be due to an inadequate separation of D protein from the 
very large mass of gene Vlll-protem molecules or due to the 
presence of dimers. Major capsid protein dimers are formed 
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even under strong denaturing conditions (14,23) and such 
dimers migrate at the same position on Polyacrylamide gels 
as D protein. 
It is clear that further studies are needed to 
establish unambiguously the genetic origin of С and D pro­
tein. Special emphasis will be given to the determination 
of the amino terminal amino acid sequences of these two pro­
teins. As mentioned in the Results, it is known that the 
capsid proteins encoded by genes III and VIII are synthe­
sized in the infected cell with a leader sequence which is 
subsequently cleaved off prior to packaging into phage 
particles. If С and D protein have an ammo acid compos­
ition identical to that of the primary translational pro­
ducts of genes VII (IX) and VI, as is suggested by our 
amino acid analysis data, this also implies that these 
small proteins have the intrinsic capacity to be packaged 
into phage particles without prior proteolytic processing 
at the host cell membrane. 
Our interest is also focussed on the location of С and 
D protein within the tubular coat. The minor capsid protein. 
encoded by gene III, is located at only one tip of the 
filament (3,4,27) and is required for adsorption of the 
phage to the tip of the F-pilus (28). If evidence could be 
provided that С and D protein, as additional minor consti­
tuents of the tubular coat,are also located at either one 
or both ends of the filament, their specific role in phage 
adsorption and/or initiation of phage assembly at the inner 
membrane of the host could be established. Comparison of 
the amounts of С and D protein relative to that of gene 
III-protein in M13 recombinant phages of varying lengths, 
should provide data as to the relative location of these 
proteins in the virion. 
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CHAPTER I I I 
GEÍlES '/Γ, VII AND IX OF PHAGE №3 CODE FOR 
MINOR CAPSID PROTEINS OF THE VIRION 
ABSTRACT 
The minor capsid proteins С and D from phage M13 have 
been characterized by differential ammo acid labeling and 
amino-terminal sequence analysis. We demonstrate that D 
protein (M 12,260) is the product of gene VI, whereas the 
С component is composed of the products of both genes VII 
(M 3580) and IX (M 3650). Our data further show that the 
proteins of genes VI, VII, and IX are not subject to pro­
teolytic processing but are packaged into mature virions as 
their primary translational products. On the basis of 
incorporation of specific amino acids, the copy numbers of 
these proteins in M13 virions could be estimated relative 
to the number of A protein molecules. The M13 phage con­
tains on the average 5 molecules of A protein, 5 molecules 
of VI-protein and 3-4 molecules of both VII- and IX-protein. 
These copy numbers remained unchanged in M13 recombinant 
phages of up to two times the length of wild-type phages 
which indicates that these minor capsid proteins are 
located at either one or both ends of the phage filament. 
INTRODUCTION 
M13 and its very close relatives fd and fl are fila­
mentous phages which infect Escheviahia coli cells carrying 
the F episome (for a review, see ref. 1) . The M13 genome 
consists of a 6407-nucleotide-long single-stranded DNA 
molecule (2), which is encapsulated in a tubular protein 
coat of about 895 nm long and 6 nm wide. Over the years 
there have been reports which suggest that the composition 
of the virion coat is more complex than originally thought 
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(3-5). The major capsid or В protein (M 5200), which is 
encoded by gene VIII, is present in about 2700 copies,which 
are arranged in a helix around the DNA (6). The gene Ill-
encoded minor capsid or A protein (M 42,600) is present as 
only four or five copies (3,7), which are located at one 
tip of the filament (4,5). Besides these two proteins, two 
additional minor capsid proteins of M 3500 and 11,500, 
designated С protein and D protein, respectively, were 
recently discovered (8, chapter II). Their genetic origin 
and their biological function have not yet been solved. 
Assembly of M13 virions does not occur in the cyto­
plasm: infectious virus has never been detected within the 
infected cell and the major capsid protein is an integral 
constituent of the cytoplasmic membrane prior to virus 
assembly. In the cytoplasm, progeny viral DNA is covered 
by the DNA-binding protein encoded by gene V, forming a 
filamentous nucleoprotein (9). The assembly process is 
apparently one of exchange of coat protein for gene V-
protein as the viral DNA leaves the cell. The minor coat or 
A protein has most probably a very early and late function. 
It may lead the DNA into the host cell (10,11) and its 
presumed site of DNA replication (12) after attachment of 
the virus to the F-pilus, and there is also evidence which 
suggests that it functions as a cut-off agent in the final 
stage of the gene V-protem-major coat protein exchange 
reaction (10). At least four other M13 genes (1,1V,VI, and 
VII) are required for virus assembly, but their specific 
role in this process has yet to be ascertained. Further 
research in this field is hampered by the fact that the 
products of some genes (VI and VII) have not yet been 
detected either in vivo or in vitro (13-15), whereas the pro­
ducts of genes I and IV are present in the infected cell 
in very low amounts (3,16). 
To gain a better understanding of the assembly 
functions of these genes and to find out whether the re-
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cently discovered minor capsid proteins are host-encoded or 
МІЗ-specifled products, we have studied these proteins in 
more detail. In this report we demonstrate that D protein 
is the product of gene VI and that the С protein component 
is composed of two polypeptides, one of which is encoded by 
gene VII and the other by gene IX. 
MATERIALS AND METHODS 
Bacteria end Phages 
The E.aoli strains KA805 (amber suppressor Sul) and 
KA807 (amber suppressor SuIIl) were obtained from B. 
Glickman. M13 and its amber mutant am7H2 have been des­
cribed (17). The recombinant phage fdl06Sm2 (18) originated 
from H. Schaller. Phages M13S100 and S200, containing the 
1.8- and 3.O-kilobase-pair Haell-A fragments of pBR322 and 
pBR325, respectively, were constructed as described in 
ref. 18. 
Growth and Purification of Radioactive Phages 
Amino acid-labeled M13 phages were prepared essential­
ly as described (8) with minor modifications. E.coli strain 
K38 was grown in 25 ml of M9 minimal medium (19) supplemen­
ted with 20 mM glucose but no amino acids were added. At 
1 χ 108 cells per ml, M13 phages were added (multiplicity 
of infection 20) and then a total of 1.0 mCi of 3H-labeled 
amino acid or 0.25 mCi of ^C-labeled amino acid was added 
in four equal portions at 15,45,75, and 105 min after in­
fection (1 Ci = 3.7 χ IO 1 0 becquerels). Labeling with [35S] 
methionine was performed similarly with a total of 0.1 mCi. 
In all cases ammo acids with the highest specific activity 
currently available were used (Amersham) . A m m o acid 
labeling of M13S100, M13S200, and fdl06Sm2 was carried out 
in the presence of ampicillin (25 yg/ml), chloramphenicol 
(25 vq/ml), or streptomycin (10 ug/ml), respectively. 
Phages were isolated after a labeling period of 4 hr and 
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further purified by two successive precipitations with 5% 
polyethylene glycol 6000 in the presence of 0.1% Sarkosyl, 
followed by centnfugation on CsCl gradients as described (8) . 
Isolation of Radioaotive Phage Ргоіегпз 
The fractionation of capsid proteins on NaDodSCi+ZS M 
urea Polyacrylamide slab gels and their subsequent electro-
phoretic elution from gel segments have been described in 
detail (8). After dialysis of the eluate, the radioactive 
proteins were precipitated, washed, and lyophilized as 
described by Shaw et al. (20). 
Automated Edman Degradation 
Prior to degradation, the protein samples were sub­
jected to a 3 M HCl treatment as described by Palmiter et al. 
(21). Thereafter the acid was removed by lyophilization and 
the sample was then washed three times with 1% triethyl-
amine and dried under reduced pressure. Samples were dis­
solved in 70% (wt/wt) formic acid and 2 mg of parvalbumin 
was then added as carrier (22). Automated Edman degradation 
was performed on a Beekman 890C sequenator, using a 0.33 M 
Quadrol program of Hunkapiller and Hood (23). The recovered 
phenylthiohydantoin ammo acids were dried under nitrogen 
and dissolved in 200 μΐ of methanol, and their radioacti­
vity was determined in 5 ml of Lumagel (Baker), using a 
Packard scintillation spectrometer. 
Quantitation of Phage Capsid Proteins 
Copy numbers of capsid proteins were determined from 
tritiated amino acid-labeled phages only. After electro-
phoretic fractionation of the individual capsid proteins 
and subsequent fluorography (24), the appropriate gel seg­
ments were excised from the dried gel. The gel segments 
were completely burned with oxygen m a Packard Tn-Carb 
model 300 sample oxidizer and the radioactivity was de­
termined by adding 10 ml of Lumagel to each [3H]water 
eluate and scintillation counting. 3H-labeled standard 
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samples (Packard) were applied for recovery determination. 
RESULTS 
Genetic origin of D protein 
Electrophoretic analysis of the proteins present in 
11+C-labeled M13 phages showed that the virion coat is 
composed of the mature products of genes III and VIII and 
two additional small protein components (Fig. 1). The 
latter, denoted С protein and D protein, have apparent 
molecular weights of 3500 and 11,500, respectively. 
14C HIS ARG MET PRO LYS TRP ASP 
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Figure 1 : NaDodSO /ureaPolyacrylamide gel electrophoresis 
of M13 phage capsiä proteins which were labeled with a inc-
arnino acid mix (lane a) , hist idine (lane b), arginine (lane c) , 
methionine (lane d) , proline (lane e) , lysine (lane f ) , 
tryptophan (lane g) and aspartic acid (lane h). Individual 
amino acids were a l l -'H-labeled. A and В refer to the gene 
Ill-encoded minor capsid protein (M
r
 42,600) and the gene 
VHI-encoded major capsid protein (M
r
 5240) . 
Because c o n v e n t i o n a l ion-exchange and e x c l u s i o n 
chromatographic methods f o r t h e i s o l a t i o n and subsequent 
c h a r a c t e r i z a t i o n of С and D p r o t e i n s were unsucess ful , we 
have a t t e m p t e d t o c h a r a c t e r i z e t h e s e p r o t e i n s on t h e b a s i s 
of t h e i r c a p a b i l i t y t o i n c o r p o r a t e s e v e r a l r e p r e s e n t a t i v e 
3 H - l a b e l e d amino a c i d s . In t h i s approach t h e e s t a b l i s h e d 
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nucleotide sequence of M13 DNA (2) was used as a guide for 
these labeling experiments. From these studies it turned 
out that D protein can be labeled with all amino acids 
except histidine (Fig. lb). Because the M13 DNA sequence 
dictated that gene VI codes for a protein of 112 amino 
acids in which histidine is absent, the genetic relation-
ship between gene VI and D protein became apparent. On the 
other hand, gene VHI-protem (M 5240) also lacks histi-
dine (Fig. lb), and the possibility therefore remained 
that D protein is not a new capsid protein but merely 
represents a gene VHI-protein dimer. This possibility, 
however, has been ruled out because D protein can be 
labeled with arginine, an amino acid that is known to be 
absent from the major coat protein (Fig. 1c). 
This conclusion, solely based on amino acid incor-
poration data, also emerged from our radioactive amino acid 
analysis of uniformly '''C-labeled D protein. Our data 
showed that the ammo acid composition of D protein is not 
identical to that of mature gene Vlll-protem but has 
strong resemblance with that of gene VI-protein (chapter II). 
To demonstrate that D protein represents in some way 
a translational product of gene VI, M13 phages labeled with 
a single radioactive ammo acid were prepared and the 
electrophoretically isolated D protein was then subjected 
to ammo-terminal sequence analysis by automated Edman 
degradation. The results obtained are presented m Fig. 2. 
The DNA sequence predicts that gene VI-protein contains a 
single rrethionine residue, which is located at the amino 
terminus of this protein. Edman degradation of D protein 
from [ 3 5S] methiomne-labeled phages, however, did not 
liberate any radioactivity after the first degradation step 
(Fig. 2), despite the fact that D protein can be labeled 
with methionine (Fig. Id). To find out whether D protein 
molecules are blocked by a formyl group at their amino 
terminus, prior to sequential degradation, the protein was 
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Figure 2• Amino-terminal sequence analysis of capsid protein D, 
isolated from M13 phages that were labeled with a single -Ή- or 
14c-labeled amino acid as indicated. The broken line indicates 
the sequence run of protein that was not pretreated with 3 M HCl; 
the solid lines represent the runs of treated protein samples. 
s u b j e c t e d t o a HCl t r e a t m e n t e s s e n t i a l l y as d e s c r i b e d by 
P a l m i t e r et al. ( 2 1 ) . I t appeared t h a t only a f t e r such t r e a t ­
ment could t h e a m i n o - t e r m m a l sequence of t h i s p r o t e i n be 
d e t e r m i n e d , s t r o n g l y s u g g e s t i n g t h a t t h i s p r o t e i n i s present 
in t h e v i r i o n in i t s N-formylated form. The y i e l d of Edman 
d e g r a d a t i o n a f t e r t h i s 3 M HCl t r e a t m e n t was low and ranged 
between 20% and 40%. Accordingly, D p r o t e i n from phages 
t h a t were l a b e l e d with p r o l i n e , g l y c i n e , o r l e u c i n e were 
t r e a t e d with HCl and s u b j e c t e d t o automated sequence 
a n a l y s i s . With t h e e x c e p t i o n of two d e g r a d a t i o n s t e p s , 
t h e r a d i o a c t i v i t i e s o b t a i n e d a f t e r t h e v a r i o u s sequence 
runs were found m f u l l accordance with t h e a m m o - t e r m i n a l 
sequence of gene V I - p r o t e i n as deduced from t h e DNA 
sequence ( F i g . 3 ) . The e x c e p t i o n s a r e t h e p o s i t i o n s 3 and 
6, where in both c a s e s e i t h e r a g l y c i n e o r a p r o l i n e 
r e s i d u e could be p r o p o s e d . On t h e b a s i s of r e p e t i t i v e y i e l d 
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of Edman sequence analysis, which was usually about 92%, 
and the pronounced intensity of proline at position б as 
compared to proline residues 2 and 8, it is obvious that we 
are elucidating the amino-terminal sequence of two 
different proteins. Proline residues 2 and 8 agree with the 
VI-protein sequence, as a proline at position 6 fits with 
the amino-termmal sequence of mature VHI-protein. A 
similar conclusion emerged from the sequence run of [ll*C] 
glycme-labeled D protein. The glycine residue at position 
6 belongs to VI-protein, and glycine at position 3 fits 
again with the sequence of mature VHI-protem. From these 
ul· \ VI-PROTEI·! 
1 5 1 0 1 ^ 
[ІМІТ] - I PRO I - VAL - [ t i y ] - ¡ LEU| - [GLY] - ILL - [ P R Ö ] - [ L E U ] - [¡SU] - \Ш} - ARG - РНЕ - [ Ш ] - [¿LTÌ 
GLY PRO 
[ALA - GLU - GLY - ASP - ASP - PRO - ALA - LYS - ALA - ALA] 
Figure 3 : The amino-terminal sequence of gene VI-protein 
as deduced from the M13 DNA sequence (2) . The sequence 
between bracke ts represen ts the amino-terminus of M13 ma]or 
coat p r o t e i n . The blocked residue are those found a f t e r 
Edman degradation of D pro te in tha t was labeled with s ingle 
r ad ioac t ive amino ac ids . 
d e g r a d a t i o n r e s u l t s we i n f e r t h a t D p r o t e i n c o n s i s t s of V I -
p r o t e m b u t a l s o of V H I - p r o t e i n d i m e r s . We c a l c u l a t e d t h a t 
a r e s i d u a l d i m e n z a t i o n of t h e m a j o r c a p s i d p r o t e i n of 
o n l y 0.2% i s s u f f i c i e n t t o c a u s e t h e a n o m a l o u s d e g r a d a t i o n 
r e s u l t s . Such low v a l u e s c a n n o t be e x c l u d e d i n t h e NaDodSO^/ 
8 M u r e a / p o l y a c r y l a m i d e s y s t e m a p p l i e d t o f r a c t i o n a t e t h e s e 
p h a g e p r o t e i n s . 
Genetic origin of С protein 
As i s shown i n F i g . 1 ( b , e , f ) , t h e s m a l l e s t m i n o r 
c a p s i d p r o t e i n С c a n n o t be l a b e l e d w i t h h i s t i d m e , p r o l i n e , 
o r l y s i n e . The o n l y M13 g e n e p r o d u c t s t h e s i z e s of w h i c h 
a r e pa 3500 d a l t o n s a n d t h a t l a c k t h e s e a m i n o a c i d s a r e 
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those of gene VII and the recently discovered gene IX (17, 
26). From the nucleotide sequence of both genes it is also 
evident that gene VII contains aspartic acid, which is 
absent in gene IX, and that tryptophan is present in gene 
IX but not in gene VII. С protein can, however, be labeled 
with both amino acids (Fig. lg,h), suggesting that this 
protein is a mixture of both gene products. 
To confirm this, automated Fdman degradation was also 
carried out with С protein that was labeled with single 
amino acids. The results obtained are shown in Fig. 4. 
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Figure 4 : Amino-terminal sequence analysis of capsid 
protein С isolated from M13 phages that were labeled with 
a single H- or ^c-labeled amino acid as indicated. The 
broken line indicates the sequence run of protein that was 
not pretreated with 3 M HCl; the solid lines represent the 
runs of treated protein samples. am7H2 represents the de­
gradation of [-^н] tyrosine-labeled С protein from am-7 
phages propagated in SuIII E.coli cells. 
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Also with this protein an amino-terminal sequence could be 
determined only after a 3 M HCl treatment. Untreated [3H] 
tyrosme-labeled С protein showed no radioactivity peaks 
even after 15 degradation steps, whereas treated С protein 
revealed a peak of great intensity at position 6 and one of 
low intensity at position 11 (Fig. 4). The intensity of the 
latter did not fit the value expected on the basis of the 
repetitive yield of the Beekman sequencer, an observation 
that, in turn, strongly suggests that the two tyrosine 
residues belong to two different proteins. This was also 
evident from our observation that at position 6 a tyrosine 
was found but also an aspartic acid residue, and at 
position 13 both a leucine and an alanine residue were 
noted. By comparing the positions of the various radio­
active residues with the amino-terminal sequence of VII-
and IX-proteins as deduced from the DNA sequence (Fig. 5), 
our interpretation of these data is that tyrosine-6 belongs 
to gene IX-protem and tyrosine-ll to gene Vll-protem. 
at fc vn-pROTt m 
1 5 io 
|FHET|- GLU - GLN ЛІ -|ALA|-1АЯр| - PHF -|ASP|- THR TIF -|TYR|- GLN -[ALA|- НЕТ 
GE IE IX-PROT:IN 
SFR - VAI -[LEU]- VAL -|TYR|- SER - РНЕ -| ALA|- SER - РНЕ - VAL -|LEU|-
Figure 5 : The amino-terminal sequence of gene VII-prote in 
and of gene IX-protein as deduced from the M13 DNA sequence 
(2) . The blocked res idues are those found a f t e r Edman 
degradat ion of С p r o t e i n t h a t was labeled with s ing le 
r a d i o a c t i v e amino a c i d s . 
L e u c i n e - 4 a n d l e u c i n e - 1 3 a r e b o t h d e r i v e d from I X - p r o t e i n . 
C o n s i s t e n t w i t h t h e r e p e t i t i v e y i e l d , a l a n i n e - 5 and 
a l a n i n e - 1 3 b e l o n g t o g e n e V I I - p r o t e i n w h e r e a s t h e h i g h e r 
i n t e n s i t y of a l a n i n e - 9 e x a c t l y f i t s w i t h t h e g e n e IX s e ­
q u e n c e . I n a s i m i l a r way we i n f e r t h a t t h e a s p a r t i c a c i d 
r e s i d u e s a t p o s i t i o n б and 8 b e l o n g t o g e n e V I I . We do n o t 
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yet have a plausible explanation for the occurrence of 
radioactivity at position 1 of the aspartic acid label, 
because at that position the occurence of methionine 
was also demonstrated. 
That С protein indeed is composed of the proteins en­
coded by gene VII (33 amino acids) and gene IX (32 amino 
acids) is further supported by the results of our labeling 
studies with the M13 phage mutant απ7Η2. Previously, it has 
been demonstrated (17) that this mutant bears two mutated 
sites. One is а С >• Τ change in gene VII at position 1114 
of the DNA sequence, which alters that CAG codon into a TAG 
codon. The other is а С -> Τ change outside gene VII but in 
the gene IX sequence (position 1141), where a CGT (Arg) 
codon is converted into a TGT (Cys) codon. Consequently, 
gene IX-protein encoded by this mutant contains only one 
instead of two arginine residues. When am7H2 phages were 
propagated in Sul E.coti cells in the presence of [ll*C] 
arginine and the proteins of the purified phages were 
analyzed on Polyacrylamide gels, the radioactivity contain­
ed in the band representing С protein was markedly 
reduced as compared to wild-type phages (Fig. 6). 
That VII protein also forms part of the С protein 
component is confirmed by our Edman degradation data of 
am 7H2 phage proteins. When this mutant phage was propagated 
in SuIII E.aoli cells in the presence of [3H]tyrosine, a 
tyrosine residue was noted m С protein not only after the 
sixth but also after the third degradation step (Fig. 4). 
Residue 6 reflects gene IX-protein, whereas residue 3 
corresponds with a tyrosine suppression at the amber codon 
in gene VII, namely at position 1114 of the DNA sequence. 
Copy numbers of С and D protein 
The great abundance of major coat protein as compared 
to С and D protein and the well-known tendency of the major 
coat protein to aggregate even under strongly denaturing 
conditions make an estimation of their copy numbers in 
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Figure 6 : NaDodS04/8 M urea/ 
Polyacrylamide gel electro­
phoresis of the capsid proteins 
of M13 wild-type phage (lane a) 
and ατηΤΆ2 phage (lane b) that 
were propagated in Sul Е.ооЪг 
cells in the presence of [^ н] 
arginine. The radioactivities 
applied were 12,503 and 11,718 
dpm, respectively. 
D 
a b 
phage particles very difficult a priori. Unless certain 
precautions have been made, cross-contamination is expected 
to occur during the electrophoretic separation of these 
phage proteins. We have circumvented these problems by 
analyzing the radioactivity distribution of D protein in 
[3H]arginine-labeled M13 phages in order to eliminate any 
radioactivity contribution of VUI-protein dimers to D pro­
tein. The ratio of 3Н-1аЬе1 in Ill-protein to the 3H-label 
in the D protein band, as estimated by oxidizing the 
corresponding gel segments in a Packard sample oxidizer and 
scintillation counting, was found to be 8.1-9.5 to 1. This 
ratio, coupled with the known arginine content of III- and 
VI-protein, allowed us to calculate the copy numbers of 
VI-protein. Assuming 5 copies of Ill-protein (4,5), a value 
of 4.7 + 0.5 was found for VI-protein in wild-type and 
cm 7H2 mutant phages (Table I). 
In a similar way we estimated the copy numbers of VII-
protein from [3H]aspartic acid-labeled phages and of IX-
o-
A-
•i 
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Table I . Copy numbers of VI, VII and IX-protein in Ml 3 wild-
type and ch 
Phage 
Wild type 
Wild type 
Wild type 
AM7H2 
Wild type 
M13S100 
M13S200 
fdl06Sm2 
imene phages. 
1H-label 
used 
Tryptophan 
Aspartic acid 
Valine 
Arginine 
Arginine 
Arginine 
Arginine 
Arginine 
4. 
5, 
4. 
4. 
3, 
3, 
Copy 
VI 
ND 
.3(0.7) 
ND 
.4(0.1) 
.3(0.3) 
. 1 
.9(0.3) 
.2(0.5) 
numbers of 
VII*' 
-
3.3(0.4) 
3.Θ 
3.1 (0.1) 
3.8(0.4) 
3.3 
3.2(0.2) 
2.9(0.3) 
proteins 
IX 
3.5(0. 
-
3.8 
3. 1(0. 
3.8(0. 
3.3 
3.2(0. 
2.9(0. 
.5) 
Л) 
.4) 
• 2) 
3) 
t The values given are c a l c u l a t e d from the determined amounts of 
^H-label in the D and I l l - p r o t e i n bands. R a d i o a c t i v i t i e s were 
determined from several independent phage p r e p a r a t i o n s and the 
molar r a t i o between D and I l l - p r o t e i n was c a l c u l a t e d on the 
b a s i s of the known number of amino acid res idues as deduced 
from the DNA sequence (2) . The copy number of VI-protein was 
then derived by mult ip ly ing the molar r a t i o by the copy number 
of I l l - p r o t e i n . The l a t t e r value i s assumed to be 5 on the 
b a s i s of data of Woolford et al. (4) and Goldsmith and 
Königsberg (5) . 
H Copy numbers of VII- and IX-proteins were est imated as described 
above. The values obtained with a r g i n i n e - and va l i ne - l abe l ed 
phages are based on the assumption t ha t these p ro t e in s are p r e -
sent in v i r i o n s in equimolar amounts as evidenced by the 
experiments with tryptophan and a s p a r t i c ac id . Parentheses 
i nd ica t e SEM. ND, not determined. 
p r o t e i n from [ З н ] t r y p t o p h a n - l a b e l e d p h a g e s . As shown i n 
Table I , t h e e s t i m a t e d v a l u e s were 3.3 and 3.5 c o p i e s f o r 
VII-and I X - p r o t e i n , r e s p e c t i v e l y , which s u g g e s t s t h a t both 
p r o t e i n s a r e p r e s e n t in phage p a r t i c l e s in e q u i m o l a r 
amounts . With [ 3 H ] v a l i n e l a b e l e d phages a v a l u e of 7.6 and 
w i t h [3H ] a r g i m n e - l a b e l e d amlH2 phages a v a l u e of 6.2 was 
found. Because genes VII and IX i n t h e s e phages have 
i d e n t i c a l numbers of v a l i n e and a r g i n i n e r e s i d u e s , t h e 
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latter values represent the sum of VII- and IX-protem 
copies m mature phage particles. They are in fair agree­
ment with the copy numbers found for these small capsid 
proteins. 
Location of С and D protein in M13 virions 
Woolford et al. (4) and also Goldsmith and Königsberg 
(5) clearly demonstrated that the minor capsid protein 
encoded by gene III is located at only one tip of the phage 
filament. To find out whether the other minor capsid pro-
teins are also located at or clustered near one tip of the 
filament, we have estimated the copy numbers of these pro-
teins in M13 recombinant phages of various length. For this 
purpose we constructed a recombinant M13 phage by insertion 
of the 1800 base pairs long Haeil-A fragment of pBR322, 
carrying the ampicillin gene, into the mtergenic region of 
M13 RF. The helper-independent recombinant phage M13S100 
was selected on the basis of its capability to transduce 
ampicillin resistance to E.aoli cells. In a similar way we 
constructed phage M13S200 by insertion of the 3000 base 
pairs long ЯаеІІ-А fragment of pBR325, carrying both the 
ampicillin and the chloramphenicol resistance gene. These 
two phages and fdl06Sm2, constructed by Herrmann et al. (18) 
have lengths which are 1.2, 1.5 and 2.0 times the length of 
wild-type phage particles. Our results obtained with these 
phages are presented in Table I. They show that with in­
creasing lengths of the phage particles the copy numbers 
do not increase but remain of the same order of magnitude 
as that in wild-type particles. Our interpretation of 
these data is that an insertion of С and D protein 
molecules m a periodical array along the longitudinal axis 
of the filamentous protein tube is very unlikely. On the 
basis of the constant ratios of Ill-protem to С and D 
protein in longer filaments, we infer that the minor 
capsid proteins encoded by genes VI, VII and IX, although 
not located per se on different ends, are clustered on the 
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tips of the filamentous phage particles. 
DISCUSSION 
Despite our detailed knowledge of the molecular bio-
logy of the single-stranded filamentous DNA phages, the 
process of virion assembly on the host cell membrane is 
still a largely unsolved problem. Although there exists 
indirect evidence that genes VI and VII are involved m 
this process, further research in this field was greatly 
hampered by the fact that the products of these genes were 
still completely unknown (13-16). Recently, their identifi-
cation has been greatly facilitated as the expected sizes 
of these proteins and their primary sequence have been 
deduced from nucleotide sequence data (2,17,26). Similarly, 
from the DNA sequence the existence of a new gene, gene IX, 
has been postulated (17,26). Our data presented here 
demonstrate that the products of genes VI, VII and IX are 
minor constituents of the phage coat, where they are pre-
sent in only a few copies per virion. These data are based 
on direct sequence analysis of wild-type proteins and were 
confirmed, where possible, by specific amino acid sub-
stitutions to be expected from conditionally lethal phage 
mutations. An identical conclusion has recently been 
reached by Lin et al. (27). Their data on fl are in fair 
agreement with our data on M13, which strengthens the 
argument for the presence of these minor capsid proteins in 
all F-specific filamentous phages. 
Our Edman degradation studies further demonstrate that 
the proteins encoded by genes VI, VII, and IX are not 
subject to proteolytic cleavage at their amino terminus as 
is the case with III- and VHI-protein but are packaged 
into mature virions as their primary translational products. 
An intriguing aspect is that these minor capsid proteins 
can be degraded only after treatment with 3 M HCl, a proce-
dure that characteristically has been applied for de-
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formylatmg the amino termini of proteins. Until now we 
could not exclude the possibility that some obscure 
circumstances have shielded a free amino terminus and, con­
sequently, simulated the presence of an N-formyl group in 
these proteins. Because such a blocking or shielding was 
not apparent during degradation of similarly isolated R 
protein, our observation argues for an N-formylated status 
of these three proteins m M13 virions. With respect to 
the amino terminus of VII- and IX-protein, our data are 
less clear. They suggest but do not prove that these pro­
teins bear a formylmethionine residue. In accordance with 
this is our finding of a phenylthiohydantoin derivative of 
[35S]methionine after the first degradation step and the 
failure to degrade [^5S] methionine or [3H]tyrosine-labeled 
С protein prior to 3 M HCl treatment. Not in accordance is 
the radioactivity at position 1 in [3H]aspartic acid-
labeled protein. A definite conclusion on the ammo-
terminal status of these proteins awaits further 
investigations. 
Data are now also available on the location and 
possible function of these three minor capsid proteins. In 
this study evidence is presented that these proteins, like 
the Ill-protem, are also located at either one or both 
ends of the phage filament. By shearing normal length fd 
and fl phages and treating the mixture with antibodies 
against gene Ill-protein, Grant et ai. (25) very recently 
provided evidence that D protein is located at the III-
protein end of the phage and, consequently, that С protein 
is at the opposite end. Such a clustering of VI- and III-
proteins and of VII- and IX-proteins is of great biological 
importance because their synthesis is under strict control. 
Genes III and VI belong to one Operon (10), whereas genes 
V and VII forma second operon (28). Moreover, our recent 
protein synthesis studies with several M13 amber mutants 
have shown that gene IX-protem synthesis also is control-
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led by gene V expression (chapter V ) . An overal picture 
emerges that the four minor capsid proteins of the F-spe-
cific filamentous phages can be divided in two functional 
groups. One consists of the products of one Operon (III 
and VI), which trigger the entry process of phage DNA into 
the host cell but also its reversed process - i.e. , the 
final stages of packaging the DNA when it leaves the cell -
whereas the other group, composed of products of the other 
operon (VII and IX), most probably directs the very early 
events of chanelling the V-protem-DNA complex through the 
host cell membrane. Our primary goal is to study the 
regulation of synthesis of these minor capsid proteins. 
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CHAPTER I V 
OLIGC bCLEOTlLE-DIRtCTri) 'ZTACFi.ESTS OF G'liE IX OF BACTERIOPHAGE Mia 
ABSTRACT 
The synthetic oligodeoxyribonucleotide pCGAAAGACTACAC 
has been applied as a site-specific mutagen to introduce a 
Τ •* G transversion mutation at nucleotide position 1223 of 
the M13 DNA sequence. The гп vitro-induced conversion of a 
TAT codon into a TAG codon at this position resulted in 
gene IX mutants with an amber mutant character thereby con­
firming that this reading frame defines a gene of an essen­
tial phage protein. The gene IX amber mutants obtained grew 
well on Sul (Ser) and SuIII(Туг) suppressing strains but 
could not be propagated on SuII(Gln) and SuVI(Leu) strains. 
Complementation studies show that amber mutants in genes V 
and VII exert a polar effect on gene IX expression suggest­
ing that these three contiguous genes form an Operon. In 
addition, we demonstrate the ъп гіго synthesis of gene IX-
protein in a coupled transcription-translation system. 
INTRODUCTION 
The nucleotide sequence of bacteriophage M13 DNA has 
learned us that the region between genes VII and VIII, 
which previously has been considered as a leader sequence 
of the major coat protein mRNA (1), could theoretically 
comprise a gene coding for a small polypeptide of 32 ammo 
acids only (2,3). Recent studies on the structure of fila­
mentous coliphages have indicated that this polypeptide, 
named gene IX-protein, really exists and forms a minor 
constituent of the phage particle (4-6, chapters II and 
III). Simons et al. (4,5, chapters II and III) and Grant et 
al. (7) further demonstrated that this protein and gene VII-
protein are located at one end of the phage filament where 
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they are present in 3-4 copies only. They also showed that 
at the opposite end about 5 copies are present of two other 
phage-encoded proteins, namely the products of genes VI and 
III. 
Their location at the ends of the filament suggests 
that these minor capsid proteins exert a crucial role during 
the process of phage assembly at the host cell membrane. 
Detailed studies on the function of gene IX in phage morpho­
genesis, however, are greatly hampered by the fact that no 
conditionally lethal mutants are known which map in this 
particularly small gene IX region. We therefore decided to 
construct such mutants by site-directed mutagenesis (8-13) 
using a synthetic oligodeoxyribonucleotide which mismatches 
at a single nucleotide to a specific complementary site on 
wild-type M13 viral DNA. After in vitro incorporation into 
closed circular duplex DNA by elongation with DNA polymer­
ase I and ligation followed by transfection of competent 
E.coli cells, amber mutants were selected which on the basis 
of their nucleotide sequence have their mutation m the 
established reading frame of gene IX. 
We report here the construction and characterization 
of an in vitro induced amber gene IX mutant and its proper­
ties in genetic complementation tests. Our data show that 
the proximal genes V and VII exert a polar effect on gene 
IX expression, and consequently, synthesis of gene IX-
protein is dependent on faithfull expression of genes V and 
VII. In addition, this mutant enabled us to demonstrate the 
synthesis of gene IX protein in vitro. 
MATERIALS AND METHODS 
Bacteria and phages 
The F.ooli strains KA798 ( змр+) , KA805 (swpD) , KA806 ( supE), 
KA807(siipF) and KA809(s^pP) used in this study were construc­
ted by introduction of the F-plasmid m XA-stralns, which 
originate from J.H. Miller (14). The M13 amber mutant 
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phages amS-НЪ, ατηΊ~Η2 and amS-Hl were o r i g i n a l l y o b t a i n e d 
from D. P r a t t . Phage M13 w i l d - t y p e was from our own s t o c k . 
Enzymes 
The large fragment of E.coli DNA polymerase I was 
obtained from Boehringer, Mannheim. T4 DNA ligase, a kind 
gift of P. van Wezenbeek, was prepared from an induced 
lysogen of \T4lig phage NM989 (15). T4-polynucleotide 
kinase was purchased from P.L.Biochemicals and the restric­
tion endonucleases used in this study were from New England 
Biolabs. 
Isolation of DNA 
Viral DNA was isolated from purified M13 phages by the 
hot phenol/chloroform-SDS extraction method described by 
Marvin and Schaller (16). M13 RF-I DNA was isolated from 
infected cells according to the method of Clewell (17) for 
isolation of plasmid DNA. M13 DNA restriction fragments 
were fractionated on 5% Polyacrylamide gels containing E-
buffer (40 mM Tns-HCl, 20 mM sodium acetate, 2 mM EDTA, 
pH 7.8) and eluted electrophoretically from gel segments m 
50 mM Tns-borate, 1 mM EDTA, pH 8.3 with the aid of an 
ISCO sample concentrator. The DNA in the eluate was re­
covered by ethanol precipitation. 
Oligonucleotide-primed synthesis of Mio RF-TV DI1A 
Primed synthesis of covalently-closed heteroduplex DNA 
was performed essentially as described by Gillam and Smith 
(11) with minor modifications. Wild-type M13 viral DNA 
(0.25 pmol) and 5 1- 3 2P -labelled oligodeoxyribonucleotide 
primer (10 pmol) m 2 μΐ of 40 mM Tns-HCl, 100 mM NaCl, 
20 mM MgCl?, 2 mM mercaptoethanol, pH 7.5 were incubated 
for 10 m m at 45 0C and annealed for 20 h at 40C. Then 1 yl 
of dNTP-mix, consisting of 66 mM Tns-HCl, pH 7.5, 33 mM 
МдСІ2, 3 mM mercaptoethanol, 2.5 mM of each dATP, dCTP, 
dGTP, dTTP and 1.2 mM rATP was added, followed by 0.5 units 
of E.coli DNA polymerase I (Klenow) and 2.5 units of T4 DNA 
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ligase. The total reaction volume was 5 и 1. After incuba­
tion for 20 h at 4 C, the reaction mixture was diluted with 
10 ul of TE-buffer (10 mM Tris-HCl, 1 mM EDTA, pH 7.5) and 
incubated with 10 yg of ethidium-bromide for 1 h at room 
temperature in the dark (18). Covalently-closed duplexes 
(M13 RF-IV DNA) were isolated after electrophoretic frac­
tionation of the reaction mixture on 1% agarose gels in E-
buffer containing 2 v.g/ml of ethidium-bromide and subse­
quent autoradiography. 
Trans feation and plaque assay 
Gel segments containing 32P-labelled RF-IV DNA were 
excised and the DNA was eluted electrophoretically as des­
cribed. The eluate was extracted twice with phenol/chloro­
form and the DNA was concentrated by ethanol precipitation. 
The preparation of competent h.aoli KA807(swpF) cells and the 
subsequent transformation procedure was essentially as 
described by Kushner (19). The transfected cells were 
plated for infective centers on E.coli KA807 cells as the 
indicator strain. Plaques were tested by plating 10 μΐ of 
each plaque suspension (obtained by needle-picking the 
plaque and transfer into 200 ul of TE-buffer) on a KA798 
(sup ) host and on a KA807(supF) host. 
Marker rescue experiments were performed by the method 
of Taketo (24) as described by van den Hondel et al.{25) . 
DNA sequence analysis 
Labelling of 5 '-terminal ends of oligodeoxynbonucleo-
tide primer and restriction fragments was carried out as 
described previously (20). Sequence analysis of the syn­
thetic oligodeoxynbonucleotide was carried out by partial 
digestion of the DNA with snake venom phosphodiesterase as 
described by Maniatis et al. (21) . The partial digestion 
products were characterized by two-dimensional finger­
printing using the homomix V of Jay et al. (22) for the 
second direction. Sequence analysis of M13 restriction 
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fragments was performed by the method of Maxam and Gilbert 
(23) . 
Cell-free protein synthesis 
Cell-free protein synthesis, programmed with either 
M13 wild-type RF or amber mutant RF, was carried out as 
described by Komngs (26) . The synthesized polypeptides 
were analysed on vertical 15% polyacrylamide-NaDodSOit gels 
containing 8 M urea as described previously (4). 
RESULTS 
The general outline of our approach to construct M13 
gene IX amber mutants is shown in Fig. 1. The oligonucleo-
1 Electrophoresis on 
17· Agarose lEtbr) 
Transleclmn on 
E coli ЗиШ I Туг I 
Figure 1 : In vitro s e l e c t i o n of M13 gene IX amber mutants 
using o l igonucleot ide pCGAAAGACTACAC. The "mutant" o l i g o ­
nucleot ide which mismatches a t nucleot ide 1223 of gene IX 
was used as primer forE.eoZtDNA polymerase I (Klenow) in 
the presence of T4 DNA l i g a s e . Closed c i r c u l a r heteroduplex 
DNA was e l e c t r o p h o r e t i c a l l y i s o l a t e d and then used t o 
t r a n s f e c t competent £ . c o l i ( S u I I I ) - c e l l s . After p l a t i n g , 
amber mutants were se lec ted by a p a r a l l e l plaque assay on a 
Su and a SuIII hos t . 
t i d e u s e d t o i n d u c e t h e amber m u t a t i o n i n w i l d - t y p e M13 
v i r a l DNA i s t h e t n s c a i d e c a d e o x y n b o n u c l e o t i d e 
pCGAAAGACTACAC. I t was c h o s e n a s i t s c o m p l e m e n t a r y s e q u e n c e 
o c c u r s o n l y o n c e i n t h e M13 v i r a l DNA s e q u e n c e , n a m e l y a t 
n u c l e o t i d e s 1218 t o 1230 of t h e g e n e IX s e q u e n c e . The 
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underlined nucleotide, eighth from the 5'-end, mismatches 
with a Τ at position 1223 of the viral DNA sequence. The 
13-mer was synthesized by the chemical phosphotriester 
method (27) and its nucleotide sequence was confirmed by 
two-dimensional fingerprinting (Fig. 2) and direct DNA 
sequencing methods. The experiments gave the anticipated 
sequence and showed that the 13-mer was virtually free of 
contaminants. 
/ A 
/ · 
Figure 2 : Two-dimensional se­
quence determination of the 5'-
P -labelled synthetic oli-
godeoxyribonucleotide pCGAAAGA-
CTACAC. The first dimension was 
electrophoresis on cellulose 
acetate strips (pH 3.5). The 
second dimension was homochro-
matography on DEAE thin-layer 
plates using homomix V (22). 
The positions of the Xylene 
xyanol (top) and Orange G 
marker (left) are indicated. 
I » 
% 
Since quite short oligodeoxyribonucleotides with one 
mismatched base pair still form stable duplex structures, 
the synthesized 13-mer was used as a primer for elongation 
with E.aoli DNA polymerase I (Klenow-fragment) in the pre­
sence of T4 DNA ligase. For this purpose we used primer 
molecules labelled with 3 2P at their 5'-ends. Circularly 
closed relaxed DNA molecules (RF-IV DNA) were isolated by 
fractionation of the reaction mixture on 1% agarose gels 
containing 2 yg/ml of EtBr (18). Under these electrophore-
tic conditions, RF-IV DNA molecules migrate slightly faster 
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than supercoiled RF-I DNA and are well separated from non-
ligated RF molecules containing a gap or nick in their com­
plementary strand and from the excess of single-stranded 
viral DNA template (data not shown). Using this method 
enrichment and selection of RF-IV molecules by Sl-nuclease 
digestion (11), filtration on nitrocellulose filters at 
high salt concentrations (8) or banding in CsCl density 
gradients (12), applied by others, can be circumvented. 
Regions of the gel containing 32P-labelled RF-IV DNA 
were excised, the DNA was electrophoretically eluted from 
the gel segments and further purified as described under 
Methods. 
Isolation and charactertzation of amber mutants 
Site-specific mutagenesis with the synthesized 13-mer 
is expected to induce a Τ -> G conversion at nucleotide 1223 
m M13 viral DNA (Fig. 1). This changes a TAT tyrosine 
codon into a TAG amber codon. The induction of such a 
mutation has the advantage that transfection with RF-IV DNA 
can now be carried out with Е.ооіг (SuIII) cells carrying a 
tyrosine suppressor, resulting in progeny mutant phages 
which are phenotypically of wild-type character. 
After transfection of Е.ооіг (SuIII) competent cells 
with 32P-labelled RF-IV DNA 160 individual plaques were 
assayed by titrating each plaque suspension on L.colt (SuIII) 
and П.ооіг (Su -). Only 4 plaques gave high titers on the 
bu host and low titers on a non-suppressing host. Of these 
four mutants a purified phage stock was prepared and the 
mutant viral DNA was isolated by phenol/chloroform extrac­
tion. A preliminary screening for the gene IX amber mutant 
character was performed by marker rescue experiments with 
purified M13 restriction fragments (25). Surprisingly, only 
the viral DNA of three mutant phages exhibited the expected 
genetic specificity in that salvage of the wild-type allele 
only occurred with M13 fragment Hbnfl-A, a fragment which 
completely covers gene IX. The fourth phage mutant could 
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only be rescued by fragment Hapll-A, a fragment which con-
tains the genetic information of gene IV. This is unexpec-
ted as a computer search shows that the fíapII-A seguence 
does not comprise a region which is complementary to the 
primer seguence (see Discussion). 
In order to show conclusively that the method applied 
here induces the intended mutation in gene IX, we have 
determined the nucleotide seguence change in the induced 
amber mutants obtained. Figure 3 shows the relevant portion 
A>C G С C+T A>C G С С+Т 
Figure 3: Autoradiograph of DNA sequencing ge l s obtained 
a f t e r p a r t i a l chemical degradation of the r i g h t hand 5 ' -
terminal end of fragment Hhal-H of аШ-113 RF-DNA ( l e f t 
panel) and of the same fragment derived from wild-type RF-
DNA ( r i g h t p a n e l ) . The nucleot ide p o s i t i o n s 1206-1232 of the 
v i r a l s t rand of these fragments are des ignated. The arrow 
i n d i c a t e s the expected Τ -> G conversion a t p o s i t i o n 1223 
of the M13 gene IX sequence. 
of a s e g u e n c i n g g e l of o n e of t h e t h r e e amber mutant DNAs 
which were r e s c u e d by t h e M13 Hinfl-A f r a g m e n t . The 
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sequence presented starts with the ATG initiation codon of 
gene IX. The only difference between this sequence run and 
that of wild-type Ml 3 DNA is noted at nucleotide 1223. In 
the amber mutant, called огчЫ-ІІЗ (left panel), a Τ -* G 
conversion has taken place which has changed the TAT tyro­
sine codon into a TAG amber codon. The other two amber 
mutants, called cavN-18 and amN-22, showed an identical 
sequencing ladder as amN-113 in that they also revealed a 
Τ • G conversion at nucleotide 1223 (data not shown). 
Our data demonstrate that the oligonucleotide 
pCGAAAGACTACAC has induced the intended mutation in that 
the sixth codon of gene IX has been converted into an amber 
codon. The isolation of amber mutants in this gene further 
demonstrates that gene IX forms an essential gene of phage 
M13, the protein product of which is needed for progeny 
phage production. 
We did not yet characterize the base change involved 
in the amber mutant, called amN-129, which was rescued by 
the IlapII-A fragment. 
T'roperties of the in vitvo-induced amhar nuLants 
To garantee the production of progeny mutant phages, 
the transfection with primed RF-IV DNA was not carried out 
on the conventional serine (Sul) but on the tyrosine 
(SuIII) suppressing strain. This precaution appeared to be 
unnecessary. The data presented in Table I show that the 
mutants amN-113, amN-18 and amN-22 not only gave progeny 
phages on strain KA807 but also on strain KA805 with equal 
efficiency. These mutants could not be propagated, however, 
on a glutamme- or a leucme-suppressing strain. The devia­
ting character of amN-129 is also apparent since replace­
ment of tyrosine by a serine or glutamme residue is now 
tolerated but incorporation of a leucine residue at the 
amber locus does not restore the protein function. 
By genetic complementation studies Lyons and Zinder 
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T a b l e I : S u p p r e s s i o n of t h e ъп u i i r o - i n d u c e d amber l e s i o n s 
i n v a r i o u s s u p p r e s s i n g h o s t s . 
S t r a i n Sul (Ser) S u i l ( G i n ) S u I I I ( T y r ) SuVI(Leu) 
Mutant 
amN-18 2 . 8 κ I O 1 2 3.3 χ I O 7 2 .6 χ I O 1 2 1.2 χ I O 7 
amN-22 2 . 5 χ I O 1 2 1.6 χ I O 7 2 . 5 χ I O 1 2 1.3 χ IO 7 
awiN-113 3.2 χ I O 1 2 2 .4 χ I O 7 2 . 8 χ I O 1 2 1.6 χ I O 7 
amN-129 7 .9 χ I O 1 2 6 . 3 χ I O 1 2 8 .0 χ I O 1 2 
S u p p r e s s i o n i s e x p r e s s e d as t h e e f f i c i e n c y of p l a t i n g on t h e 
v a r i o u s s t r a i n s 
( 2 8 ) w e r e f i r s t t o d e m o n s t r a t e t h a t n o n s e n s e m u t a n t s i n 
g e n e V e x e r t a p o l a r e f f e c t o n g e n e V I I e x p r e s s i o n . As 
g e n e I X i s d i s t a l t o g e n e V I I we f o u n d i t o f p a r t i c u l a r 
i n t e r e s t t o i n v e s t i g a t e w h e t h e r t h i s p o l a r i t y a l s o i n c l u d e s 
T a b l e I I : G e n e t i c c o m p l e m e n t a t i o n v a l u e s be tween v a r i o u s amber 
mutants in genes V, 
am5-H3 
(2m7-H2 
amN-113 
am8-Hl 
атЬ-НЪ 
0.001 
0.002 
0.01 
0.25 
VII, IX and 
am7-H2 
0.002 
0.001 
0.003 
0.07 
VIII 
amN-113 
0.01 
0.003 
0.001 
0.23 
am8-Hl 
0.25 
0.07 
0.23 
0.001 
The values given are the r a t i o s of plaque formers t o t o t a l 
c e l l s p l a t e d , correc ted for w t - r e v e r t a n t s , found in s ing le 
i n f e c t i o n s of both phages. Complementation i s c l a s s i f i e d as 
strong when the r a t i o i s g r e a t e r than 0.15, weak when the 
r a t i o i s between 0.01 and 0.15 and negative when the r a t i o 
i s l e s s than 0 .01 . 
g e n e I X . F o r t h i s r e a s o n s t a n d a r d c o m p l e m e n t a t i o n t e s t s 
w e r e c a r r i e d o u t . Our r e s u l t s , w h i c h a r e s u m m a r i z e d i n 
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Table II, demonstrate that the mutual complementation of 
defined amber mutants in gene V, VII and IX is very low 
but that each of these mutants complement normally with a 
gene VIII amber mutant. These data strongly suggest that 
the contiguous genes V, VII and IX form an operon with 
gene V amber mutants polar on genes VII and IX and with 
gene VII amber mutants polar on gene IX. 
In vitro synthesis of gene IX-protein 
With the aid of a DNA-dependent cell-free protein 
synthesizing system up to now only the products of six out 
of the eight known M13 genes have been identified (29,30). 
For unknown reasons and despite extensive efforts the 
products of genes VI and VII have not been found. On the 
other hand, M13 DNA directs the in vitro synthesis of two 
polypeptides (mol.wt. 12,000 and 3500) which could not be 
assigned to known M13 genes (29-31). One originates from 
the hypothetical gene X, the nucleotide sequence of which 
forms the C-terminal part of gene II. The origin of the 
small polypeptide remained obscure. As the nucleotide 
sequence of gene IX predicts that its translation product 
is only 32 ammo acids long (3,20) and gene IX amber mutants 
are now available, we have carried out coupled trans-
cription-translation analysis to find out whether the 3500 
dalton protein could be the product of this gene. As shown 
in Fig. 4, protein synthesis under the direction of RF-DNA 
derived from amN-113 gives rise to a number of M13-speci-
fied products which are also present among the products 
synthesized under the direction of wild-type M13 RF-DNA. 
Since [35S] cysteine was used as label, synthesis of gene 
VHI-protem cannot be detected as this ammo acid is 
absent in this protein. The sole difference is in the lowe·" 
part of the gel where the absence of the 3500 dalton pro-
tein is noted when synthesis is programmed by the mutant 
RF. Our conclusion therefore is that the in vitro synthesized 
3500 dalton protein is the product of gene IX. 
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F i g u r e 4 : NaDodSO^j-S M urea 
P o l y a c r y l a m i d e g e l e l e c t r o ­
p h o r e s i s of t h e М І З - s p e c i -
f i e d p r o t e i n s s y n t h e s i z e d 
u n d e r t h e d i r e c t i o n of : 
(b) and ( c ) , w i l d - t y p e M13 
RF-DNA 
( a ) , amN-113 RF-DNA 
( d ) , amN-129 RF-DNA 
S y n t h e s i s r e a c t i o n s (a) 
and (b) were c a r r i e d o u t i n 
t h e p r e s e n c e of [ 3 5 s ] c y s ­
t e i n e , r e a c t i o n s (c) and 
(d) i n t h e p r e s e n c e of 
[ H ] p r o l i n e . Roman numer­
a l s i n d i c a t e t h e p r o d u c t s 
s p e c i f i e d by t h e M13 g e n e s . 
The p o s i t i o n of t h e prema­
t u r e l y t e r m i n a t e d am-IV 
p r o t e i n i s i n d i c a t e d w i t h 
a b l a c k d o t . Note t h e a b ­
s e n c e of gene V H I - p r o t e i n 
i n t h e l e f t l a n e s and of 
gene I X - p r o t e i n i n t h e 
r i g h t l a n e s . 
As j u d g e d f r o m t h e p r o t e i n s y n t h e s i s d a t a ( F i g . 4 ) , 
t h e m u t a n t amN-129 b e a r s i t s m u t a t i o n i n g e n e I V . P r o t e i n 
s y n t h e s i s u n d e r t h e d i r e c t i o n o f a m N - 1 2 9 RF-DNA s h o w s t h e 
d i s a p p e a r a n c e o f t h e w i l d - t y p e g e n e I V - p r o t e i n ( 4 8 , 8 0 0 
d a l t o n s ) a n d t h e a p p e a r a n c e o f a n a b o r t i v e l y t e r m i n a t e d 
p o l y p e p t i d e o f a b o u t 4 0 , 0 0 0 d a l t o n s . T h e in y - i t p o - i n d u c e d 
a m b e r m u t a t i o n i s t h e r e f o r e l o c a t e d i n t h e C - t e r m i n a l p a r t 
o f g e n e I V . I t i s w o r t h m e n t i o n i n g t h a t t h i s e x p e r i m e n t 
s u b s t a n t i a t e s o u r c o n c l u s i o n o n g e n e I X - p r o t e i n . S i n c e t h e 
g e n e IX s e q u e n c e l a c k s p r o l i n e , s y n t h e s i s o f t h i s p r o t e i n 
c a n n o t b e d e t e c t e d . 
D I S C U S S I O N 
N e a r l y a l l p h a g e M13 a m b e r m u t a n t s u s e d a t p r e s e n t 
h a v e b e e n s e l e c t e d a f t e r m u t a g e n e s i s o f m a t u r e M13 p h a g e 
p a r t i c l e s w i t h h y d r o x y l a m i n e . T h i s c y t o s i n e - s p e c i f i c 
m u t a g e n i s a priori u n s u i t a b l e f o r t h e i n d u c t i o n o f a m b e r 
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mutants in gene IX as the nucleotide sequence of this gene 
lacks any CAG codons which can be converted into a TAG amber 
codon. On the other hand, the gene IX sequence comprises 
two TAT (Tyr) codons. They are attractive targets for the 
induction of amber mutations since selection of such mu­
tants can be performed with tyrosme-suppressmg strains 
warranting the production of mutant phage progeny. By ъп 
vitro incorporation into closed circular duplex DNA of an 
oligodeoxyribonucleotide complementary to a defined gene 
IX region except for one mismatch at the third base of its 
first TAT codon followed by transfection of .аоіг (SuIII ) 
cells, we have been able to induce and select such gene 
IX mutants. 
With respect to mutant N-129, the amber locus of which 
is in the distal quarter of gene IV, we do not know yet 
which nucleotide change has taken place. The region con­
cerned does not contain a sequence which is complementary 
to the 13-mer. If G-T base pairing is taken into account, 
there are several regions which theoretically can base pair 
with 8 out of 13 nucleotides but in all cases the induction 
of an amber mutant lesion is accompanied by base changes 
in the contiguous codons leading to ammo acid replacements. 
DNA sequence analysis will provide more information on 
which part of the oligodeoxyribonucleotide has actually in­
duced the amber mutation. 
The number of amber mutants obtained was low as com­
pared to the results of other groups (8,9,11). We have no 
clear explanation for this but the reduced efficiency could 
be due to reduced priming efficiency, if this was limiting, 
or due to editing out the mismatched nucleotide by the in­
trinsic 3'-exonuclease activity of ί.σοϊτ DNA polymerase I. 
The mismatched nucleotide in the 13-mer is followed by 5 
nucleotides at the 3'-end. Since Gillam and Smith (11) 
demonstrated that efficient specific mutagenesis already 
can be achieved with primers containing as few as seven 
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nucleotides provided the mismatch is followed by one or 
preferably two nucleotides at the 3'-end, we expect that in 
our case editing out of the mismatch by the 3'-exonuclease 
has not contributed significantly to the reduced efficiency. 
On the other hand, a crucial step in our procedure is the 
immediate ligation of relaxed duplexes without concomitant 
repair of the mismatch by the 5'-exonuclease activity of 
E.aoli DNA polymerase I. For this purpose we used the large 
(Klenow) fragment of this enzyme. Since control experiments 
showed that closed duplexes were formed even when the 
primer was deprived of its 5'-phosphate, we cannot exclude 
that the reduced percentage of amber mutants scored is due 
to remnants of 5'-exonuclease in the Klenow enzyme. 
By Edman degradation studies we recently provided 
evidence that one of the minor capsid proteins of the M13 
phage particle has an N-terminal amino acid sequence which 
fits the DNA sequence of gene IX (5, chapter III). The 
production of an amber codon, starting at nucleotide 1221 
and which is lethal m Su hosts, constitutes a formal 
synthetic confirmation that this reading frame does define 
the gene of an essential protein. Furthermore, we now have 
been able to demonstrate and identify this essential pro-
tein by in vitro DNA-dependent protein synthesis under the 
direction of M13 RF-DNA. 
The most interesting conclusion of our study is that 
synthesis of gene IX-protein is under strict control of the 
expression of its proximal genes V and VII. This is not 
only concluded from the genetic complementation data pre-
sented here but finds now strong support also from our in 
vivo studies with E.coli minicells (31). In this system the 
synthesis of a 3500 dalton protein, the nature of which 
was ambiguous, became apparent m case such minicells 
harboured wild-type M13 RF. It was absent, however, in 
minicells harbouring RF derived from gene V and gene VII 
amber mutants. Now this protein has been identified as the 
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product of gene IX, at augments our conclusion that this 
cluster of genes forms a regulatory unit. The mechanism 
which regulates the expression of these genes will be des­
cribed in detail in chapter V . 
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CHAPTER V 
SYNTHESIS OF THE MINOR CAPSID PROTEIUS OF 
PHAGE Ml 2 IN ESCHERICHIA COLI MINICELLS 
ABSTRACT 
With the aid of differential amino acid labeling tech­
niques and defined M13 amber mutants, it has been demon­
strated that mimcells harbouring M13 Replicative Form DNA 
are capable of synthesizing not only the proteins encoded 
by genes III, V and VIII (Smits, M.A., Simons, G., Konings, 
R.N.H. and Schoenmakers, J.G.G., 1978 Biochim. Biophys. 
Acta 521, 27-44), but also the minor capsid proteins en­
coded by genes VII and IX. Furthermore, it was observed 
that a nonsense mutation in gene V is polar on the expres­
sion of genes VII and IX and that a nonsense mutation in 
gene VII is polar on gene IX. These data indicate that 
genes V, VII and IX form an operon. The molecular basis of 
this mutational polarity will be discussed. 
INTRODUCTION 
The F-specific, filamentous coliphages M13, fd and fl 
consist of a circular single-stranded DNA genome(M 1.98 χ 
IO6; 6407 nucleotides) (1) encased in a flexible tubular 
sheath composed of approximately 2700 molecules of the 
major coat protein (the product of gene VIII, or В protein) 
and 3 - 5 copies each of four minor coat proteins, the pro­
ducts of gene III (A protein), gene VI (D protein) and 
genes VII and IX (C protein) 2-8, chapters II and III, this 
thesis). 
Filamentous phages are unique in that they do not kill 
nor lyse their host cells. During the infection cycle a 
fine balance is maintained between host and phage functions 
and progeny phages are extruded continuously through the 
host cell membrane (for a recent review, see ref. 9). 
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Currently we are interested in the гп г о synthesis of 
the minor capsid proteins encoded by genes VI, VII and IX. 
In addition, we would like to know which mechanism(s) regu-
late(s) the synthesis of these polypeptides. One of the main 
difficulties in studying the ъп vtvo synthesis of M13 spe­
cific polypeptides is that during the infection cycle no 
shut-off of the synthesis of host specific RNA and protein 
occurs. Consequently, identification and characterization 
of phage-specific products among the bulk of gene products 
encoded by the host cell genome is almost impossible. 
To circumvent this problem we have studied the syn­
thesis of phage specific proteins m an in vivo system de­
rived from minicells (10). Mimcells are small DNA-defi-
cient non-growing bodies produced by aberrant cell 
divisions at the polar ends of rod-shaped bacteria. Their 
size is about one tenth the size of whole cells (for a re­
view, see ref. 11). In case the parent strain harbours a 
plasmid, the plasmid is segregated into the minicells and 
these are then capable of synthesizing plasmid-specific RNA 
and protein. When the parent strain is plasmid-free, the 
minicells lack DNA and are incapable of RNA synthesis (12, 
13). Since phage M13 neither lyses nor kills its host cell, 
its replicative form DNA therefore can be considered as a 
plasmid-like extrachromosomal element which during aberrant 
cell division of a M13 infected appropriate E.ooli strain is 
segregated into minicells (10, 14) . Consequently, identifi­
cation of M13 specific polypeptides is greatly facilitated 
in E, eoli minicells . 
In this chapter, it will be demonstrated that in M13 
RF-harbounng minicells the capsid proteins encoded by 
genes III, VIII, IX and VII are made. Furthermore, evidence 
will be presented that synthesis of the minor capsid pro­
teins encoded by gene VII and gene IX is dependent on the 
expression of gene V. 
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MATERIALS AND METHODS 
Bacterial strains and bacteriophages 
S t r a i n s o f Escherichia coli K12 used a r e l i s t e d i n 
Table I . 
Table I: Bacterial strains 
Strain 
Ρ67Θ-54 
DS410,P678-54 χ CSH74 
KMBL 2019 
N359LDS410 X KMBL2019 
Relevant genotype 
thr leu thi lacY 
rpsL minPi тгпв supE 
thr leu thi rpsL 
minh minB 
(F) his trp 
(F) thr leu thi rpsh 
minh minB 
Reference 
Adler et al 115) 
Dougan and Sheratt (16) 
M.B.L. (Ri]swi3k) 
Bacteriophage M13 was from our own stock. The Ml 3 mutants 
am5-H3, am7-H2, arrß-Ul, amS-tìl and ts5-Hl, the characteris-
tics of which have been described (17), were kindly pro-
vided by D. Pratt. The construction of the M13 mutant 
am9-N113 has been described previously (18, chapter IV, 
this thesis). 
Isolation and labeling of minicells 
The minicell-producing strains were grown at 37 С in 
Brain Heart Infusion medium (19). For the preparation of 
minicells from phage M13 infected cells (M13 minicells), 
cultures of the E.coli strain N3591 [sup ) vere infected with 
M13 phages (multiplicity of infection of 50) at a density 
of 2xl08 cells/ml.After an infection period of 3 h at 37 C, 
the culture was spun down for 2.5 min at 3000 rpm in a 
Beekman JA14 rotor (16). Subsequently, the supernatant was 
centrifugad in the same rotor for 15 min at 13,000 rpm. 
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The pellet was suspended in BSG buffer (0.85% NaCl, 0.03% 
КНрРОі+^НгО, 0.06% ЫагНРОі, .2H20, 100 νg/ml of gelatine, pH 
7.7) and minicells were purified by banding on two succes­
sive 5 to 20% linear sucrose gradients. The final prepara­
tions contained less than one viable cell per 5xl05 mini-
cells . 
Purified minicells were suspended in labeling medium 
(M9 minimal medium (19) supplemented with 20 ug/ml of each 
of the four deoxynucleosides, 1 yg/ml of thiamine and 40 
ug/ml of each of the twenty L-amino acids except the amino 
acid used to label the proteins) to an absorbancy of 0.5 at 
620 nm and preincubated for 30 min at 37 C. Then, 50 цСі of 
[35S] methionine (specific activity 800-1100 Ci/mmol) or 150 
pCi of either [3H]arginine, [JH]proline or [3H]tryptophan 
(20-30 Ci/mmol) was added per ml of incubation mixture and 
incubation was continued for another 30 min at 37 C. After 
labeling, the minicells (250 yl) were pelleted and resus-
pended in 50 μΐ of cracking buffer (2). The samples were 
heated for 5 m m in a boiling water bath, chilled and 
frozen at -20oC. 
Polyaarylamide gel electrophoresis 
Analysis of the labeled polypeptides was performed on 
15% Polyacrylamide gels containing 8 M urea and 0.1% 
NaDodSOi, as described in chapter II. Usually, 10 μΐ of the 
35S-labeled or 25 yl of the 3H-labeled minicells samples 
were analysed. After completion of the electrophoresis the 
gels were prepared for fluorography (20), dried in vacuo 
and placed in contact with X-ray film (Kodak RP/R54) at 
-70oC. 
RESULTS 
Protein synthesis in MIZ Replicative Form DNñ-harbouring minicells 
D e s p i t e many e f f o r t s of s e v e r a l g roups , the in vivo 
s y n t h e s i s of t h e p o l y p e p t i d e s encoded by genes VI, VII and 
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IX which form structural elements of the phage filament, 
has not been observed. A major breakthrough was the elu-
cidation of the nucleotide sequence of M13 DNA (1) which 
enabled us to predict the length and amino acid sequence of 
these gene products and to construct amber mutants of their 
genes (18, chapter IV, this thesis). Since in recent years 
E.ooli mimcells have been approved to be a very useful 
system to approach the in vivo synthesis of several phage-
and plasmid-encoded proteins (10,21,22), we have applied 
this system for our studies on the synthesis and the regu-
lation of synthesis of the M13 phage minor capsid proteins. 
Analysis on NaDodSO^ Polyacrylamide gels of the [35S] 
methionine labeled polypeptides synthesized in mimcells 
prepared from phage M13 infected cells revealed that in 
these M13 mimcells a large number of polypeptides ranging 
in molecular weight from 60,000 to 3500 are made (Fig. 1 ; 
lane c). 
To deduce which of these are M13-encoded polypeptides, 
we compared this polypeptide pattern with the patterns of 
the proteins synthesized in mimcells prepared from un-
infected (M13-) cells of strain DS410 and N3591 (Fig. 1 ; 
lanes a and b ) . From these data it can be concluded that m 
M13 mimcells at least five M13 specific proteins are made. 
In M13~ mimcells prepared from strain DS410 (Fig. 1 ; 
lane a) still a number of proteins are made. These poly-
peptides are translated from stable mRNA molecules which 
are chromosomally encoded and segregated into mimcells 
during cell division (23). The major three polypeptides 
have molecular weights of about 37,000, 33,000 and 7000. 
These polypeptides are membrane proteins which form integral 
parts of the outer cell envelope (24). The 37,000 polypep-
tide band corresponds to the matrix protein I which is 
characterized by its tight, noncovalent association with 
peptidoglycan. The 33,000 dalton protein is called polypep-
tide II* and is encoded by the ompA gene (25). The smallest 
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37,000— 
33,000^" 
42,600-
7000— 
Figure 1 : Fluorogram of [-i-5s] methionine labeled polypeptides 
synthesized in minicells. Lane a, polypeptides produced by 
strain DS410; lane b, polypeptides produced by F+ parents 
(strain N3591); lane c, polypeptides produced by bacteriophage 
M13-infected F+ parents (strain N3591). The molecular weights 
of the three major membrane proteins (on the left) and the 
molecular weights of the bacteriophage M13 specific products 
are indicated. Lane d, polypeptides present in uniformly Re-
labeled M13 phages. 
membrane p o l y p e p t i d e (M 7000), d e s i g n a t e d Braun ' s l i p o p r o -
t e i n (26), i s c o v a l e n t l y l i nked t o t he p e p t i d o g l y c a n . The 
l e v e l of s y n t h e s i s of t h e s e t h r e e p o l y p e p t i d e s was depen-
dent on t he age of the c u l t u r e s from which the m i n i c e l l s 
were i s o l a t e d . In m i n i c e l l s i s o l a t e d a f t e r 16 h of c u l t u r e 
growth, t he l e v e l of s y n t h e s i s of t h e s e p o l y p e p t i d e s was 
g r e a t l y reduced . 
In M13- m i n i c e l l s i s o l a t e d from s t r a i n N3591 {Fig. 1; 
l ane b) , b e s i d e s t he major t h r e e membrane p o l y p e p t i d e s a l s o 
s e v e r a l o t h e r p r o t e i n s wi th molecu la r weights r ang ing from 
- 9 0 -
60,000 to 6500 can be noted. Although the conjugative F-
plasmid segregates with a much lower frequency into mini-
cells than most other plasmids, we assume that these poly­
peptides are encoded by the F-plasmid. They are most 
probably products of the DNA transfer ( Lra ) genes (27). 
To identify the M13-specific polypeptides synthesized 
in M13 minicells, use was made of M13 phages bearing dif­
ferent amber mutations. In addition, protein synthesis was 
studied in the presence of different 3H-labeled amino acids. 
Infection of the miniceli-producing strain with M13 
phages carrying an amber mutation in either one of the 
genes III, V and VIII resulted in the disappearance of poly­
peptides with a molecular weight of 42,600, 9700 and 5200, 
respectively. The conclusion therefore seems to be justi­
fied that in M13 minicells at least the phage-specific 
proteins encoded by genes III, V and VIII are made (10, cf 
Fig. 3). 
As gene VHI-protein lacks arginine (28) and gene V-
protein lacks tryptophan (29), the synthesis of these poly­
peptides can also be demonstrated by analysing [3H]arginine 
or [3H]tryptophan labeled M13 minicells. This is shown in 
Fig. 2. In M13 minicells labeled with t3H] arginine, no 
polypeptide is detectable which co-migrates with the major 
coat protein encoded by gene VIII (Fig. 2; lane b). In the 
fluorogram of the polypeptides synthesized in M13 minicells 
labeled with [3H] tryptophan the absence of gene V-protein 
can be noted (Fig. 2; lane f). 
As shown in Fig. 1 (lane c), the smallest polypeptide 
synthesized m M13 minicells co-migrates exactly with the 
minor capsid protein, designated С protein present in 
mature M13 phage particles (Fig. 1; lane d). This polypep­
tide is also detectable on the gel electropherogram in case 
the M13 minicells are labeled with the ammo acids [ 3H] 
arginine and [3H] tryptophan (Fig. 2; lanes b and f) . It is 
absent, however, in M13 minicells which were labeled with 
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ARG PRO TRP 
- + - + - + 
-P 
Ρ'· 
à—ν -ρ 
Vil i-Ρ 
— IX -Ρ 
f 
Figure 2 : Fluorogram of the polypeptides synthesized in 
minicells. Lanes a, c, e: polypeptides synthesized by un­
infected F+ parents (strain N3591) and labeled with [3Й 
arginine, [3H]proline and [Зн] tryptophan, respectively. 
Lanes b, d, f: polypeptides synthesized by F+ parents in­
fected with wild-type bacteriophage M13 and labeled with 
[Зн] arginine, [-^ н] proline and t Η] tryptophan , respectively. 
Note the absence of the lipoprotein (M
r
 7000) in proline 
and tryptophan labeled minicells (lanes c-f). These data 
are consistent with the amino acid composition of this 
protein which lacks these amino acids. 
[ 3 H ] p r o l i n e (Fig . 2; l a n e d ) . I t s s i z e of approx imate ly 
3500 d a l t o n and i t s amino a c i d l a b e l i n g p r o p e r t i e s co­
o r d i n a t e w i t h t h a t of gene I X - p r o t e i n . To d e m o n s t r a t e unam­
b i g u o u s l y t h a t t h i s very smal l p o l y p e p t i d e , s y n t h e s i z e d in 
vivo , o r i g i n a t e s from gene IX, we made use of t h e r e c e n t l y 
c o n s t r u c t e d M13 mutant am9-N113 ( 1 8 ) . M i n i c e l l s c a r r y i n g 
r e p l i c a t i v e form DNA d e r i v e d from t h i s mutant did n o t show 
any s y n t h e s i s of t h e 3500 d a l t o n p o l y p e p t i d e (Fig . ЗА; 
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lane e). We therefore conclude from these data that this 
band consists of the polypeptide encoded by gene IX. 
As demonstrated in chapter III, С protein isolated 
from purified Ml 3 virions consists of a mixture of the 
polypeptides encoded by gene VII and gene IX. To provide 
evidence that the 3500 polypeptide made in mimcells also 
consists for a part of gene Vll-protem, differential amino 
acid labeling studies with [3H]aspartic acid, an amino acid 
which is only present in gene Vll-protem, were performed. 
These attempts, however, have been unsuccessful. On the 
other hand, infection of the minicell-producing strain 
N3591 with the M13 mutant am7-H2, followed by fractionation 
of the labeled miniceli polypeptides on Polyacrylamide gels, 
also resulted in the disappearance of the 3500 polypeptide 
band (Fig. ЗА; lane d). Although this undoubtfully indi­
cates that gene VII-proteir is made in mimcells, a defi­
nite proof cannot yet been given due to the fact that 
synthesis of gene Vll-protem based on [3H]aspartic acid 
incorporation is to low to be detected. 
To identify the minor capsid protein encoded by gene 
VI (D protein) among the miniceli products, use was made 
of the characteristics that the amino acid sequence of this 
12,600 dalton protein lacks histidine but has an unusually 
high leucine content (1). M13 mimcells labeled with [ 3H] 
histidine, however, did not show the disappearance of a 
polypeptide of around 12,600 dalton, whereas M13 mimcells 
labeled with [3H]leucine did not reveal the appearance of 
an intensified band of this molecular weight (data not 
shown). Furthermore, the autoradiograph of the polypeptides 
synthesized in mimcells carrying M13 атв-Ul RF was 
identical to that of mimcells harbouring wild-type M13 RF. 
The failure to detect the synthesis of gene VI-protein is 
still unclear but might be due to the extreme hydrophobicity 
of this protein (1). 
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Co-ordinate expresszon of genes V, VII and IX 
By genetic criteria, Lyons and Zinder (30) have 
demonstrated that gene V nonsense mutations are polar on 
gene VII. By studying the complementation behaviour between 
amber mutants in genes V, VII and IX (18, cf chapter IV), 
we furthermore could demonstrate that a nonsense mutation 
in gene V is also polar on gene IX and a nonsense mutation 
in gene VII is polar on gene IX. These data suggest that 
genes V, VII and IX form an operon. As the synthesis in 
gene IX-protem is very well detectable m L.coli mimcells, 
we investigated the co-ordinate expression of these three 
genes in more detail. 
We therefore infected the minicell-producing strain 
N3591 with either one of the M13 mutants отБ-НЗ, am7-H2, 
am9-N113 and am8-Hl. Subsequently, the polypeptides were 
labeled with [35s]methionine and fractionated on NaDodSO^ 
Polyacrylamide gels. As shown in Fig. ЗА, in am 5-H3 RF-
harbounng mimcells (lane c) the absence of both gene V-
protein and gene IX-protem can be noted. Gene IX-protein 
is also absent m aml-B2 and am9-N113 M13 RF-carrymg mini-
cells (lanes d and e). On the other hand, am8-Hl RF-
harbounng mimcells synthesize gene IX-protein to almost 
the same extent as wild type M13 RF-harbounng mimcells 
(lane f). These data are in complete accordance with our 
genetic complementation studies. Both studies indicate that 
genes V, VII and IX form an operon and that expression of 
gene VIII is not controlled by its proximal gene cluster. 
The observed polar effect is due to the absence of 
synthesis of gene V-protein and not to biologically active 
gene V-protein itself. This conclusion emerged from our 
observation that M13 mimcells harbouring the DNA of a 
temperature sensitive gene V mutant (ts5-Hl) were capable 
of synthesizing gene IX-protein at both the permissive and 
non-permissive temperature. Both polypeptides profiles were 
practically identical to that of wild-type M13 mimcells 
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(data not shown). A p p a r e n t l y , t r a n s l a t i o n of t h e messenger 
RNAs coding f o r gene V - p r o t e i n i s r e q u i r e d f o r a f a i t h f u l 
e x p r e s s i o n of genes VU and IX. 
Figure 3 : Fluorogram of [3 5s]methionine labeled polypeptides 
synthesized in minicells produced by strain N3591 infected with 
different M13 amber mutants. Lane a, non-infected; lane b, 
infected with bacteriophage M13 wild-type; lane c, infected with 
M13 am5-H3; lane d, infected with M13 аот7-Н2,· lane e, infected 
with M13 am9-N113,· lane f, infected with M13 am8-Hl. A; exposure 
time 120 h. B; exposure time 600 h. 
A p r e r e q u i s i t e f o r t h e e x i s t e n c e of t h e gene V-VII-IX 
operon model i s t h a t in a77i9-N113 RF-harbour ing m i n i c e l l s 
s t i l l gene V- and gene V I I - p r o t e i n should be made. As shown 
in F i g . ЗА ( l a n e e) , M13 a?7i9-Nll3 R F - c a r r y i n g m i n i c e l l s 
indeed d i r e c t t h e s y n t h e s i s of a s u b s t a n t i a l amount of gene 
V - p r o t e i n . However, t h e r e a r e no i n d i c a t i o n s f o r t h e syn­
t h e s i s of gene V I I - p r o t e i n . As d e m o n s t r a t e d i n c h a p t e r I I I , 
gene V I I - p r o t e i n has t h e same e l e c t r o p h o r e t i c m o b i l i t y on 
P o l y a c r y l a m i d e g e l s as gene I X - p r o t e i n . To f i n d o u t whether 
gene V I I - p r o t e i n i s made in very low amounts i n M13 am9-
N113 RF-harbour ing m i n i c e l l s , we have exposed t h e g e l 
e l e c t r o p h e r o g r a m of F i g . ЗА t o X-ray f i l m f o r a l o n g e r 
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period of time. As shown in Fig. 3B (lane e) , a faint band 
with a molecular weight of 3500 can now be noted. This 
polypeptide can be labeled with [35s]methionine and [35S] 
cysteine but not with [3H] tryptophan, indicating that it is 
the product encoded by gene VII. 
DISCUSSION 
Minicells have proven to be a useful tool for studying 
the expression of bacteriophage M13 RF in vivo. With the aid 
of defined M13 amber mutants and differential labeling 
techniques, it could be demonstrated that in minicells the 
major capsid protein encoded by gene VIII and three minor 
capsid proteins encoded by genes III, VII and IX are made. 
We have been unable, however, to detect the synthesis 
of the minor capsid protein encoded by gene VI. The failure 
to detect the synthesis of this protein might be due to its 
extreme hydrophobicity (1). 
Gene IX-protein and gene VII-protein are present with­
in the phage particle in almost the same molar amount 
i.e. 3-4 copies per mature virion (chapter III). The 
difference in the amount of gene VII-protein and gene IX-
protein synthesized in minicells, however, is remarkable 
(Fig. 3B). A possible explanation might be that in case it 
is not immediately packaged into M13 virions, gene VII-
protem is very unstable and rapidly degraded in Г.ооіг 
minicells. 
One of the most important conclusions which could be 
drawn from our in vivo protein synthesis studies is that a 
nonsense mutation in gene V is polar on the expression of 
genes VII and IX and that a nonsense mutation in gene VII 
is polar on the expression of gene IX. This mutational 
polarity could be regulated at the level of transcription 
or at the level of translation. A better insight in the 
mechanism of this mutational polarity should enable us to 
understand the diversity in expression of genes VII and IX 
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compared to gene V. 
Regulation at the level of transcription can be due to 
transcriptional termination mediated by the termination 
factor rho (31). According to this model, rho will terminate 
transcription when it has free access to growing RNA chains. 
A nonsense mutation, for instance, in the first gene of the 
observed Operon i.e. gene V, causes premature polypeptide 
chain termination. As a consequence, the region of the mRNA 
between the nonsense codon and the beginning of the next 
gene i.e. gene VII, remains unoccupied with nbosomes. At 
the "naked1 part of the mRNA, vho is able to attach and to 
induce premature termination of transcription. Consequently, 
the amounts of mRNA sequences downstream to the mutated 
gene are greatly reduced and synthesis of gene Vll-protem 
and gene IX-protein will not occur. This kind of mutational 
polarity caused by rho , however, is rather unlikely since 
the patterns of mRNA species in t.colt cells infected with 
wild-type M13 phages or with M13 phages bearing an amber 
mutation in either gene V, VII or IX are indistinguishable 
(32) . 
Regulation of gene expression at the level of trans-
lation can be controlled by secondary or tertiary structures 
in the mRNA within or around their ribosome binding sites. 
Examination of the M13 DNA sequence has learned us that 
immediately in front of gene VII and gene IX stable hairpin 
structures can be formed (33). In case nbosomes are pre-
maturely released from the nascent RNA chain e.g. at the 
position of the am5-H3 and am7-H2 nonsense mutation, these 
nbosomes are not able to reach the end of gene V or gene 
VII message and consequently, the hairpin can be formed. 
This structure will prevent, by stenc hindrance, the 
attachment of a 30S nbosomal subunit to the initiation 
codon of gene VII or gene IX, respectively, and consequent-
ly, the synthesis of gene VII- or gene IX-protem cannot 
occur. A similar phenomenon of stenc hindrance has been 
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found for the expression of the A protein gene and the 
replicase gene in bacteriophage MS2 (34). 
Another regulatory mechanism to be considered is that 
de novo nbosome binding and initiation at the translational 
start sites of gene VII and gene IX cannot occur and that a 
nbosome already translating gene V, upon termination, is 
able to reinitiate and to start translation of the next 
cistron. The same type of regulation might also be respons­
ible for the translation of the gene IX cistron upon 
termination of the gene VII cistron. 
To get more insight in the mechanism(s) by which the 
expression of genes VII and IX is regulated, we have cons­
tructed recombinant plasmids which contain various parts of 
the gene V-VII-IX operon. Expression of these chimeric 
plasmids has been studied by means of in ог о protein syn­
thesis in L.colb minicells and with the aid of genetic 
complementation tests. The results of these studies will be 
presented in chapters VI and VII. 
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CHAPTER VI 
EXPRESSION OF IN VITRO CONSTRUCTED RECOMBINANT PLASMIDS 
CARRYING VARIOUS PARTS OF THE GENE V-VII-IX OPERON 
ABSTRACT 
Chimeric plasmids have been constructed by insertion 
of M13 DNA fragments, encompassing various parts of the 
gene V-VII-IX Operon, into the unique EcoRI site of the 
promoter-probe plasmid pBRH2. Expression of these recom-
binant plasmids has been studied in E.aoli mmicells. In 
addition, the ability of these plasmids to complement M13 
amber mutants has been investigated. These studies have 
shown that the mRNA which is initiated at the G- .„ promo-
ter, located immediately in front of gene IX, does not 
synthesize gene IX-protein. Furthermore, the data demon-
strate that the synthesis of the polypeptides encoded by 
genes VII and IX occurs on recombinant plasmids which carry 
the entire cluster of genes V, VII and IX. These data de-
finitely proof that our previous assumption that genes V, 
VII and IX form an operon, is correct. 
INTRODUCTION 
The genome of bacteriophage M13, a small filamentous 
male-specific coliphage, consists of a circular single-
stranded DNA molecule on which ten genes are located (1). 
As the phage encoded polypeptides are synthesized in the 
infected cell m vastly different amounts, their synthesis 
must be regulated. 
Numerous in vitro and in vivo transcription studies have 
demonstrated that during the life cycle of bacteriophage 
M13 its DNA region encompassing the genes II through VIII, 
is subjected to a cascade-like mechanism of transcription 
(2-6) . According to this regulatory mechanism, RNA synthe-
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sis is initiated at different promoter sites but is termin­
ated at only a single гйо-independent termination signal, 
which is located immediately after gene VIII (see genetic 
map of bacteriophage МІЗ; Fig. 1, chapter I). This leads to 
a stepwise gradient of transcriptional activity along the 
phage genome and results in an maximum expression of those 
genes the products of which during the infection cycle are 
most abundantly needed г.е. the helix-destabilizing protein 
encoded by gene V and the major coat protein encoded by 
gene VIII. 
Just in between genes V and VIII two small genes are 
located i.e. genes VII and IX which code for minor capsid 
proteins (7-9, chapters II and III). In accordance with the 
cascade transcription mechanism the latter genes are trans­
cribed very frequently. Their polypeptides, however, are 
made in the infected cell m only very small amounts. This 
strongly suggests that synthesis of the proteins encoded 
by genes VII and IX is not regulated at the level of trans­
cription but at the level of translation. 
To acquire a better understanding of the regulatory 
mechanism underlying the synthesis of gene VII-protein and 
gene IX-protein, we have investigated their synthesis in 
other genetic environments. For this purpose, various re­
combinant plasmids were constructed which contain appropri­
ate M13 DNA fragments inserted into the plasmid pBRH2. The 
expression of these recombinants, which were constructed to 
contain gene IX and several extensions 5'-ward of gene IX, 
have been studied in E.ooli minicells and have been analysed 
in their capability of complementing defined phage amber 
mutants. 
MATERIALS AND METHODS 
Bacterial strains and phages 
Escherichia coli K12 strains used were: KA798 (F'pro 
lac) ara pro lac thi, KA805 (KA798) nalA rif supD, DS410 thr leu 
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thí rpsL тъпА тггіВ and JA221 C^QQ hscM hsdR trp 5 leu recA from P. 
Pouwels, R i j s w i j k . The M13 amber mutants am5-H3, am7-H2, 
a77i7-H3 and am8-Hl were o r i g i n a l l y o b t a i n e d from D. P r a t t . 
The c o n s t r u c t i o n and c h a r a c t e r i z a t i o n of t h e M13 mutant 
CWI9-N113 has been d e s c r i b e d p r e v i o u s l y (10, c h a p t e r IV) . 
Materials 
Restriction endonucleases were from New England Bio-
labs. T4 polynucleotide kinase was purchased from P.L. 
Biochemicals and calf intestine phosphatase (CIP) from 
Boehringer. T4 DNA ligase was prepared from an induced 
lysogen of XTAlig phage NM989 (11). Linker molecules 
(5'-GGAATTCC-3') were purchased from Collaborative Research, 
Waltham. Plasmid pBRH2 was obtained from H. Heyneker. 
Isolation of DNA 
Plasmid DNA was isolated essentially as described by 
Clewell (12). The same method was used for the isolation of 
bacteriophage M13 RF from infected cells. Rapid screening 
of recombinant plasmid clones was performed on 10 ml 
cultures according to the method of Klein et al. (13). M13 
DNA restriction fragments were fractionated on 5% Poly­
acrylamide gels containing E-buffer (40 mM Tris-HCl, 20 mM 
sodium acetate, 2 mM EDTA, pH 7.8). After electrophoresis, 
gel segments containing the DNA fragments were excised and 
the DNA was eluted electrophoretically using an ISCO sample 
concentrator. The buffers used were 100 mM Tris-borate, 
1 mM EDTA, pH 8.3 (2 χ TBE) in the electrode compartments 
and 0.2 χ TBE in the inner compartments. The eluted DNA was 
recovered by ethanol precipitation. 
Construction of ahimeria plasmids 
Recombinant DNA molecules were constructed essential­
ly as described by Van Wezenbeek (14). Blunt-ended M13 DNA 
fragments were created by incubation of 2 pmoles of frag­
ments with T4 DNA polymerase (0.5 units) m a 20 μΐ reaction 
mixture containing 25 mM Tris-HCl pH 7.6, 10 mM МдСІ2, 10 
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mM DTT, 0.15 тМ dNTP. After incubation for 20 minatl50C, 
T4 DNA polymerase was inactivated by heating the reaction 
mixture for 5 m m at 65 C. Chemically synthesized DNA 
octamers (GGAATTCC) containing the Eoo RI endonuclease 
cleavage site (150 pmoles) were phosphorylated at their 5' 
ends with T4 polynucleotide kinase during 45 min at 37 С in 
a 20 vi 1 reaction mixture containing 25 mM Tris-HCl pH 7.6, 
10 mM МдСІ2 , 10 mM DTT and 0.1 mM [γ-32Ρ]ΑΤΡ (specific 
activity 50 Ci/mmol). The 32P-labeled linker molecules were 
added to the blunt-ended M13 DNA fragment solution and the 
reaction mixture was adjusted to 1 mM ATP. After the addi­
tion of 2-3 μΐ of T4 DNA ligase (the optimal amount of 
enzyme needed to lígate blunt-ended fragments was tested 
on a small scale with 32P-labeled linker molecules),liga-
tion was performed at 15 С for 3 h followed by o/n in­
cubation at 4 C. Subsequently, the mixture was subjected to 
electrophoresis on a 5% Polyacrylamide gel in TBE buffer 
and the M13 DNA fragments containing £eoRI linker molecules 
were eluted electrophoretically from the excised gel seg-
ments . 
M13 fragments with Eco RI-cohesive ends were then 
generated by digestion of the DNA recovered from gelseg-
ments with a vast excess (20 units) of £coRI endonuclease 
during 30 min at 37 С in a 10 ul reaction mixture contain­
ing 100 mM Tris-HCl pH 7.6, 10 mM МдСІг , 10 mM DTT and 
50 mM NaCl. Endonuclease was inactivated by heating for 
10 min at 65 C. Subsequent ligation to 0.2 ug of LooRI-
lineanzed pBRH2 was carried out in a reaction mixture of 
40 μΐ containing 25 mM Tris-HCl pH 7.6, 10 mM МдСІ2 , 
10 mM DTT, 12.5 mM NaCl and 0.25 mM ATP. The amount of T4 
DNA ligase added was 10 times less than in the blunt end 
ligation reaction. After ligation for 3 h at 150C, the 
mixture was used directly for transformation. 
Transformatbon 
Preparation of competent E.aoli JA221 cells and subse-
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quent transformation was essentially as described by 
Kushner (15). Routinely,half of the ligated DNA mixture 
(20 ul) was added to 4 χ 10 й cells (100 yl). After a heat 
shock for 30 seconds at 45 C, 5 ml of Luna broth was added 
and cells were kept at 37 С for 60 min without shaking. 
Transformed cells were concentrated by centrifugation and 
spread on five Luna Broth nutrient plates supplemented 
with ampicillin at a concentration of 20 ug/ml and tetra­
cycline at 5 yg/ml. 
Hybridization to M13 DNA 
Recombinant plasmid DNA obtained from mimscreen 
isolates was denatured by heating for 5 min in a boiling 
water bath, rapidly frozen at -80 С and spotted on nitro­
cellulose filters (each spot contained l/50th of the amount 
of DNA isolated from a 10 ml culture) filters were dried 
and baked in vacuo at 80 С for 2 h. Prehybridization and 
hybridization of the filters was performed in Denhardt 
solution supplemented with 50 yg/ml of salmon sperm DNA as 
described by Humphries et al. (16). Hybridization was per­
formed m small sealed plastic bags with 1 ml of "P-label-
ed (nick translated) M13 RF (specific activity 10 6 cpm/yg 
DNA). Filters were washed twice with 2 χ SSC (150 mM NaCl, 
15 mM Na-citrate) , 0.5Sá NaDodSC^, followed by washing in 
0.5 χ SSC (each wash at 60oC for 1 h). Filters were dried 
at room temperature and subjected to radioautography. 
Complementation analysis 
The non-suppressor strain E.ooli KA798 was transformed 
with purified supercoiled recombinant plasmid DNA according 
to the method of Kushner (15). Cells were grown at 37 С in 
L-Broth (IX Bacto tryptone, 0.5% Bacto yeast extract, 1% 
NaCl, 0.1% glucose, pH 7.2)supplemented with 20 pg/ml of 
ampicillin and 5 ug/ml of tetracycline. The M13 amber mu­
tant phages were titered on these cells and the number of 
plaque forming units was determined by plating with 10 ml 
of CW agar. Plates were incubated o/n at 370C. 
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Synthesis of MIZ spécifia proteins in miniaells 
The miniceli producing E.coli stram DS410 was trans-
formed with recombinant plasmids using the method of 
Kushner (15). Each strain harbouring a plasmid, was grown 
for 16 h at 37 С in Brain Heart Infusion medium in the 
presence of ampicillin (20 pg/ml) and tetracycline (5 ug/ 
ml). The methods used for the isolation and labeling of the 
minicells has been described (chapter V ) . Fractionation of 
the labeled polypeptides on Polyacrylamide gels was as 
described m chapter II. 
RESULTS 
Molecular cloning and characterization of transformants 
The molecular cloning of individual genes or gene 
clusters of bacteriophage M13 into plasmid vectors provides 
a new tool for studying the mechanisms by which the expres­
sion of the M13 genome is regulated. As cloning vehicle, 
we have chosen for the multicopy plasmid pBRH2 (M 2.7 χ 
IO 6)(17). This plasmid is almost identical to pBR322 (18). 
It contains, in addition to the ampicillin resistance (Ap ) 
gene, the entire tetracycline resistance (Te ) gene. It 
lacks, however, the RNA polymerase recognition site of the 
promoter which is located immediately in front of the Tc 
gene. As a consequence, expression of the Tc gene in 
pBRH2 is extremely low. Immediately in front of the Tc 
gene a unique ico RI site is located. We have chosen this 
site for the insertion of M13 DNA fragments. As all frag­
ments applied contain at least one promoter site, insertion 
in the right orientation of a DNA fragment into this site 
will raise the tetracycline resistance level of the trans­
formed cell significantly (14,19), thus allowing a positive 
selection method. 
The strategy which has been followed for cloning M13 
DNA fragments is schematically presented in Figure 1. Each 
fragment was made blunt-ended and then provided with sticky 
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MIGONA 
fragment — 
Tt polymi 
Ti. ligase 
Figure 1 : Diagrammatic representation of the construction of 
recombinant plasmids. Numbers indicate the separate biochemical 
steps between the reisolation of the products. Apr and Tc r 
represent the ampicillin or tetracycline resistance genes, 
respectively. 
ends c h a r a c t e r i s t i c for fco R I - g e n e r a t e d DNA f r a g m e n t s . 
A f t e r in vitro l i g a t i o n in t h e p r e s e n c e of E c o R I - l i n e a n z e d 
pBRH2 and s u b s e q u e n t t r a n s f o r m a t i o n of E.aoli competent 
c e l l s , as d e s c r i b e d under M a t e r i a l s and Methods, t r a n s f o r ­
mants were s e l e c t e d on t h e b a s i s of r e s i s t a n c e a g a i n s t t h e 
a n t i b i o t i c s a m p i c i l l i n and t e t r a c y c l i n e . Under t h e con­
d i t i o n s used, 1-6% of t h e a m p i c i l l i n r e s i s t a n t t r a n s f o r ­
mants were a l s o r e s i s t a n t a g a i n s t a c o n c e n t r a t i o n of 5 pg/ 
ml of t e t r a c y c l i n e (250-1500 c o l o n i e s ) . 
To v e r i f y whether indeed t h e s e t r a n s f o r m a n t s c o n t a i n e d 
a p lasmid w i t h t h e expected i n s e r t e d s e q u e n c e s , t r a n s ­
formants were grown up in smal l s c a l e l i q u i d c u l t u r e s and 
t h e p lasmid DNA was i s o l a t e d ( 1 3 ) . A l i q u o t s of t h e i s o l a t e d 
DNA were a n a l y s e d on 1% a g a r o s e g e l s and only t h o s e mole-
rase | I , dNTP 
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cules which were larger than unit-length pBRH2 were further 
characterized by hybridization and restriction enzyme ana­
lysis . 
For the hybridization assay, isolated miniscreen DNA 
was spotted in a denatured form on several nitrocellulose 
filters and hybridized to 32P-labeled M13 RF and/or 3 ? P -
labeled M13 restriction fragments (data not shown). Only 
recombinant plasmids which exhibited strong hybridization 
to the 32P-labeled M13 fragment used for insertion, were 
analysed m detail with respect to insert length and orien­
tation . 
Ίο this end, recombinant plasmid DNA was isolated on a 
preparative scale, purified and digested with several 
restriction endonucleases. The digests were fractionated on 
Polyacrylamide gels. Digests of several representative 
clones are exemplified in Fig. 2. The inserted M13 fragment 
Hin fI-A/ HaeXïI-B present in a plasmid pGS551 was character-
ized by digestion with restriction enzyme Hhal. The esta-
blished nucleotide sequence of pBR322 (20) and its deriva-
tive pBRH2 (17) dictates that Hhal cleavage sites are lo-
cated 101 base pairs to the left and 79 base pairs to the 
right of the EcoRI site. Fragment Нгпі-А/Нае III-B contains 
three Ilhal-sites dividing the fragment into four parts of 
290, 75, 93 and 219 base pairs. The 290 bp- and 219 bp-
fragments are located at the 5'- and 3'-ends, respectively. 
As shown in Fig. 2,lane g, one of the two 180 base pairs 
fragments is absent in the digestion pattern of the recom­
binant plasmid pGS551 and two new bands are visible speci­
fying fragments with a length of 395 and 302 base pairs. 
These sizes are expected if the 5' -»• 3 ' polarity of the 
viral strand is directed towards the Tc r gene (101 base 
pairs pBRH2 + 4 base pairs linker DNA + 290 base pairs M13 
DNA and 219 bp рШН2 +4 bp linker DNA + 79 bp M13 DNA, res­
pectively) . In a similar way, the exact length and the 
orientation of the M13 DNA inserts in the other phage M13-
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Figure 2 : Hhaï cleavage p a t t e r n s of the constructed recombinant 
Plasmids. Elec t rophores is was performed on a 4% Polyacrylamide 
ge l . Fragments were v i sua l ized by s t a in ing with 1 yg/ml of 
ethidium bromide. Lane a, pBRH2 ; lane b , pGS912,· lane c, 
pPWSOl; lane d, pGS901; lane e, pGS74 3; lane f, pGS715; lane g, 
pGS551,· lane h, pGSlOll. The s izes in base pa i r s of some 
re levan t fragments are indica ted a t the l e f t . The 180 base pa i r 
fragment (which i s a doublet in pBRH2) contains the unique 
iTeoRI s i t e , used as cloning s i t e . The 395 and 302 base pa i r 
fragments are generated a f t e r d iges t ion of pGS551 with Hhal. 
pBRH2 r e c o m b i n a n t s w e r e d e t e r m i n e d . The r e c o m b i n a n t s we 
h a v e c o n s t r u c t e d f o r t h e p u r p o s e of t h i s s t u d y a r e s c h e m a -
t i c a l l y o u t l i n e d i n F i g . 3 . 
Expression of the recombinant plasmids 
The e x p r e s s i o n of t h e c l o n e d M13 g e n e s h a s b e e n s t u -
d i e d i n two d i f f e r e n t w a y s . F i r s t , we e x a m i n e d t h e c a p a b i -
l i t y o f t h e r e c o m b i n a n t p l a s m i d s t o d i r e c t t h e s y n t h e s i s of 
M13 s p e c i f i c p o l y p e p t i d e s i n E.aoli m i n i c e l l s . F o r t h i s 
p u r p o s e , t h e m i n i c e l l - p r o d u c i n g s t r a i n was t r a n s f o r m e d w i t h 
t h e i n d i v i d u a l r e c o m b i n a n t p l a s m i d s and p l a s m i d - b e a r i n g 
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Figure 3: Schematic representation of the M13 DNA fragments inserted into the unique CcoRI 
site of pBRH2. Part of the genetic map is presented in a linear form at the upper part. The Roman 
numerals refer to the M13 genes. The positions of the ъп vitvo G-promoter sites are indicated 
with black bars. The hatched bar represents the position of the central terminator of transcrip­
tion. The numbers beneath the linear genetic map refer to the first nucleotide of the gene. 
The nucleotide positions of the M13 inserts refer to their position on the M13 genome. All frag­
ments are orientated in the 5' •* 3' polarity of the viral Ml 3 strand (which is the direction of 
transcription on the Ml 3 genome) directed towards the tetracycline resistance gene. 
cells were selected on the basis of ampicillin resistance. 
Minicells were then isolated from liquid cultures of these 
cells, purified, and labeled with several radio-active 
ammo acids. The polypeptides made in minicells were ana­
lysed by NaDodSO L, Polyacrylamide gel electrophoresis follow­
ed by fluorography. 
Second, we investigated whether the recombinant plas­
mi ds are able to complement defined M13 amber mutants. To 
this end, the plasmids were transferred to a non-suppressor 
Е.ооіг strain carrying the F-plasmid by standard transfor­
mation and selection prodedures. Cells bearing the various 
recombinants were infected with amber M13 mutant phages 
and their complementation capabilities were measured by 
determining the number of plaques formed on isogeneic hosts 
which do or do not harbour the recombinant plasmid studied. 
The [35S] methionine labeled polypeptides produced in 
E.ooli minicells harbouring the vector plasmid pBRH2 or 
either one of the constructed recombinant plasmids are 
shown in Fig. 4. In contrast to our studies with minicells 
harbouring M13 RF, the minicells used for studying the ex­
pression of recombinants were isolated after 16 hours of 
culture growth (instead of 3 hours). For this reason, the 
three major membrane polypeptides which are translated from 
stable, host-encoded mRNA species (21), are absent. 
In minicells harbouring a recombinant plasmid (Fig.4,· 
lanes b-h) a number of polypeptides are made which have, 
with respect to their electrophoretic mobility, an equi­
valent among the polypeptides encoded by the vector plasmid 
(lane a). The most strongly labeled polypeptide (M 31,000) 
is the major B-lactamase enzyme (22) which is encoded by 
the ampicillin resistance gene. By comparing the various 
electropherograms of Fig. 4 it is also evident that in 
minicells harbouring recombinant plasmids several polypep­
tides are made which are absent m the pattern of products 
synthesized in pBRH2-harbouring minicells. All recombinant 
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Figure 4 : Fluorogram of[ -'Sjmethionine labeled polypeptides 
synthesized in Е.аоЪъ minicells harbouring the following 
Plasmids: lane a, pBRH2,· lane b, pPWSOl; lane c, pGS901,· lane 
d, pGS912; lane e, pGS715; lane f, pGS743; lane g, pGS551 and 
lane h, pGSlOll. The molecular weights are indicated at the 
le f t . At the right the positions of gene V-protein and gene 
IX-protein are denoted. 
P lasmids ( l a n e b-h) s p e c i f y , though t o a v a r y i n g e x t e n t , 
t h e s y n t h e s i s of a p o l y p e p t i d e wi th a m o l e c u l a r weight of 
37,000. S ince a p o l y p e p t i d e of t h i s s i z e i s n o t encoded by 
t h e v e c t o r p lasmid ( l a n e a) and s i n c e t h i s p o l y p e p t i d e has 
t h e same e l e c t r o p h o r e t i c m o b i l i t y a s t h e p o l y p e p t i d e en-
coded by t h e To gene i n t h e r e l a t e d p l a s m i d s pMB9 and 
pBR322 ( d a t a not shown), we i n f e r t h a t t h i s p o l y p e p t i d e i s 
t h e r e s u l t of i n s e r t i o n a l a c t i v a t i o n of t h e Te gene. 
Bes ides t h e 31,000 and 37,000 d a l t o n s p o l y p e p t i d e s 
mediated by t h e a n t i b i o t i c r e s i s t a n c e genes, t h e recombi­
n a n t p l a s m i d s a l s o d i r e c t t h e s y n t h e s i s of s e v e r a l p o l y ­
p e p t i d e s r a n g i n g in m o l e c u l a r weight from 3,000 t o 10,000. 
As t h e s e p o l y p e p t i d e s a r e a b s e n t i n t h e v e c t o r p lasmid, we 
presume t h a t t h e y a r e encoded by M13 DNA s e q u e n c e s . Only 
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the recombinant plasmids pGS551 and pGSlOll specify a poly­
peptide with a molecular weight of 3500 which is identical 
to that of the products encoded by genes VII and IX. The 
other low molecular weight-polypeptides are most probably 
the result of fusion of codogenic sequences of M13 DNA linked 
to plasmid pBRH2. The fused polypeptides comprise the a m m o 
terminal end of gene VHI-protein, followed by ammo acids 
encoded by the linker DNA and by pBRH2 sequences. The sizes 
of the various fusion products is thus determined by the 
size of the gene VIII fragment present in the recombinant 
plasmid and by the reading frame m which the pBRH2 se­
quence is translated. In all recombinants constructed, 
translation of the gene VHI-sequence into the pBRH2 se­
quence results in abortive termination at either one of the 
three stop codons located at 5,13 or 27 nucleotides down­
stream the EaoRI site. This is exemplified in the pattern 
of products of pPWSOl and pGS901. The sizes of their 
fusion products (5000 and 6500 dalton, respectively) are in 
accordance with the lengths of their gene VIII inserts (cf, 
Fig. 3). 
In the ammo acid sequence of the fused polypeptides, 
as predicted from the nucleotide sequence, the amino acid 
cysteine is lacking. On the other hand, gene VII- and gene 
IX-protem contain one cysteine residue. To facilitate the 
characterization of the M13 specific polypeptides encoded 
by genes VII and gene IX, we have labeled the plasmid-
containing mimcells with this ammo acid. As shown in Fig. 
5, among the polypeptides synthesized in Е.соіг mimcells, 
the fused polypeptides are no longer visible. In the mini-
cells which harbour the plasmids pGS551 or pGSlOll, the 
polypeptides which comigrate with gene VII- or gene IX-
protein is, however, still detectable. 
Amino acid labeling studies furthermore have demon­
strated that the 3500 polypeptide can be labeled with 
[3H]tryptophan, an amino acid which is characteristic for 
-113-
Figure 5 : Fluorogram of l-"s] cysteine labeled polypeptides 
synthesized in E.eoli minicells carrying the following Plas-
mids: lane a, pBRH2; lane b, pPWSOl; lane c, pGS901; lane d, 
pGS743; lane e, pGS551; lane f, pGSlOll. The positions of 
gene V-protein and gene IX-protein are denoted at the r ight . 
gene I X - p r o t e i n . Al l t h e s e d a t a a r e c o n s i s t e n t wi th t h e 
assumption t h a t t he 3500 p o l y p e p t i d e r e p r e s e n t s t he p roduc t 
of gene IX. No c o n c l u s i v e answer can y e t be given whether 
t h i s smal l p o l y p e p t i d e c o n s i s t s a l s o of gene V I I - p r o t e i n . 
A comple te ly d i f f e r e n t approach for d e t e c t i n g gene IX-
and gene V I I - p r o t e i n i s based on complementat ion t e s t s . For 
t h i s purpose t h e n o n - s u p p r e s s o r s t r a i n KA798 h a r b o u r i n g 
t h e v a r i o u s recombinant p lasmids was i n f e c t e d wi th phages 
c a r r y i n g an amber muta t ion w i t h i n gene VII or gene IX. I f 
t h e c lone produces a f u n c t i o n a l gene V I I - or gene I X - p r o -
t e i n , i n f e c t i o n wi th amber mutant phages w i l l then r e s u l t 
in t h e p r o d u c t i o n of phage progeny. Our da t a ob t a ined from 
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these complementation studies are presented in Table I. 
The results completely support our observations made with 
E.ooli minicells. Only strains carrying plasmids pGS551 or 
pGSlOll fully complement M13 phages bearing an amber mu­
tation in either gene VII or gene IX. The .ооіг strams 
which harbour the other recombinant plasmids relieve the 
genetic defects m the different amber mutants only to a 
very small extent (less than 1% than in case of plasmids 
pGS551 or pGSlOll). As one would expect, strains which 
harbour plasmid pGS551 or pGSlOll are also able to comple­
ment M13 mutants which have an amber mutation in gene V. 
Our conclusion from these genetic data is that func­
tional gene Vll-protem and gene IX-protem is made only 
in cells which harbour the plasmids carrying the entire 
operon. They furthermore indicate that the synthesis of 
gene VII- and gene IX-protein is linked to the synthesis of 
gene V-protein. 
To prove that not the presence of a functional gene 
V-protem but merely the translation of the cistron coding 
for gene V-protem is a prerequisite for the translation of 
the cistrons coding for gene VII- and gene IX-protein, we 
have introduced plasmid pGS512 into the non-suppressor host. 
The latter plasmid contains genes X and V but not genes 
VII and IX (Fig. 3). We were interested to see whether this 
strain is able to propagate M13 mutants containing an amber 
mutation within gene V. As shown in Table I, no viable 
phages are extruded after infection with M13 am5-H3, al­
though our protein synthesis studies have shown that in 
these cells a substantial amount of gene V-protein is made. 
These data provide definite proof for our observations that 
the contiguous genes V, VII and IX form an operon and that 
synthesis of the proteins encoded by genes VII and IX is 
directly coupled to the synthesis of the polypeptide en­
coded by gene V. 
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σ. Table I. Complementation values between various M13 amber mutants and the non-suppressor 
1
 strain KA 798 containing recombinant plasmids. 
Am 
Am 
Am 
Am 
9-N113 
7-H2 
7-H3 
5-H3 
E.aoli 
KA805 
(.sup D) 
3.2 χ 10 1 2 
2.7 χ 10 1 2 
12 6.8 χ 10 
2.1 χ 10 1 2 
E. oolt 
KA798 
(SMp ) 
2.4 χ 
6.6 X 
3.1 χ 
3.0 χ 
io7 
io6 
io7 
io6 
KA798 
+ 
pPWSOl 
2.0 χ 10 9 
8.0 χ 10 7 
2.0 χ 10 9 
N.D. 
KA798 
+ 
pGS901 
6.2 χ 10 8 
6.3 χ IO6 
7.0 χ 10 8 
N.D. 
KA798 
+ 
pGS74: 
2.3 χ 
9.0 χ 
1.0 χ 
2.2 χ 
KA798 KA79R 
+ + 
pGS715 pGS551 
10 9 2.1 χ 10 9 2.5 χ 
10 8 1.5 χ 10 8 8.2 χ 
10 1 0 1.5 χ 10102.4 χ 
10 6 6.9 χ 10 7 4.1 χ 
KA798 
+ 
pGSlOll 
1012 7 
l O 1 1 ! ^ 
10121.5 
I O 1 ^ ^ 
X 
X 
X 
X 
io 1 1 
io 1 2 
io 1 2 
io 1 0 
KA798 
+ 
pGS512 
6.4 χ 10 7 
N.D. 
N.D. 
3.0 χ 10 9 
N.D. : not determined 
DISCUSSION 
In the previous chapters IV and V we have presented 
evidence that the synthesis of the minor capsid proteins 
encoded by genes VII and IX is dependent on the expression 
of their proximal gene(s) indicating that the contiguous 
genes V, VII and IX form an Operon. 
To get a better understanding of the regulatory mecha­
nism involved we have dissected the operon into DNA frag­
ments of varying length and have integrated these fragments 
into a promoter-probe plasmid. The various recombinants 
were then tested for their capability of synthesizing the 
proteins encoded by the inserted fragments, either directly 
by analysing the proteins made in Е.ооіг minicells or in­
directly by genetic complementation analysis. 
The combined data now have clearly shown that the same 
regulatory principle underlying the expression of genes V, 
VII and IX in the intact phage DNA genome is also operative 
in the recombinants comprising the operon. Apparently, 
regulation of synthesis of gene V-, VII-and IX-protein, as 
observed in plasmids pGS551 and pGSlOll, is enclosed m the 
DNA sequence of the genes and the regulatory elements con­
cerned. Regulation is neither dependent on the integrity of 
the viral genome nor on any other phage-encoded products 
derived from parts of the genome outside the operon. Our 
data obtained so far are in favour of a model m which the 
expression of genes VII and IX is regulated at the trans-
lational level. This is enforced by our studies with plas­
mid pGS512 which demonstrate that not gene V-protem itself 
but the coupled translation of the gene V-protem-encoding 
polycistronic mRNA is required for the synthesis of gene 
VII- and IX-protein. 
An interesting observation is that recombinant plas­
mids pGS901 and pPWSOl, which carry the entire gene IX se­
quence including the гп г о promoter G
n
 .„, are not capable 
U . 1 о 
of synthesizing detectable levels of gene IX-protein. This 
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is rather striking since cells carrying these recombinants 
show high levels of tetracycline resistance thereby indi-
cating that transcriptional initiation occurs with high 
frequency at this promoter. RNA sequence analysis (23) have 
shown that the distance between the 5' end of this mRNA and 
the initiating AUG codon of gene IX is 11 nucleotides. 
Although the latter sequence shows good complementarity to 
the 3'-OH terminal sequence of 16S nbosomal RNA which is 
characteristic for a ribosome binding site (Shine & 
Dalgarno, ref. 24), it might be too short to allow ribosomes 
to attach to the mRNA. Alternatively, the 5' end of the 
mRNA forms part of a stable stem-loop structure which does 
not allow ribosomes to jump on. In any way, the most impor-
tant conclusion which can be drawn from these data is that 
gene IX-protem synthesis is not possible on mRNA species 
which have started at the G„
 1Q promoter but only on mes-
U . lo 
sages which are initiated at the promoter preceding gene V. 
Although the regulatory principle on gene VII- and 
IX-protein synthesis is thought to occur during the trans-
lation of the polycistronic mRNA encompassing the genes 
concerned, other molecular events have certainly to be 
taken into account. Recent studies of Smits et al. (25) have 
demonstrated that in the infected E.aoli cell the M13-
specific primary transcripts are subject to RNA-processing. 
The 5'-end of one of the most prominent secondary trans-
cripts ( i.e. "9S RNA") is located within gene VII at a dis-
tance of 60 nucleotides upstream of the AUG initiation co-
don of gene IX. From a theoretical point of view this 
secondary transcript has the intrinsic property to synthe-
size gene IX-protein. If true, it implies that synthesis of 
gene IX-protem can be uncoupled from the synthesis of gene 
V- and gene VII-protein. This is, however, in conflict with 
our genetic complementation data (ref. 10, chapter IV) and 
the in vivo protein studies as well (this chapter and chap-
ter V) . 
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The m a m perspective of the results presented in this 
chapter is that the regulatory mechanism operating at the 
gene V, VII and IX Operon can also be studied in other 
genetic environments. To obtain additional information 
about the translational regulatory mechanism which is ope­
rative during the synthesis of gene VII- and gene IX-pro-
tem, we have investigated the expression of genes VII and 
IX under control of a strong external promoter with or 
without a nbosome binding site. These studies will be 
presented in the next chapter. 
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CHAPTER V I I 
TRANSLATIONAL REINITIATION EVENTS UNDtRLYING THE SYNTHESIS OF THE 
MINOR CAPSID PROTEINS ENCODED BY GtNbS VI, VII AND IX 
ABSTRACT 
The mechanism which regulates the synthesis of the 
minor capsid proteins encoded by the M13 genes VII and IX 
has been studied with two new expression plasmids pPW231 
and pGS251. Both plasmids are pBRH2-derivatives which have 
inserted a strong external promoter (M13 gene Il-promoter) 
immediately in front of a unique £coRI site. Plasmid pPW231 
contains in addition the gene II nbosome binding site. 
Insertion of genes VII and IX into the unique EaoRI site 
of these new vector plasmids places their expression under 
control of the gene II promoter with or without the gene 
II nbosome binding site. Both in vivo protein synthesis 
studies as well as genetic complementation tests have shown 
that the nbosome binding sites of gene VII and gene IX are 
not accessible to nbosomes. Instead, translation of gene 
VII and gene IX occurs by nbosomes which have been at-
tached at the gene V nbosome binding site. Termination of 
translation at the end of the gene V message is most 
probably followed by a translational reinitiation event 
allowing the nbosomes to shift their reading frame and, 
as a consequence, to initiate the synthesis of gene VII-
protein. A similar reinitiation event underlies the syn-
thesis of gene IX-protem after termination of translation 
of the gene VII message. 
INTRODUCTION 
Expression of the circular M13 DNA genome must be 
regulated according several regulatory mechanisms since 
some of the Ml 3 gene products, like that of gene V and 
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Vili, are synthesized in the infected E.coli cell in very 
large amounts, others like the gene Ill-product are present 
at moderate levels whereas the products of genes VI and 
VII can hardly be detected. 
One of the mechanisms which undoubtedly contributes 
to the observed diversity of gene expression and which has 
been identified to operate during the transcription of the 
Ml 3 genome, is the so-called cascade transcription mecha-
nism (1). This mechanism, however, cannot give a conclusive 
explanation for the observation that in the infected cell 
only very small amounts of the proteins encoded by genes 
VII and IX are made. Therefore, other regulatory mecha-
nism(s), most probably operative at the level of trans-
lation, must regulate the synthesis of the latter polypep-
tides . 
Our previous studies on the expression of genes V, VII 
and IX (chapters IV, V and VI) have demonstrated that these 
three contiguous genes form an operon. Evidence is also 
provided that the expression of this operon is regulated 
at the level of translation. We assume that gene VII- and 
gene IX-protein are the translational products of a poly-
cistromc mRNA which is initiated in front of gene V and 
that synthesis of the latter polypeptides is dependent on a 
faithful translation of the gene V cistron. In other words, 
synthesis of gene VII- and IX-protein is coupled to the 
translation of the gene V message. 
Several models which account for a translational 
coupling can be postulated. 
First, in the absence of gene V translation the ribo-
some binding sites of gene VII and gene IX on the poly-
cistronic mRNA are 'blocked' due to secundary structures. 
A change in conformation or a RNA-processing event must 
occur in order to make these sites accessible. 
Second, nbosomes which translate the codogenic 
sequence of gene V are admitted to translate the contiguous 
-122-
cistrons coding for gene VII- and gene IX-protein. This 
implies that de novo ribosoire binding at the translational 
start sites of genes VII and IX does not occur. Translation­
al termination at the ends of the gene V and/or gene VII 
message is immediately followed by a shift of the reading 
frame allowing the nbosome (or the 30S nbosomal subunit 
still attached) to initiate the translation of the follow­
ing cistron. 
At the present time there is no convincing experiment­
al data which would either refute or validate either one 
of these hypothesis. We favour, however, the latter model 
since the nucleotide sequence at the gene junctions of 
this operon are considered good candidates for a trans­
lational reinitiation event. 
To gain more insight in this regulatory principle at 
the molecular level we have investigated the expression of 
the minor capsid proteins encoded by genes VII and IX under 
transcriptional control of a strong external promoter and 
under translational control of an efficient nbosome 
binding site. 
MATERIALS AND METHODS 
Recombinant DNA teohmques 
The isolation of DNA fragments, plasmid DNA, ligation 
of DNA fragments and transformation of E.ooli cells was 
carried out as described in chapter VI. 
Construction of plasmid pPW231 
For the construction of pPW231 (2) use was made of 
pPW202. The latter plasmid was constructed by providing the 
M13 fragment HaeIII-Ό (nucleotide position 5869-6181) with 
Eco RI linkers, followed by insertion into the unique EcoRI 
site of plasmid pBRH2. Plasmid pPW231 was constructed by 
blunt end ligation of partially EcoRI cleaved pPW202. 
Linear DNA was separated from circular molecules by repeat­
ed electrophoresis on 1% agarose gels. The sticky ends, 
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generated by Eoo RI digestion, were filled in with dNTPs 
and T4 DNA polymerase and the blunt ended DNA fragments 
were subsequently ligated with T4 DNA ligase. As a result 
four additional base pairs are inserted into pPW202 there­
by eliminating an original EaoKl site 
5'-G+AATTC-3' 5'-GAATTAATTC-3' 
3 '-CTTAA^G-S' "" 3' -CTTAATTAAG-5 ' 
τ 
After transformation, two new vector plasmids with a single 
Eoo RI site can be isolated. One with the CeoRI site located 
at the 5'-end of the M13 fragment contained in pPW202 and 
the other with a unique EooRl site at the S'-end just in 
front of the Tcr gene i.e. pPW231. 
Construction and aharacterization of plasmid pGS251 
For the construction of plasmid pGS251 (Fig. 1), 
pGS212 was used as starting material. The latter plasmid 
was obtained by insertion of the M13 fragment Taql-G/HapII-F 
(nucleotide position 5684-5997) in the Eoo RI site of pBRH2. 
Plasmid pGS212 (25 pg) was digested to completion with 
Eoo RI and fractionated on 5% Polyacrylamide gels. The small 
Eoo RI fragment was isolated and digested with Haelll. The 
M13 fragment (nucleotide position 5867-5997) was isolated 
and ligated to S?oRI digested linear pBRH2 (0.3 \ig) with 
T4 DNA ligase. In principle, ligated molecules can be ar­
ranged in two ways but only the possibility which is of our 
interest is shown in Fig. 1. The ligated mixture is then 
treated with Si nuclease (30 U) in a reaction volume of 
100 μΐ containing 30 mM Na-acetate pH 4.6, 300 mM NaCl and 
4,5 mM ZnCl2 in order to remove the cohesive ends of the 
vector plasmid. After 30 m m at 22 С and 15 m m at 10 С 
(3), the mixture was phenolized and the DNA was concentrated 
with ethanol. Circulanzation was achieved by the action 
of T4 DNA ligase. Transformation resulted in recombinants 
with a unique Eoo RI site i.e. pGS251. 
Plasmid pGS251 was characterized by double digestion 
with EccRI and PstI, as shown in Fig. IB. The EooRI/PstI 
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AATTCCC 
of pGS2t2 
НаеШ 
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GG 
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endonuclease 
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- G G G 
—CCCTTAA G-
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A p / 
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Г 
•щ^ 
xKv 
pBRH2 И 
w 
EcoRI endonuclease 
τ 
5869 5997 
φ T4 DNA ligase (sticky end) 
@ SI nuclease 
Pst I 
748 
Figure 1 : Diagrammatic representation of the construction of 
Plasmid pGS251 (for detai ls see Materials and Methods). 
B; EaoRl/PstI double digestion pattern of the following 
Plasmids: lane a, pBRH2; lane b, pGS251; lane c, pGS212. 
Fragments were analysed on a 1% agarose/4% Polyacrylamide gel 
and visualized by staining with ethidium bromide. 
The sizes of the fragments are indicated at the le f t . 
d i g e s t i o n p a t t e r n of pBRH2 ( l a n e a) shows two f ragments of 
3588 and 748 base p a i r s . Double d i g e s t i o n of pGS212 r e s u l t s 
(lane c) i n t h r e e f ragments of which two run in p a r a l l e l with 
pBRH2 components ( t h e 3588 and 748 base p a i r s f r a g m e n t s ) . 
The o t h e r i s t h e M13 fragment Taql-G/HapII-F w i t h EaoRI 
c o h e s i v e e n d s . The d i g e s t i o n p a t t e r n of p lasmid pGS251 
( lane b) shows, as e x p e c t e d , only two fragments wi th lengths 
of 3588 and 875 base p a i r s , r e s p e c t i v e l y . 
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Molecular alomng гп pPW231 and pGS251 
Insertion of DNA fragments into the unique fco RI site 
of pPW231 or pGS251 was essentially as described in Chapter 
VI. To circumvent circulanzation of the linearized vector 
prior to ligation, the 5'-terminal phosphate was removed 
with calf intestine phosphatase (CIP). For this purpose 
3 yg of vector DNA (in 25 μΐ) was digested with Eoo RI under 
standard conditions. The reaction volume was increased to 
50 μΐ and 0.1 unit of CIP was added. After 45 m m at 370C 
and 10 m m at 65 C, the phosphatase was removed by extract­
ion with phenol/chloroform-isoamylalcohol and the DNA was 
concentrated with ethanol. Subsequent ligation was per­
formed with 0.1 yg of vector DNA and purified fragment 
obtained from EaoRI digestion of 1 yg of plasmid DNA. 
The M13 fragments which have been cloned into pPW231 
and pGS251 are summarized in Table I. The orientation of 
the inserts was determined by restriction enzyme analysis 
as described in the previous chapter. 
Table I 
Plasmid 
PGS2322 
PGS2321 
PGS2525 
pGS2 391 
pGS2596 
PPW2 312 
pPW2 311 
Vector 
plasmid 
pPW2 31 
pPW231 
pGS251 
pPW2 31 
pGS251 
pPW2 31 
pPW231 
EaoRI fragment 
obtained from 
pGS901 
pGS901 
pGS901 
pGS743 
pGS743 
pPWl02 
pPW102 
M13 nucleotide 
position 
1128-1510 
1128-1510 
1128-1510 
1016-1397 
1016-1397 
2846-3261 
2846-3261 
Orientation 
-* 
-*-
- > • 
-> 
->-
->-
4-
The plasmids in the first column were created by insertion of the 
small EaoRI fragments, obtained from the plasmids mentioned in the 
third column, into the EeoRI site of pPW231 or pGS251 (second column). 
An arrow to the right indicates that the insert has the 5' •* 3' 
polarity of the viral strand directed towards the tetracycline re­
sistance gene. The inverted orientation is indicated by a leftward 
arrow. 
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DNA sequence analysis 
Labeling of 5'-terminal restriction fragments and 
subsequent sequence analysis was performed bv the method 
of Maxam and Gilbert (4). 
RESULTS 
Expresston of the recombinant plasmids 
To study the mechanism which regulates the synthesis 
of the minor capsid proteins encoded by genes VII and IX 
in more detail, we have constructed two new expression 
Plasmids, г. e. pPW231 and pGS251. Both plasmids are pBRH2-
denvatives which contain a unique EcoRI site immediately 
in front of the tetracycline resistance gene. In pGS251 
this EooRl site is preceded by a small M13 fragment carry­
ing the gene II promoter whereas in pPW231 this site is 
preceded by the gene II promoter and the gene II ribosome 
binding site. 
We have chosen for the insertion of the gene II pro­
moter since studies with various M13 promoters inserted 
into the promoter-probe plasmid pBRH2 have shown that this 
phage promoter functions as a very efficient RNA initiation 
site in the Е.соіь cell (2). Consequently, insertion of 
genes into the unique EooRl site of these vector plasmids 
places their expression either under control of the gene 
II promoter (plasmid pGS251) or under the control of both 
the gene II promoter and the gene II ribosome binding site 
(plasmid pPW231). These plasmids therefore should enable 
us to answer the question whether genes VII and IX possess 
a functional ribosome binding site or whether they are 
expressed as a result of a translational reinitiation event. 
The M13 fragments which we have cloned for this pur­
pose into the vector plasmids pPW231 and pGS251 are schema­
tically outlined in Fig. 2. 
Expression of the newly constructed recombinant plas­
mids has been studied in E.coli minicells and with the aid 
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Figure 2: Schematic representation of the M13 DNA fragments inserted into the unique EaoRl site 
of plasmids pPW231 or pGS251 (see also Table I). Part of the genetic map is presented in a linear 
form at the upper part. The Roman numerals refer to the M13 genes. The positions of the in Vitro 
promoter sites are indicated with black bars. The hatched bar represents the position of the central 
terminator of transcription. The numbers beneath the linear genetic map refer to the first 
nucleotide of the gene. The nucleotide positions of the M13 inserts refer to their position on 
the M13 genome. All fragments are orientated in the 5' -s- 3' polarity of the viral M13 strand 
(which is the direction of transcription on the M13 genome) directed towards the tetracycline 
resistance gene. 
of genetic complementation tests as described in chapterVI. 
The recombinant plasmids were introduced into the 
minicell-producing strain DS410. Minicells harbouring the 
recombinant plasmids were isolated, labeled with [35S] 
cysteine and the polypeptides formed were fractionated on 
15% Polyacrylamide gels containing 8 M urea and 0.1% 
NaDodSOit. 
A fluorogram of the polypeptides specified by the 
plasmids PGS2322, pGS2525, pGS2391 and pGS2596 is shown in 
Fig. 3. For labeling the polypeptides [35S] cysteine was 
used in order to facilitate the identification of the M13-
a b c d e 
Flg. 3: Fluorogram of [ S ]cysteine labeled polypeptides syn­
thesized in Е.аоЪг minicells carrying the following plasmids: 
lane a, pGS2322; lane b, pGS2525,· lane c, pGS551; lane d, 
pGS2391; lane e, pGS2596. The position of gene IX-protein is 
denoted. 
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I 
t—» 
0 Table II: Complementation values between various M13 amber mutants and the non-suppressor 
1
 strain KA798 containing recombinant plasmids. 
Am9-Nll3 
Лт7-Н2 
Агт-вз 
E.eoli 
KA805 
(Slip D) 
3.2 χ IO 1 2 
2.7 χ IO 1 2 
6.8 χ IO 1 2 
E. coli 
KA798 
{sup ) 
2.4 χ IO7 
6.6 χ IO6 
3.1 χ IO7 
KA798 
+ 
pGS2 321 
1.4 χ IO9 
1.2 χ IO7 
5.4 χ IO8 
KA798 
+ 
pGS2322 
7.0 χ IO 1 1 
1.3 χ IO7 
4.8 χ IO7 
KA798 
+ 
pGS2525 
9.1 χ IO9 
2.0 χ IO7 
1.3 χ IO9 
KA798 
+ 
pGS2391 
4.1 χ IO 1 2 
2.9 χ IO 1 2 
7.9 χ IO 1 2 
KA798 
+ 
PGS2596 
2.6 χ IO 1 2 
6.0 χ IO8 
9 
2.5 χ 10 
specific polypeptides encoded by genes VII and/or IX. 
Using this amino acid as protein label, the synthesis of 
the polypeptides which are the result of fusion of the 
amino terminal part of gene VIII to the pBRH2 sequence are 
no longer detectable (Chapter VI). From the fluorogram it 
can be deduced that none of the recombinant plasmids is 
able to direct the synthesis of visible amounts of gene 
VII- and/or gene IX-protein (M 3500). 
To verify whether indeed plasmids pGS2322, pGS2525, 
pGS2391 and pGS2596 are not able to specify gene VII- and/ 
or gene IX-protein , we have performed complementation 
tests between these plasmids and M13 mutants carrying an 
amber mutation in either gene VII or gene IX. The data ob­
tained from these studies are presented in Table II. From 
these tests several interesting data emerged. 
Plasmids pGS2322 and pGS2525 contain the same insert, 
but they show a remarkable difference in complementation 
capacity. Only .ооіг cells which carry plasmid pGS2322 are 
capable of complementing an amber mutation in gene IX al­
though neither one of these plasmids are capable of direct­
ing the synthesis of visible amounts of gene IX-protem. 
That the high values scored with pGS2322 are the result of 
plasmid-encoded gene IX-protein which complements the 
genetic defect of amber phage mutants in gene IX rather 
than the result of recombination events is inferred from 
our observation that low figures are also scored with plas­
mid pGS2321. The latter plasmid is identical to pGS2322 
but carries the gene IX insert in the inverted orientation. 
Taken into account that the difference between plas­
mids pGS2322 and pGS2525 is that m the former the external 
(gene II) promoter is equipped with a nbosome binding 
site, our data strongly suggest that gene IX has either a 
nbosome binding site which is not accessible or has no 
nbosome entry site at all. The data furthermore indicate 
that functional gene IX-protein is synthesized only in 
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those cases that nbosomes are allowed to initiate protein 
synthesis at the gene II ribosome binding site. 
With respect to the synthesis of gene VII-protein 
similar observations have been made. Plasmid pGS2391 and 
pGS2596 carry the same M13 insert m the same orientation 
(Table I, Fig. 2). In minicells, neither one of these Plas­
mids is able to direct the synthesis of visible amounts of 
gene VII-protein (Fig. 3). In the complementation assay, 
however, only the recombinant plasmid which contains the 
gene II ribosome binding site i.e. pGS2391 is able to fully 
complement the genetic defects in the M13 mutants am7-H2 
and атТ-ВЗ (Table II). The conclusion therefore seems to be 
justified that gene VII is not equipped with a functional 
ribosome binding site and that in pGS2391 synthesis of 
gene VII-protein is coupled to the initiation of protein 
synthesis at the ribosome binding site of gene II. 
Striking, however, are the observations made with 
plasmid pGS2596 (Table II). In this plasmid both genes VII 
and IX are under the control of the gene II promoter only. 
Nevertheless, this plasmid is able to complement an amber 
mutation in gene IX but not those in gene VII. These data 
suggest that the synthesis of gene IX-protein can be un­
coupled from the synthesis of gene VII-protein. This is, 
however, in conflict with our previous conclusion that 
genes V, VII and IX form an Operon and that gene IX does 
not possess an independent ribosome entry site. 
To find out by what kind of mechanism the nbosomes 
which are initiated at the gene II ribosome binding site 
are able to promote the synthesis of gene VII- and/or gene 
IX-protein, it is important to know the reading frame in 
which the region downstream the Z-coRI Imker DNA is trans­
lated. To deduce this reading frame we have determined the 
nucleotide sequence at the junctions of the M13 DNA frag­
ments . 
The established nucleotide sequences of this particu-
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lar region in plasmid pGS2596 and pGS2391 are given in Fig. 
4. In both plasmids the sequence found corresponds exactly 
to the sequence theoretically expected. The Ml 3 gene II 
sequence m pGS2391 ends at nucleotide position 6181 where-
as the gene V sequence starts at nucleotide position 1016. 
These two sequences are separated by the octamer GGAATTCC 
containing the £eoRI cleavage site. In a similar way, the 
expected sequence between nucleotide position 5997 and 1016 
of plasmid pGS2596 comprises the synthetic EaoRl linker 
fragment only. 
Given these sequence data it now can be concluded that 
m pGS2391 the region downstream the EaoRI linkers is 
translated not in the zero or wild-type reading frame but 
in the +1 reading frame . Reading in this frame, termination 
of translation occurs at the UGA codon at nucleotide posi-
tion 1072, at a distance of 36 nucleotides upstream the 
AUG initiation codon of gene VII. How termination of trans-
lation at this position still leads to the synthesis of 
gene VII- and gene IX-protein will be discussed in the 
next section. 
Determination of the nucleotide sequence downstream 
the ZTccRI linkers in pGS2391 also enabled us to calculate 
the size of the fused polypeptide which initiates at the 
AUG start codon of gene II and which terminates at the 
UGA termination codon within the gene V sequence. The size 
of this fused polypeptide in pGS2391 amounts 80 ammo 
acids; the amino terminal 59 amino acids of gene II-pro-
tein, followed by 3 amino acids (partially) encoded by the 
linker DNA and 18 amino acids coded by the gene V sequence. 
A polypeptide of this size is clearly visible on the 
fluorogram of the polypeptides synthesized in minicells 
harbouring plasmid pGS2391 (Fig. 3, lane d). This polypep-
x The +1 reading frame corresponds to codons that begin at the second 
position of a zero frame codon and end at the first position of 
the next zero frame codon. Accordingly, a codon of the -1 reading 
frame begins at the third position of a zero frame codon. 
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A>C G C+T А>С 
С+Т 
1016-
5997-
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I G-6181 
Figure 4 : Autoradiograph of the DNA sequence at the junctions 
of the M13 DNA fragments present in plasmid pGS2596 (left panel) 
and plasmid pGS2 391 (right panel). 
tide can be labeled with [35S] methionine and [3H]proline 
but not with [3H] tryptophan {data not shown). As these 
labeling properties are in complete agreement with the de­
duced amino acid composition of the fused polypeptide, we 
conclude that the heavily labeled polypeptide specified 
by pGS2391 (Fig. 3, lane d) is derived from the gene II 
ribosome binding site. 
Similar results have been obtained with plasmid 
pGS2322, a plasmid which fully complements an amber muta­
tion in gene IX (Table II). The nucleotide sequence dic­
tates that the region downstream the EaoRI linkers also is 
translated in the +1 reading frame. As a consequence, 
translation terminates in the gene VII-sequence at nucleo­
tide position 1148 at a distance of 59 nucleotides upstream 
the AUG initiation codon of gene IX. 
-134-
Termination within the gene VII sequence results m a 
fused polypeptide of 68 amino acids; the amino terminal 59 
amino acids of gene II-protein, followed by 3 amino acids 
(partially) encoded by the linker DNA and 6 amino acids 
encoded by the gene VII sequence. According to this, in 
minicells harbouring the plasmid pGS2322 a polypeptide of 
this size is made (Fig. 3, lane a). Also the labeling 
characteristics of this polypeptide were in complete agree­
ment with the deduced amino acid composition. 
Furthermore, plasmid pGS2322 directs the synthesis of 
a small [35S] cysteine containing polypeptide with a size 
of about 20-25 amino acids (Fig. 3, lane a). This small 
polypeptide can also be labeled with [35S] methionine but 
not with [3H]proline (data not shown). 
Besides the polypeptides encoded by genes VII and IX, 
the M13 virion also is composed of the minor capsid pro­
tein encoded by gene VI (5,6,7, chapter III). Despite many 
efforts, we have been unable to demonstrate the synthesis 
of gene VI-protein in M13 RF harbouring minicells (Chapter 
V ) . 
Therefore, it was of interest to know whether recom­
binant plasmids containing gene VI were able to direct the 
synthesis of biologically active gene VI-protein. As plas­
mid pPW102, which contains the entire gene VI sequence, is 
not able to complement an amber mutation in gene VI (Table 
III), we inserted the M13 DNA containing EaoRI fragment of 
Table III: Complementation values between M13 am6-Hl and the 
non-suppressor strain KA798 containing recombinant plasmids. 
Лстб-НІ 
E.ooli 
KA805 
(sup D) 
3.4 χ 10 1 2 
E.coli 
KA798 
(sup ) 
2.9 χ 10 6 
KA798 
+ 
pPW102 
4.6 χ 10 9 
KA798 
+ 
PPW2311 
7 χ 10 9 
KA798 
+ 
pPW2 312 
4.1 χ 10 1 2 
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PPW102, into the bcdRI site of plasmid pPW231. As shown in 
Table I, two recombinant plasmids designated pPW2311 and 
pPW2312 were obtained. The latter contained the M13 insert 
with its 5' -* 3' polarity of the viral strand directed to­
wards the Tc gene whereas the orientation of the M13 in­
sert m pPW2311 is inverted. In minicells harbouring these 
plasmids, no visible synthesis of a polypeptide (M 11,500) 
characteristic for gene Vl-protem could be demonstrated. 
Complementation studies, however, revealed that plas­
mid pPW2312 is able to fully complement the genetic defects 
in M13 mutants having an amber mutation in gene VI (Table 
III). The meaning of these observations will be discussed. 
DISCUSSION 
Synthesis of gene VII-pvotein 
Gene VII codes for a polypeptide of 33 ammo acids 
which is present in 3-4 copies per mature virion (7, Chap­
ters II + III). 
Genetic complementation and in г о protein synthesis 
studies (8,9, Chapters IV, V and VI) have demonstrated that 
gene VII forms part of an operon constituting the genes V, 
VII and IX. Expression of gene VII is only achieved via 
polycistronic mRNAs which are initiated at promoters in 
front gene V (10). To obtain insight m the mechanism by 
which the synthesis of gene Vll-protem is regulated, we 
have investigated the expression of gene VII in other 
genetic environments and under the control of external 
regulatory elements. 
Our data have shown that transcripts containing only 
the gene Vll-protem cistron are not translated suggesting 
this cistron does not permit nbosomes to attach either by 
poor binding or by secondary structures masking this site. 
Gene VII-protein synthesis only occurs if simultaneously 
translation of its preceding cistron (gene V) takes place. 
This dependency is designated "translational coupling". 
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These conclusions are based upon the observations that 
Plasmid pGS2596 does not but that plasmid pGS2391 does com-
plement the genetic defects of the M13 mutants am7-H2 and 
aml-H2 . 
Whether this translational coupling might be due to 
translational reinitiation events, we have examined the 
nucleotide sequence of pGS2391 at and around the junction 
of the M13 DNA fragment of the vector and the gene VII con-
taining fragment. This sequence is shown in Fig. 5. 
6 1 7 4 EcoRI linker 1016 
GTC TCC GG¡G GAA TTC CfrG GTC TGT АСА CCG TTC АТС TGT CCT CTT 
ι ι 
Val Ser Gliy Glu Phe L|eu Val Cys Thr Pro Phe lie Cys Pro Leu 
57 
ι 
Met lie Asp Arg Leu Arg 
* * * * 
TCA AAG TTG GTC AGT TCG GTT CCC TTAT£ ATT GAC CGT CTG CGC 
Ser Lys Leu Val Ser Ser Val Pro Leu 
80 
ι ι 
Leu Val Pro Ala Lys 1108 
CTC GTT CCG GCT AAG TAAC ATG GAG 
* * * 
Met Glu-Gene V I I - p r o t e i n 
Figure 5: Nucleotide sequence of plasmid pGS2391 of the region 
encompassing the linkage of the vector plasmid to the gene 
VII-containing fragment. Translational stop signals are under­
lined. Nucleotides complementary to the 3'-OH terminus of 16S 
ribosomal RNA are indicated with asterisks. 
The sequence t o t h e l e f t hand s i d e of t h e EcoRl-
l i n k e r sequence be longs t o t h e 5 ' - t e r m i n a l p a r t of gene I I 
( i n c l u d i n g t h e promoter and i t s r ibosome b i n d i n g s i t e 
(of. F i g . 2) ; t h e sequence r i g h t w a r d s t o t h e Eco RI-sequence 
r e p r e s e n t s t h e 3 ' - t e r m i n a l p a r t of gene V s t a r t i n g a t 
n u c l e o t i d e 1016 which p r e c e e d s t h e i n t a c t gene VII sequence. 
Due t o t h e i n s e r t i o n of t h e EooRl-octamer, t h e r ibosomes 
which have s t a r t e d s y n t h e s i s a t t h e gene I I r ibosome 
b i n d i n g s i t e read t h e gene V sequence downstream t h e ¿'coRI 
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linker in the +1 reading frame. As a consequence a polypeptide 
of 80 amino acids is formed, the synthesis of which easily 
can be detected in E.ooli mimcells (Fig. 3, lane d) . The 
UGA termination codon of this fused polypeptide overlaps an 
AUG codon. Consequently, ribosomes which terminate the syn­
thesis of the fused polypeptide have oriented this AUG 
codon very near the P-site of the ribosome. We assume that 
after termination such a sequence configuration can lead 
to a so-called translational reinitiation event which will 
allow ribosomes to shift their reading frame and start 
translation at this AUG signal which now functions as an 
initiation codon. The polypeptide then formed is only 11 
amino acids long. It has to be emphasized, however, that 
its synthesis has taken place in the zero reading frame of 
gene V. This means that this part but also the sequence 
next to it (г.е. gene VII) is translated in the same read­
ing frame as in the wild-type M13 genome. In the close 
proximity of the UAA termination of gene V, the AUG start 
codon of gene VII is located. We assume that at this 
particular sequence again a translational reinitiation 
event occurs resulting in the synthesis of gene Vll-protein. 
Synthesis of gene IX-protein 
The product of gene IX consists of a polypeptide of 
32 amino acids. This protein is also present in 3-4 copies 
within the tubular coat (5,6,7,11, Chapters II + III). 
Although gene IX is very frequently expressed via the mRNA 
species initiated at the G
n
 .„ promoter (cf. Fig. 2), these 
mRNAs are not able to direct the synthesis of gene IX-
protein (chapter VI). We left therefore with the conclusion 
that gene IX-protein is formed on larger mRNA molecules 
which are initiated at the promoter(s) preceding gene V. 
Based upon the results obtained with the recombinant 
Plasmids pGS2525 and pGS2322, we assume that a similar 
mechanism which underlies the synthesis of gene Vll-protein 
is involved in the synthesis of gene IX-protein. Synthesis 
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of gene IX-protein occurs only when it is under the control 
of the gene II ribosome binding site. The sequence of 
pGS2322 around and downstream the junctions of the M13 DNA 
fragments is presented in Fig. 6. 
ι 
6174 EcoRI linker 1128 1141 Met lie 
ι , ,1 * * i t GTC TCC GGiG GAA TTC CiCG АСА CAA TTT АТС AGG CGATG ATA 
ι ι 
Val Ser Gl]Y_Glu_Phe_P¡ro Thr Glu Phe Ile Arg Arg 
57 "" ~" 68 
Gin lie Ser Val Val Leu Cys Phe Ala Leu Gly Ile Ile 
CAA АТС TCC GTT GTA CTT TGT TTC GCG CTT GGT ATA АТС 
20 
Ala Gly Gly Gin Arg 
• 1 2 üb 
GCT GGG GGT CAA AGATG AGT GTT 
** *+* * 
Met Ser Val- Gene IX-p ro te in 
Figure 6 : Nucleotide sequence of plasmid pGS2322 of the region 
encompassing the linkage of the vector plasmid to the gene IX-
containing fragment. Translational stop signals are underlined. 
Nucleotides complementary to the 3 '-OH terminus of 16S n b o -
somal RNA are indicated with asterisks. 
Due t o t h e i n s e r t i o n of t h e EcoRl-octamer, t h e r i b o -
somes which have s t a r t e d s y n t h e s i s a t t he gene I I r ibosome 
b ind ing s i t e read t h e gene VII sequence downstream the 
EaoRI l i n k e r in t he +1 r e a d i n g frame r e s u l t i n g in a fused 
p o l y p e p t i d e of 68 amino a c i d s . The s y n t h e s i s of t h i s p o l y -
p e p t i d e can r e a d i l y be r ecogn ized in E.aoli m i n i c e l l s (F ig . 
3, l ane a ) . The UGA t e r m i n a t i o n codon of t h i s fused p o l y -
p e p t i d e o v e r l a p s a AUG codon. In analogy t o t h e r e g u l a t i o n 
of s y n t h e s i s of gene V l l - p r o t e m , we assume t h a t a t t h i s 
p a r t i c u l a r sequence c o n t a i n i n g o v e r l a p p i n g s t a r t and s t o p 
s i g n a l s nbosomes s h i f t t h e i r r e a d i n g frame and s t a r t t h e 
s y n t h e s i s of a n o t h e r p o l y p e p t i d e . As t he i n i t i a t i o n codon 
of t h i s p o l y p e p t i d e i s l o c a t e d in t he zero r e a d i n g frame 
of gene VI I , n b o s o m e s t r a n s l a t e t h i s p a r t of t h e M13 DNA 
m the same r e a d i n g frame as in t h e w i l d - t y p e M13 genome. 
As a r e s u l t a p o l y p e p t i d e of 20 amino a c i d s can be formed. 
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Although a definite proof is lacking, we suggest that the 
polypeptide with a size of 20-25 ammo acids found in mini-
cells (Fig. 3, lane a) is a good candidate for this poly-
peptide. By means of a second reinitiation event, nbosomes 
are now able to direct the synthesis of gene IX-protein. 
Not in accordance with the translational reinitiation 
mechanism is our finding that complementation of the M13 
amber mutant in gene IX (am9-N113) is also accomplished 
with plasmid pGS2596. In the latter plasmid genes VII and 
IX are under control of the gene II promoter only. A 
possible explanation for this observation could be that a 
sequence at or beyond the ffcoRI site can form a stem-loop 
structure with a sequence located immediately proximal to 
the AUG initiation codon of gene IX in such a way that a 
proper alligment of a polypurme tract and the AUG codon 
of gene IX is achieved. An example of such a proper allig-
ment of sequences has recently been found in the mRNA for 
bacteriophage T4 gene 38 protein (of. ref. 12). 
In our studies two different M13 phage mutants carry-
ing an amber mutation in gene VII have been used. RNA as 
well as DNA sequence analyses have demonstrated that the 
single point mutation in M13am7-H3 is located at nucleotide 
position 1141 (13). This mutation changes a CAG (Gin) codon 
into a TAG amber codon. Complementation studies (unpublish-
ed data) have shown that in contrast to M13 aml-Wl the 
am7-H3 mutant is able to complement M13 am9-Nll3. In E.coli 
minicells, however, the M13 am7-H3 mutant does not give 
rise to the synthesis of detectable amounts of gene IX-
protem. At first glance, these data are rather surprising. 
Examination of the nucleotide sequence, reveals that the 
UAG amber codon of M13 am7-H3 is followed by a AUG codon 
three nucleotides more upstream, nucleotide position 1147 
(Fig. 6). As this AUG codon most likely functions as an 
initiation codon m plasmid pGS2322, we assume that in 
cells infected with M13 am7-H3 phages, the synthesis of 
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gene IX-protein occurs by a similar mechanism as is opera-
tive in cells harbouring plasmid pGS2322. 
Synthesis of gene VI-protein 
Gene VI codes for a very hydrophobic polypeptide of 
112 amino acids (14). It is present in the virion m 5 
copies which are located at one end of the filament (5,6,7, 
11, chapter III). Based upon genetic data, gene VI forms 
part of an operon encompassing genes III, VI and I (15). 
Recombinant DNA studies in which M13 DNA fragments 
containing gene VI are inserted into the promoter-probe 
plasmid pBRH2 (2) and studies on the occurance of M13 tran-
scripts in the infected cell (16) have indicated that in 
front of gene VI no functional promoter is located. There-
fore gene VI-protein is almost certainly formed from poly-
cistronic mRNA species only which are initiated in front 
of gene III. 
The intergenic region between genes III and VI amounts 
two nucleotides only (14). These structural features 
suggest that synthesis of gene VI-protein is regulated by 
a similar translational reinitiation mechanism as the 
synthesis of gene VII- and gene IX-protein. 
This assumption is supported by our results obtained 
with plasmid pPW2312. In this plasmid, the synthesis of 
gene VI-protein is controlled by the gene II ribosome 
binding site. As shown in Table III, pPW2312 fully comple-
ments a nonsense mutation in M13 am6-Hl whereas pPW2311, 
which contains the same insert but in the inverted orient-
ation, does not. 
As shown in Fig. 7, the insertion of the EcoRI-octamer 
in plasmid pPW2312 has been achieved in such a manner that 
this region is now read in the original zero reading frame. 
In other words ribosomes attached at the gene II ribosome 
binding site read the sequence downstream the ¿'co RI linker 
sequence in the same reading frame as gene III of the in-
tact M13 genome. Consequently, the complementation be-
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6 1 7 4 EaoRI linker 2846 2856 
| , I | 
GTC TCC GGG GAA TTC CIAG TCT TAA TC ATG CGA GTT 
I * * 
ι ι 
Val Ser Gl|Y_Glu_Phe_G¡ln Ser Met Pro Val-Gene VI-protein 
Figure 7• Nucleotide sequence of plasmid pPW2312 of the region 
encompassing the linkage between the vector plasmid to the gene 
VI-containing fragment. Trans la t iona l stop s ignal i s under l ined. 
Nucleotides complementary to the 3'-OH terminus of 16S ribosomal 
RNA are ind ica ted with a s t e r i s k s . 
hav iou r of p lasmid pPW2312 towards t h e g e n e t i c d e f e c t s of 
amber mutants in gene VI i s s i m i l a r l y exp l a i ned on t h e 
b a s i s of a t r a n s l a t i o n a l r e i n i t i a t i o n event o c c u n n g a t t h e 
gene I l l / g e n e VI j u n c t i o n . 
In b a c t e r i o p h a g e M13 DNA, 7 n u c l e o t i d e s upst ream t h e 
AUG codon of gene VI can t h e o r e t i c a l l y base p a i r wi th t h e 
3'-OH t e r m i n a l sequence of 16S rRNA (14) whereas m plasmid 
pPW2312 base p a i r i n g i s l i m i t e d t o 2 n u c l e o t i d e s only [of. 
F i g . 7) 
D e s p i t e t h e f a c t t h a t in plasmid pPW2312, t h e o r i g i n a l 
Shine and Dalgarno domain has been r e p l a c e d by a sequence 
wi th no base p a i r i n g a b i l i t y , t he p lasmid i s s t i l l c apab le 
of f u l l y complementing t h e g e n e t i c d e f e c t s in M13 gene VI 
amber m u t a n t s . This s t r e n g t h e n s our argument t h a t in phage 
M13 DNA the sequence immediately p r e c e d i n g gene VI does not 
f unc t i on as a r ibosome b ind ing and e n t r y s i t e , b u t i n s t e a d , 
gene V l - p r o t e m s y n t h e s i s i s only ach ieved by t h o s e n b o -
somes which have s h i f t e d t h e i r r ead ing frame. 
General disoussion 
Bac te r iophage M13 DNA c o n t a i n s two opé rons . One con-
s i s t s of t h e genes V, VII and IX whi le t h e o t h e r comprises 
the genes I I I , VI and (most probably) I . 
From t h e d a t a we have p r e s e n t e d in t h i s and the p r e -
v ious c h a p t e r i t i s c l e a r t h a t t h e e x p r e s s i o n of both 
opérons i s r e g u l a t e d by a t r a n s l a t i o n a l mechanism in which 
only p o l y c i s t r o n i c mRNA's a r e i n v o l v e d . The p o l y c i s t r o n i c 
mRNA of t he f i r s t operon i s formed by t r a n s c r i p t i o n a l 
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initiation events at the promoters in front of gene V where-
as that of the second Operon is derived from the Xn — 
promoter immediately preceding gene III. 
Our genetic as well as our in vivo protein synthesis 
studies direct to a conclusion that the distal cistrons on 
these mRNAs have no nbosome entry site and that trans-
lation of these cistrons only occurs by nbosomes which 
have started translation at the first cistron. We infer 
that during translation of the polycistronic mRNA not all 
the nbosomes are released at the termination codon between 
two contiguous cistrons but remain transiently attached to 
the mRNA. In case the mtercistronic region remains within 
the domain that is protected by the nbosome, a reorient-
ation of the latter can occur which then leads to a trans-
lational reinitiation. 
Support for such a mechanism has been provided by 
studies on the in vitro translation of the coat protein 
cistron of bacteriophage f2 RNA (17). These studies have 
shown that the dissociation kinetics of the nbosomal sub-
units at the termination codon differ m that a rapid 
release of the 50S subunit was noted while the 30S n b o -
somal subunit remained transiently attached. Furthermore, 
Van Duyn et al. (18) in studying the translation of the coat 
protein cistron of bacteriophage MS2 and QS, have recently 
shown that a preformed mRNAOOS binary complex can start 
translation in the presence of inhibitors of de novo initi-
ation. 
During the course of our studies several groups have 
re-examined the translation mechanism of some structural 
genes belonging to well-known E.aoli or phage opérons. From 
these studies it turned out that a translational reinitia-
tion mechanism as suggested from our studies also is oper-
ative during the expression of the tvpD gene (19), the 
rllB region of bacteriophage T4 (20) and of the lysis gene 
of bacteriophage MS2 (21). 
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Examination of the nucleotide sequences preceding the 
AUG initiation codons of the trpD gene and the lysis gene 
show that these regions have a very good complementarity 
to the 3'-OH terminal sequence of 16s ribosomal RNA 
which is supposed to be characteristic for nbosome binding 
sites (Shine and Dalgarno, 22). Similarly, the regions in 
front of the initiation codon of genes VI and IX have 7 
and 6 nucleotides, respectively, which potentially can base 
pair according to the Shine and Dalgarno principle. The 
reason why the latter E.aoli and phage genes are expressed 
by a translational reinitiation mechanism, albeit their 
cistrons comprise very good nbosome binding sites, is 
still not clear. It might be that good complementarity 
positively influences the transient attachment of ribosomes 
and, consequently, enhances the translational reinitiation 
frequency of the next cistron. 
It has to be kept in mind that in addition to trans-
lational reinitiation events additional regulatory mecha-
nisms may operate during the expression of the M13 opérons. 
One of the first M13-encoded proteins needed in the infec-
tion cycle is the RF-I nicking enzyme (gene II-protein) 
whereas very recent reports suggest that also gene X-pro-
tein encodes for a very early gene function (23). 
At later stages of infection, progeny phage production 
demands that very high levels of gene V-protein and of gene 
VHI-protem are formed. The former is needed for the 
switch of RF-replication towards viral single-strand DNA 
synthesis whereas the latter is needed in 2700 copies per 
viral DNA during maturation of the phage particle. In the 
latter process only 3-4 copies per virion of gene VII- and 
IX-protein are needed and only 5 copies of each gene III-
and VI-protein. As several genetic data have indicated that 
excess of these proteins in the infected cell can lead to 
"cell-killing", it is obvious that the expression of the 
latter genes is under strict control. The translational 
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reinitiation mechanism is one of the ways to garantee high 
levels of gene V-protein and low levels of gene VII- and 
IX-protein. The regulatory principle responsible for the 
control of low levels of gene III- and Vl-protem is not 
yet clear. It might well be that formation of the gene 
III- and VI containing polycistronic mRNA is dependent on 
gene VIII transcription, as suggested by the M13-promoter 
function studies of Van Wezenbeek (2) . If so, the cell is 
capable of synthesizing high levels of gene VHI-protem 
and meanwhile it controls the levels of gene III- and VI-
protein. Further studies, however, are needed to clarify 
this. 
Additional mechanisms, in particular the RNA-proces-
sing studied in detail by Smits et al. (10,16), undoubtedly 
contribute to the functional diversity of M13 gene expres-
sion. Processing of the RNA, initiated at the gene X pro-
motor (G. „,), into pieces which have their 5'-end proximal 
U . Do 
to the gene V-cistron not only provides a mechanism to 
control and to prevent excessive synthesis of gene X-pro-
tein, it also garantees that still gene V-protem is made 
in excess as compared to gene VII- and IX-protein. Similar-
ly, the 9S mRNA species formed by a second processing 
reaction, and which have their 5'-end within gene VII, have 
lost their capability to direct the synthesis not only of 
gene V-protein but also of gene VII- and gene IX-protein 
but still remain perfect messages for gene Vlll-protem 
synthesis. 
Secondary structures, noticeable in the nucleotide 
sequence of the genes X, V, VII and IX, are most probably 
the regulatory signals for the above mentioned RNA proces-
sing reactions (16). Uncertainty exists whether the second-
ary structures in gene VII and IX have a direct regulatory 
effect on the synthesis of the proteins encoded by these 
genes. 
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SUMtlARY 
Bacterxophage M13 belongs to the group of filamentous, 
single-stranded DNA containing phages. The phage is unique 
among coliphages since the release of progeny phages is not 
accompanied by lysis of the host-cell. Phage production 
continues for hours and can give rise to the synthesis of a 
few thousands of progeny phage particles. 
Despite our detailed knowledge of the molecular biol­
ogy of bacteriophage M13, the process of virion assembly at 
the host cell membrane is not well understood. Although 
there exists indirect evidence that gene VI and gene VII 
are involved in this process, the products of these genes 
have never been observed either ьп гіго or гп г о. Our 
primary goal was to identify these 'unknown' gene products 
and to study their regulation of synthesis. 
A breakthrough m the identification of these 'unknown' 
gene products was the elucidation of the complete nucleo­
tide sequence of the M13 genome. It enabled us to predict 
the length and amino acid sequence of these gene products. 
Moreover, from these sequencing studies a new hitherto un­
identified gene (gene IX) became apparent. 
With the aid of differential amino acid labeling 
studies, using the DNA sequence as a guide, it could be 
demonstrated that besides the 'known' coat proteins encoded 
by gene VIII (B protein) and gene III (A protein), M13 
virions also contained two minor protein components design­
ated С and D protein (Chapter II). These polypeptides have 
molecular weights of 3500 and 11,500, respectively. 
By determination of the amino terminal sequence on С 
and D protein an unambiguous gene-product relationship 
could be established for these proteins (Chapter III). It 
appeared that the С protein component is composed of equi-
molar amounts of the proteins specified by gene VII and the 
recently discovered gene IX whereas D protein is the pro-
-149-
duct of gene VI. Our Edman degradation studies further have 
demonstrated that, in contrast to the coat proteins encoded 
by genes VIII and III, the polypeptides encoded by genes 
VI,VII and IX are assembled into mature virions as their 
primary translation products. Furthermore, the data argue 
for an N-formylated status of these proteins in M13 virions. 
In this Chapter evidence is also presented that the 
minor capsid proteins are not located in a periodical array 
along the longitudinal axis of the filamentous protein tube 
but are clustered at or near the tips of the phage filament. 
At one tip 3-4 molecules each of the polypeptides encoded 
by genes VII and IX are located whereas at the other tip 
5 molecules each of gene III- and gene VI- protein are 
situated. 
In the second part of this thesis our knowledge on the 
structure of the minor capsid proteins has been applied to 
investigate the regulation of synthesis of these proteins, 
in particular the synthesis of gene VII- and IX-protein. 
Regulation of synthesis of the latter proteins is apparent 
from the observation that the amounts of gene VII- and IX-
protein in the infected cell are far less than that of gene 
V-protein despite the fact that these three genes are 
transcribed in about equal frequencies. Initially, a draw-
back in our studies was that conditionally lethal mutants 
were only available of genes VII and V but not of gene IX. 
In Chapter IV we describe our successful attempts to 
construct an amber mutant in this gene. Using the method 
of site-directed mutagenesis in which a synthetic oligo-
deoxynbonucleotide has been applied for the in vitro in-
duction of such a mutation, mutants were selected which 
have their amber codon in the reading frame of gene IX 
thereby confirming that the latter frame does define a gene 
which codes for an essential phage protein. In this Chapter 
we further demonstrate that the amber mutation in gene IX 
cannot be complemented by either an amber mutation in 
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gene VII or gene V, suggesting that the genes V-VII-IX form 
an Operon. 
The Operon model, as deduced from our genetic comple-
mentation tests, could be confirmed by our studies in b.ooli 
minicells (Chapter V ) . In this system, which reflects the 
situation operating m the infected cell, not only the syn-
thesis of gene VII- and IX-protein could be demonstrated 
but also their synthesis cut-off in case the protein syn-
thesis machinery in E.aoli minicells was programmed with 
either the genomes of gene VII or gene IX amber mutant 
phages. 
In Chapter VI, the translational regulatory principle 
underlying the expression of the gene V-VII-IX Operon has 
been studied in more detail in other genetic environments. 
For this purpose, recombinant plasmids have been construct-
ed between plasmid pBRH2 and M13 DNA fragments containing 
various parts of the Operon. Our results on the expression 
of these recombinants in E.aoli minicells as well as our 
data obtained from complementation analyses have clearly 
shown that synthesis of gene VII- and IX-protein only 
occurs on polycistronic mRNA species which also comprise 
the gene V-protein cistron and that synthesis of gene VII-
and IX-protein is directly coupled to the translation of 
the gene V message. This dependency, termed "translational 
coupling", implies that the nbosome binding sites of 
genes VII and IX are not freely accessible to ribosomes 
but translation only occurs by ribosomes which have started 
initiation at the gene V nbosome binding site. 
In Chapter VII we have studied this model in more de-
tail. This was achieved by inserting gene VII and/or gene 
IX into new plasmids in such a way that the expression of 
these genes is under control of a strong external promoter 
which is equipped with or without an efficient nbosome 
binding site. The results obtained led us to conclude that 
synthesis of gene VII- and gene IX-protein occurs by a 
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translational reinitiation event at the end of the preceding 
cistron. In both cases, synthesis of gene VII- and gene IX-
protein is most probably achieved by nbosomes which after 
termination remain transiently attached to the polycistronic 
mRNA. Thereafter, nbosomes are capable of shifting their 
reading frame and to start translation of the next cistron. 
SAMENVATTING 
Bactenofaag M13 behoort tot de groep filamenteuze 
enkelstrengs DNA bevattende fagen. De faag neemt een unieke 
positie in onder de colifagen doordat het vrijkomen van 
nakomelingen niet gepaard gaat met de lysis van de gast-
heercel. De produktie van fagen vindt gedurende enige uren 
plaats en resulteert in de synthese van enige duizenden 
nakomelingen. 
Ondanks het feit dat de kennis omtrent de moleculaire 
biologie van bactenofaag M13 gedetailleerd is, is over het 
assemblage proces van het virus, welke plaats vindt aan de 
celmembraan, weinig bekend. De produkten van twee genen 
- gen VI en gen VII - waarvoor indirecte aanwijzingen be-
staan dat ze betrokken zijn bij dit proces, zijn nooit 
waargenomen, in vitro noch in vivo. Onze primaire doelstel-
ling was de identificatie van deze "onbekende" genprodukten 
en bestudering van de regulatie van hun synthese. 
Een doorbraak bij de identificatie van deze "onbekende" 
genprodukten was de opheldering van de nucleotidenvolgorde 
van het M13 genoom. Dit stelde ons in staat de lengte en de 
aminozuurvolgorde van de "onbekende" genprodukten te voor-
spellen. Bovendien werd op grond van deze sequentie-studies 
het bestaan van een nieuw, tot nu toe niet geïdentificeerd 
gen (gen IX) aannemelijk geacht. 
Met behulp van differentiële aminozuurlabelmg-studies 
- met de nucleotidenvolgorde als leidraad - kon aangetoond 
worden dat naast de "bekende" manteleiwitten gecodeerd 
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door gen VIII (В eiwit) en gen III (A eiwit), M13 virions 
ook twee "minor eiwitcomponenten bevatten die aangeduid 
worden met de letters С en D (Hoofdstuk II). Deze Polypep­
tiden hebben een moleculair gewicht van 3500, respectieve­
lijk 11.500. 
Een ondubbelzinnige gen-produkt relatie kon vastge­
steld worden voor deze eiwitten door de N-terminale amino­
zuurvolgorde van С en D eiwit te bepalen (Hoofdstuk III). 
Hieruit bleek dat de C-eiwitcomponent is samengesteld uit 
een equimolaire hoeveelheid van de eiwitten gecodeerd door 
gen VII en het recent aangetoonde gen IX, terwijl D eiwit 
het produkt is van gen VI. Uit onze Edman-degradatie stu­
dies bleek verder dat, in tegenstelling tot de manteleiwit-
ten die gecodeerd worden door de genen VIII en III, de 
Polypeptiden welke gecodeerd worden door de genen VI, VII 
en IX zich in het faagdeeltje bevinden als primaire trans-
latieprodukten en dat hoogstwaarschijnlijk assemblage 
plaatsvindt zonder dat de N-terminus van deze eiwitten 
wordt gedeformyleerd. 
In dit hoofdstuk wordt ook aannemelijk gemaakt dat de 
"minor" manteleiwitten niet regelmatig gerangschikt zijn 
langs de lengte-as van de cilindervormige eiwitmantel maar 
dat ze geclusterd voorkomen aan of nabij de uiteinden van 
de faag. Aan een uiteinde bevinden zich 3 à 4 moleculen van 
zowel het polypeptide gecodeerd door gen VII als van dat 
gecodeerd door gen IX; aan het andere uiteinde zijn 5 mole-
culen van zowel gen III-eiwit als gen VI-eiwit gelokali-
seerd. 
In het tweede deel van dit proefschrift is onze kennis 
omtrent de structuur van de "minor" eiwitten aangewend om 
de regulatie van de synthese van deze eiwitten te onder-
zoeken. De nadruk is hierbij komen te liggen op gen VII- en 
gen IX-eiwit. De synthese van deze eiwitten is onderworpen 
aan regulatie zoals blijkt uit de waarneming dat de hoe-
veelheden gen VII- en gen IX-eiwit in de geïnfecteerde cel 
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aanzienlijk geringer zijn dan de hoeveelheid gen V-eiwit 
ondanks het feit dat deze genen met een even hoge frequen­
tie worden getranscribeerd. Een nadeel bij de bestudering 
van dit regulatiemechamsme was aanvankelijk dat conditio-
neel-lethale mutanten slechts voorhanden waren van de 
genen VII en V, terwijl mutanten m gen IX niet beschikbaar 
waren. 
In Hoofdstuk IV beschrijven we de constructie van een 
amber mutant in dit gen. Middels plaatsgebonden mutagenese, 
waarbij een synthetisch oligodesoxynbonucleotide gebruikt 
is voor de гп vttro inductie van een mutatie, werden mutan­
ten geselecteerd met een amber codon in het 'lees-raam 
van gen IX. Hiermee werd bevestigd dat dit lees-raam een 
gen afbakent dat codeert voor een essentieel faageiwit. In 
dit hoofdstuk wordt verder aangetoond dat de amber mutatie 
in gen IX niet gecomplementeerd kan worden door fagen die 
een amber mutatie bezitten in gen VII of in gen V wat erop 
wijst dat de genen V VII en IX in de vorm van een operon 
voorkomen. 
Het operon-model, zoals dat is afgeleid uit onze 
genetische complementatie-expenmenten, kon bevestigd wor­
den door onze studies in Е.соіг minicellen (Hoofdstuk V ) . 
In dit systeem, welke de situatie in de geïnfecteerde cel 
weerspiegelt, kon de synthese van gen VII- en gen IX-eiwit 
aangetoond worden. Daarnaast werd gevonden datE.coit mini-
cellen die faag DNA bevatten met een amber mutatie m de 
genen VII of IX, geen aanleiding gaven tot de synthese van 
deze eiwitten. 
Het translationele regulatiemechanisme dat ten grond-
slag ligt aan de expressie van het gen V-VII-IX operon is 
vervolgens gedetailleerd bestudeerd in een andere gene-
tische omgeving. Hiervoor werden recombinant plasmiden 
geconstrueerd door M13 DNA fragmenten die verschillende ge-
bieden van het betreffende operon bevatten te inserteren 
in het vector-plasmide pBRH2. Onze resultaten aangaande 
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de expressie van deze recombinanten in E.coli minicellen 
en onze gegevens die verkregen zijn uit complementatie-
analyses zijn beschreven in Hoofdstuk VI. De bevindingen 
tonen duidelijk aan dat de synthese van gen VII- en gen IX-
eiwit slechts kan plaatsvinden op een polycistrone bood-
schapper RNA waarop tevens het gen V-cistron is gelegen en 
dat de synthese van gen VII- en gen IX-eiwit direct gekop-
peld is aan de translatie van het gen V cistron. Deze af-
hankelijkheid, "translationele koppeling" genoemd, impli-
ceert dat de ribosoombindingsplaatsen van het gen VII en 
het gen IX niet zonder meer toegankelijk zijn voor nbo-
somen maar dat translatie van deze genen slechts mogelijk 
is door nbosomen die zijn opgestapt op de ribosoombindings-
plaats van het voorafgelegen gen V. 
Deze implicaties zijn meer gedetailleerd bestudeerd 
door gen VII en/of gen IX in verschillende expressie-plas-
miden te subkloneren op een zodanige wijze dat de expressie 
onder regie staat van een sterke externe promoter die in 
het ene geval niet, m het andere geval wel is uitgerust 
met een efficiente nbosoombindingsplaats. De verkregen 
resultaten, zoals weergegeven in Hoofdstuk VII, wijzen 
erop dat de synthese van gen VII- en gen IX-eiwit tot stand 
komt door een translationele reinitiatie gebeurtenis aan 
het einde van het voorafgaande gen. De synthese van zowel 
gen VII- als gen IX-eiwit vindt zeer waarschijnlijk 
slechts dan plaats indien na terminenng het ribosoom de 
polycistrone boodschapper RNA niet geheel verlaat maar, 
nadat een verandering van het 'lees-raam" heeft plaatsge-
vonden, weer kan starten met de translatie van het volgende 
cistron. 
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STELLINGEN 
I 
Uit de -in vitro translatie studies in aanwezigheid van 
ribosome releasing factor concluderen Ryoji et al. ten 
onrechte dat bij elk terminenngscodon in een poly-
cistrone mRNA de nbosomen de mRNA verlaten. 
Ryoji, M., Berland, R. and Kaji, A. (1981) Proc. Natl. 
Acad.Sci. USA 78, 5973-5977. 
Dit proefschrift. 
II 
De verschillen tussen de prokaryotische en eukaryo-
tische eiwitsynthese m aanmerking nemend, lijkt het 
onwaarschijnlijk dat het mechanisme van translatio-
nele reinitiatie ook bij eukaryoten voorkomt. 
III 
De conclusie van Dotto et al. dat in E.ooli cellen die 
zijn geïnfekteerd met amber V mutanten van bacteno-
faag fl, het gen X-eiwit wordt gesynthetiseerd, wordt 
experimenteel op geen enkele wijze ondersteund. 
Dotto, G.P., Enea, V. and Zinder, N.D. (1981) Proc. 
Natl. Acad. Sci. USA 78, 5421-5424. 
IV 
Serotherapie van acute lymfoblastaire leukemie met 
behulp van monoclonale antilichamen heeft slechts 
kans van slagen indien hiermee ook de 'committed' 
stamcellen worden herkend. 
Ritz, J., Pesando, J.M., Sallan, S.E., Clavell, L.A., 
Notis-McConarty, J., Rosenthal, P. and Schlossman, 
S.F. (1981) Blood, SS, 141-152. 
ν 
De bewering van Schlothauer en Alig dat de syndiotak-
ticiteit van PVC sequenties met toenemend acetaat ge­
halte in vmylchloridevinylacetaat kopolymeren afneemt, 
is onjuist. 
Schlothauer, К. and Alig, I. (1981) Polymer Bulletin 
5, 299-303. 
Okada, T., Hashimoto, K. and Ikushige, T. (1981) J. 
of Polymer Science 19, 1821-1834. 
VI 
Het lijkt wenselijk de modellen die zijn opgesteld voor 
DNA-eiwit interacties, waarin verondersteld wordt dat 
het DNA in de B-configuratie aanwezig is, in herover­
weging te nemen nu gebleken is dat het Z-DNA niet 
slechts een organisch-chemisch curiosum is, doch wel 
degelijk biologische significantie heeft, zoals onlangs 
door Nordheim et al. voor de interbanden van de polyteen-
chromosomen van Dvosophila melanogaster aannemelijk is 
gemaakt. 
Nordheim, Α., Pardue, M.L., Lafer, E.M., Moller, Α., 
Stollar, B.D. and Rich, Α. (1981) Nature 294, 417-422. 
VII 
Bij de therapeutische toepassing van biologische pro­
ducten die op basis van de recombinant DNA technology 
via bacteriele cellen worden verkregen, mag men de 
mogelijke schadelijke gevolgen van kleine verontreini­
gingen doch ook afwijkende chemische conformaties van 
deze producten niet onderkennen. 
Vili 
Het enigste winstpunt van verlaging van de maximum 
snelheid van 50 naar 30 km/uur in de bebouwde kom is 
dat men nu inderdaad 50 km/uur gaat rijden. 
IX 
Nu er duidelijk aanwijzingen zijn dat matig alcohol 
gebruik de kans op een hartinfarct verkleint kan de 
overheid met een gerust 'hart' de accijnzen op al-
coholische drank verhogen. 
A.F.M. Simons Nijmegen, 22 april 1982 



